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ABSTRACT 
The X-organ sinus gland complex, situated in the eyestalks of decapod crustaceans, 
are known to be a source of a variety of neuropeptide hormones that regulate a 
number of diverse physiological processes. This neuroendocrine complex was 
investigated in 3 crustacean species, viz. the European shore crab Carcinus maellas, 
and 2 spiny lobster species Jasus lalandii and Panulirus homarus by means of tissue 
immunocytochemistry and an enzyme-linked immunosorbent assay (ELISA). Positive 
immunoreactions, associated with the X-organ - sinus gland system only, were 
obtained with antisera raised against crustacean hyperglycaemic hormone (cHH) of 
. the American lobster (Homarus americanus), the Mexican crayfish (Procambarus 
bouvieri) and the edible crab (Cancer pagurus), as well as with antisera raised against 
vitellogenesis-inhibiting hormone (Vill) of the H. americanus and moult-inhibiting 
hormone (MIH) of C. pagurus. This is the first time that the immunolocalisation of 
these 3 hormones have been studied in a single crustacean species. The chief results of 
this comparative immunocytochemical study showed that (1) neuropeptide hormones 
of the shore crab and the 2 spiny lobster species were sufficiently homologous in 
primary structure to be recognised by the heterologous antisera, thus, an indication of 
conserved peptide structures across the species and infraorder boundaries; (2) 
preabsorbed complexes of purified peptides and antisera from the edible crab did not 
produce any immunoreactions in tissue immunocytochemistry, nor in ELISA, thus, 
indicating the specificity of the anti-cHH and anti-Mill sera; (3) the anti-VIH serum 
demonstrated the ability to bind epitopes on cHH and MIH peptides and is, thus, not a 
specific antiserum in this study; (4) there is co-localisation of cHH, MIH, VIH 
immunoreactivity in the eyestalk neuroendocrine complexes of all 3 species studied 
which suggests that the different peptide hormones can be synthesized in the same 
neuronal cell bodies. This co-localisation of neuropeptides in the eyestalk of J 
lalandii was confirmed by a double-staining immunoflourescence experiment, and 
finally (5) immunoreactivity of antisera raised against cHH of H. americanus and 
MIH ofC. 
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pagurus was associated with distinct and unique peak fractions, following reverse-
phase high pressure liquid chromatographic (RP-HPLC) separation of sinus gland 
extracts from J. lalandii. 
A total of 6 neuropeptide hormones belonging to the cHHIMIHNIH peptide family 
were isolated, functionally characterised and sequenced from extracts of sinus glands 
from the South African west coast rock lobster, Jasus lalandii. This is the first 
complete report on these peptides from any species belonging to the Palinuridae 
infraorder. 
The cHH-family peptides were identified after RP-HPLC by ELISA; analyses using 
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry showed that a single HPLC step yielded sufficiently pure fractions of 
these peptides for sequencing by automated Edman degradation. A novel strategy was 
employed to fully elucidate the primary structures of these large, hydrophobic 
. neuropeptides with their 6 cysteine residues and 3 interconnecting disulfide bridges: 
(1) only native, i.e. non.:..linearised (non-reduced) peptide material was used for initial 
N-terminal sequencing and for generating specifically-cleaved peptide fragments; (2) 
these peptide fragments, arising from digestion with endopeptidases and chemicals, 
were separated on HPLC, analysed by mass spectrometry and sequenced; (3) 
interpretation of the sequence information from these fragments was facilitated by 
knowledge of the N-terminal sequence of the peptide and from overlapping sequence 
information. 
Functional analyses of the cHH-family peptides from J. lalandii were carried out by 
means of biological assays: (1) hyperglycaemia:- a homologous in vivo assay in which 
the concentration of glucose in the haemolymph is measured spectrophotometrically 
before and after injection ofthe purified peptides; (2) moult-inhibition:- a homologous 
in vitro assay in which the effect of the purified peptides on the output of moulting 
hormones (ecdysteroids) from the moulting gland (Y -organ) is assessed by means of a 
competitive enzyme immunoassay (EIA); and (3) vitellogenesis-inhibition:- a 
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heterologous in vitro assay in which the effect of purified peptides on the de novo 
synthesis of peptides in the ovary of a penaeid prawn is detennined by incorporation 
of radiolabeled amino acids into ovarian proteins; this was assessed by radioactivity 
counts of the proteins, as well as by gel electrophoresis coupled with autoradiography. 
Two biologically active hyperglycaemic peptides were isolated from 1. lalandii. Both 
peptides have: (i) a free N-terminus and an amidated C-tenninus, (ii) 72 amino acid 
residues, and (iii) 6 cysteine residues at positions 7, 23, 26, 39, 43 and 52. The major 
isofonn (code-named Jala cHH-I) has a molecular mass of 8380 Da and is present in 
a ratio of 4: 1 relative to the minor isofonn (Jala cHH-II) which has a mass of 8357 
Da. The Jala cHHs have 90 % sequence identity. The Jala cHH-I fraction seems to 
consist of homogenous material: the presence of different chiral fonns of this peptide, 
viz. L-Phe3 versus D-Phe3 molecules have been investigated with the aid of synthetic 
peptides, HPLC and mass spectrometry. Only the L-Phe3 fonn of Jala cHH-I was 
isolated. 
Two other peptides, identified as cHHs by ELISA, demonstrated no hyperglycaemic 
activity; their full primary sequence revealed that they were C-tenninally truncated 
fonns of Jala cHH-I and -II. These truncated cHH peptides were also inactive in the 
moult-inhibition and vitellogenesis-inhibition assays, which suggests that the C-
tenninal part of the cHH peptide is important for biological activity. 
A fifth peak of irregular frequency, with cHH immunoreactivity, a molecular mass of 
8389 Da and a less-hydrophobic nature, was partially sequenced up to residue 52; the 
sequence was 100 % identical to Jala cHH-I. It is 'believed that this peak: represents a 
modified fonn of Jala cHH-I in which the methionine (Met) residue at position 71 has 
undergone oxidation. This theory was confinned by carrying out a tryptic digest with 
subsequent mass analyses. 
In a comparative, preliminary study, sinus gland extracts from another South African 
spiny lobster species, Palinurus gilchristii, were passed over HPLC and a putative 
cHH was identified by ELISA. This peptide of mass 8523 Da, was partially sequenced 
(residues 1-30) with 100 % sequence identity to Jala cHH-L It is predicted that amino 
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acid substitutions are likely to occur in the complete sequence that will account for the 
mass difference and chromatographic behaviour of the putative Pagi cHH. It is 
interesting to observe that species of the same infraorder share so much sequence 
identity; this might be a useful indicator of phylogenetic relationships. 
Considerable moult-inhibiting activity was detected in a peak that was 
irnmunochemically also identified as a peptide with MIH antigenic epitopes. This 
peptide (code-named Jata MIH) has 74 amino acid residues, a mass of 9006 Da, a free 
N-terminus and an ami dated C-terminus. The full sequence reveals 6 cysteine residues 
in unique positions for an MIH peptide, viz. 6, 23, 26, 39, 43 and 52. Jala MIH is 40 
% identical to other known MIHs and 30 % identical to the eHHs. 
Jala cHH-I also displayed moult-inhibiting activity. The major eedysteroid in the 
haemolymph of J lalandii appears to be 20-hydroxyecdysone, as established by 
normal-phase (NP) HPLC on haemolymph samples and EIA. The profile of the 
circulating ecdysteroid titre during different stages of the moult cycle of J lalandii is 
presented; the distinction between intermoult, premoult and postmoult is easily made 
on this basis. A dramatic decrease in the ecdysteroid titre is evident in the late-
premoult period (shortly before ecdysis) in eyestalk-ablated spiny lobsters, as well as 
in spiny lobsters with the eyestalks intact. This excludes the role of MIR at this stage 
and argues for negative-feedback from the Y -organ itself, or an extra-eyestalk source 
of MIH. Crude extracts of sinus glands have no inhibitory effect on Y -organs from 
postmoult spiny lobsters (at least, 3-21 days post-ecdysis) and the output of 
ecdysteroids during this time is very low. Again, the level of control over the Y -organ 
at this stage is not resting with MIH. 
VIR activity is not attributable to a unique peptide of 1. lalandii. Jala eRR-II showed 
the strongest inhibitory effect on de novo protein synthesis in the prawn ovary (46% 
inhibition), followed by the Met-oxidised Jala cHH-I (34 %) and Jala cRR-I (27 % 
inhibition). Jala MIR had only a slight effect (15 % inhibition) in this assay and the 
truncated cRRs had no effect. General protein synthesis was inhibited in these assays 
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and not exclusively the synthesis of vitellin. 
Non-cHH-family peptides were repurified and isolated from the less-hydrophobic 
RPLC fractions that resulted from separation of hydrophobic peptides from crude 
extracts of 1. lalandii sinus glands. A total of 5 peptide sequences were elucidated. 
One of these is the red pigment-concentrating hormone (RPCR). This octapeptide 
displayed pigment-concentrating biological activity in a heterologous in vivo assay 
with shrimps. The full elucidation of the primary sequence revealed that this is not a 
novel sequence; in fact, all the crustacean species studied to date, from a variety of 
infraorders, have this same, conserved, RPCR peptide structure. The antagonist to 
RPCR, i.e. pigment-dispersing hormone (PDR), was not detected and isolated in this 
study. It is believed that this peptide hormone is not preserved during the extraction 
procedure. 
Four structures were completely elucidated that are homologous to crustacean 
hyperglycaemic hormone precursor-related peptides (CPRPs). The biological function 
or relevance of these CPRPs .have not yet been determined in any species. The 4 
CPRPs of 1. lalandii eluted as 2 sets of peptides, one set being more hydrophobic than 
the other. The first set of precursor-related peptides (code-named Jala CPRP-l and 
2) eluted as an inseparable doublet and consisted of 32 amino acids with an identical 
amino acid sequence, save for a single substitution at position 18. The second set of 
precursor-related peptides (code-named Jala CPRP-3 and --4) could be completely 
separated; Jala CPRP-3 consists of 29 amino acid residues which are identical to the 
first 29 residues of Jala CPRP-4 which has a total length of 36 amino acid residues. 
The presence of 4 CPRPs implies that 1. lalandii must have 4 eRR precursor 
molecules (preprohormones) and, hence, 4 distinct cRR peptides. Only 2 full-length 
cRRs have been isolated in this study, however, and it is more likely that Jala CPRP-
1 and -2 represent microheterogeneity in the spiny lobster populations and that Jala 
CPRP-3 is a C-terminally truncated form of Jala CPRP-4, not arising naturally. Thus, 
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only 2 CPRPs are present In a J. lalandii individual. This theory was not 
experimentally tested. 
A cDNA library was constructed from RNA extracted from J. lalandii X-organs. 
Specific primers were designed to correspond to the N- and C-terminus of Jala cHH-
1. These primers were used to amplify a 200 bp product by PCR; the sequence of,this 
PCR product is 100 % identical to the partial sequence of Jala cRR -I and is, thus, a 
potential candidate for a probe with which to screen the Jala X-organ library for cRR-
family precursor molecules. 
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1. INTRODUCTION 
1.1. Neurosecretion 
In living organisms, the ability to coordinate the functioning of cells, tissues and 
organs, and to elicit the appropriate physiologicallbiological response to ever-
changing internal and external factors, is paramount for survival. In arthropods this is 
achieved in three ways: (i) the nervous system, in which neurons receive and conduct 
electrical signals to effect a rapid response; (ii) the endocrine system, in which 
secretory cells are grouped together to form ductless glands from which the 
synthesised peptide or steroid hormones are directly released into the circulation to 
effect a relatively slow response in the target organs; (iii) the neuroendocrine system, 
which is a combination of the first 2 systems and thus, consists of secretory neurons 
which transport their peptide hormones rapidly along the axonal tract to the nerve 
terminal endings; these endings are in close proximity to the haemolymph and are 
collectively referred to as a neurohaemal organ, from which the neurohormones are 
released into the general circulation. 
The neuroendocrine system is not unique to arthropods and is shown to exist in many 
metazoan groups, being already present in Cnidaria, the first metazoan group with 
neurons, and in the most recently developed group, the vertebrates (see Gabe, 1966; 
Berlind, 1977; Morris et al., 1978). Since the concept of neurosecretion was first 
formulated in 1928 (see Scharrer, 1990), several neuroendocrine organs have been 
described and studied in vertebrates, as well as in invertebrates. 
1.2. Neurosecretion in decapod crustaceans 
Crustacean preparations have contributed tremendously to the development of 
concepts of neurosecretion (see Scharrer and Scharrer, 1945). Because of their 
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availablity and size, decapod crustaceans have received the most attention In the 
experimental study of neurosecretion In crustaceans. In decapod crustaceans, 
neurosecretory cells are located in the cerebral ganglia, eyestalk, sub-oesophageal 
ganglia and thioughout the thoracic and abdominal ganglia, whereas the three main 
neurohaemal organs are the post-commissural organs, the pericardial organs and the 
sinus gland (see Cooke and Sullivan, 1982). 
The most extensively studied neuroendocrine complex in decapod crustaceans is the 
so-called X-organ - sinus gland system which is located in the eyestalks. The X-organ 
(XO) is the collective name given by Bellonci in 1882 to a group of neurons, of then-
unknown function (see Gabe, 1966). Situated in one of the four optic ganglia, viz. the 
medulla terrninalis, these neurosecretory neurons synthesise peptide hormones which 
are stored in the sinus gland (SG), so-named because the nerve endings of the XO 
abuts onto a large haemolymph sinus. From eyestalk ablation studies, extirpation of 
the SG and reimp.lantation studies, early, experimental biologists deduced that the XO-
SG complex was a source of hormones that influenced major physiological processes 
in crustaceans (see Kleinholz and Keller, 1979). Despite many of these biologists not 
taking into account the side-effects brought about by the actual surgery, a number of 
important conclusions were reached which has set' the basis for on-going research into 
the inventory of neuropeptide hormones from the XO-SG complex. Information about 
the role of neuropeptides in the eyestalk was also gained from observations following 
the injection of crude extracts of eyestalks into test animals. 
From these early, rather crude ways of experimentation, it became evident that the 
eyestalk contained factors that affected several physiological processes, such as 
movement of pigments, glucose metabolism, moulting and reproduction. More 
recently, however, with increasingly sophisticated technology available, such as high 
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pressure liquid chromatography (HPLC), mass spectrometry, improvements in peptide 
chemistry (especially micro sequencing and peptide synthesis), it became easier to 
purify and sequence neuropeptides from the neuroendocrine organs. Improved 
biological assays and the sensitivity and ease of immunological methods, also assisted 
in identifying and characterising neuropeptides and has led to the burgeoning of the 
field of invertebrate neuroendocrinology. Further, the more recent application of 
molecular biological techniques has provided important information about· the 
preprohormone structures, give.n insights into the expression of the hormones during 
development, and has provided biologists with another set of "tools" with which to 
manipulate and study the crustacean neuropeptide hormones. 
1.3. Hormones from the XO-SG system 
1.3.1. Chromatophorotropins 
Many crustaceans are able to change their body colour to adapt to their background 
surroundings. This adaptation is accomplished by the differential movement of 
pigment granules III chromatophores ( specialised pigment cells). 
Chromatophorotropins are neuropeptide hormones from the XO-SG complex which 
affect this pigment migration in the chromatophores of the epidermis and the 
ommatidia (Josefsson, 1983). The colour change is quickly effected (within minutes), 
is reversible and under the control of two antagonistic neurohormones. 
Red pigment-concentrating hormone (RPCH). RPCH causes the aggregation of 
pigment in the epidermal cells, which results in an overall blanching effect. RPCH 
was purified from the prawn Pandalus borealis and was the first invertebrate 
neuropeptide hormone to be fully sequenced; its primary structure was determined as: 
pQLNFSPGWamide (Fernlund and Josefsson, 1972). This octapeptide seems to be 
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highly conserved in a range of crustacean species and infraorders with no change in 
the primary structure of RPCH peptides isolated thus :far in species of crab, crayfish, 
prawn and shrimp (Table 1). 
By comparing the structure of RPCH with neuropeptides elucidated from an insect 
species, it became clear that the crustacean RPCH is homologous to the metabolic 
neurohormones of insects, the so-called adipokinetichormones (AKH; Mordue and 
Stone, 1976; Gade, 1997). Based on the high degree of structural homology between 
RPCH and the octapeptide AKHs, especially the pQI, F4 and W8amide, a family of 
structurally related peptides was recognised and is called the RPCHI AKH peptide 
family (see Gade, 1997). Whereas there is only one RPCH peptide of conserved 
primary structure in all crustaceans, the AKHs in insects are present as multiple 
isoforms with variable primary structures (see Table 1). 
Table 1. Primary structures of select members of the RPCHIAKH peptide family from 
arthropods. Substitutions are indicated in bold letters. For more AKHstructures, see 
Gade (1997). 
SPECIES 
RPCH*: 
Pandalus borealisl , Cancer magister2, 
Carcinus maenai, Orconectes limosui, 
Penaeus japonicul 
Variants of AKH: 
SEQUENCE 
pQLNFSPGW-NH2 
Locusta migratoria (Lom-AKH-II) pQLNFSAGW-NH2 
Schistocerca gregaria (Scg-AKH-III) pQLNFSTGW-NH2 
Onitis aygulus (Ona-CC) pQYNFSTGW-NH2 
Melolontha melolontha (Mem-CC) pQLNYSPDW-NH2 
* Peptides with identical amino acid compositions and with RPCH biological activity 
have been isolated but not sequenced from a further 7 crustacean species (see Gaus et 
aI., 1990). 
IFernlund and Josefsson, 1972; 2Gaus et al., 1990; 3Yang et al., 1999. 
Application of the polymerase chain reaction (PCR) was successfully used to 
characterise a preproRPCH from a cDNA library constructed from the XO of the 
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European shore crab, Carcinus maenas (Linck et ai., 1993) and the blue crab, 
Callinectes sapidus (Klein et al., 1995). The preprohormone structure of RPCH 
consists of a 25 amino acid signal peptide, the octapeptide RPCH and a RPCH~ 
precursor-related peptide (RPRP) of 74 amino acid residues. This structural 
organisation (see Fig. 1) of preproRPCH is similar to that of the preprohormone of the 
insect AKHs, for example, in the locusts Locusta migratoria and Schistocerca 
gregaria there is a 22-mer signal peptide, the sequence for the AKH peptide and a 61-
63 amino acid AKH-precursor-related peptide (APRP; 0' Shea and Rayne, 1992). 
There is, however, very low homology between the RPRPs and the APRPs (O'Shea 
and Rayne, 1992; Gade, 1996). 
Pigment-dispersing hormone (PDH). PDH works antagonistically to RPCH to 
disperse the pigment in the chromatophores and the ommatidial cells of the retina, 
with a nett darkening effect of the epidermis and the eyes. Fernlund (1976) was the 
first to isolate and sequence a PDH, then referred to as DRPH (distal retinal pigment 
hormone), from the prawn Pandalus borealis (Table 2). PDH has since been 
elucidated from a number of crustacean species; a few amino acid substitutions have 
occurred in the octadecapeptide structure (Table 2). This has given rise to the 
classification of PDHs into 2 groups, viz. a-PDH which is prevalent in pandalid 
shrimps, and P-PDH which is more widely distributed (crabs, crayfish, penaeid 
prawns) (see Rao and Riehm, 1993; Desmoucelles-Carette et al., 1996; Yang et al., 
1999). 
Neuropeptides with pigment-dispersing activities have also been characterised in 
insects as pigment-dispersing factors (PDF; Table 2), which are structurally 
homologous to the crustacean PDHs (Rao et al., 1987). Thus, PDHs and PDFs are 
considered to be members of a neuropeptide family common to arthropods, viz. the 
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PDHlPDF family (Rao and Riehm, 1988). Although the function of PDH has been 
clearly established as a chromatophorotropin in crustaceans, the role of PDF in insects 
is not yet known. 
Table 2. Primary structures of the PDHlPDF peptide family from arthropods. Substitutions are 
indicated in bold letters. 
Variants of a-PDR: 
P andalus borealis1, P andalus jordani2 
Pandalus jordan;] 
NSGMINSILGIPRVMTEA-NHz 
NSGMINSILGIPKVMADA-NHz 
Variants of f)-PDR: 
Uca pugiiato'?, Cancer magister4, Callinectes sapidus5, NSELINS ILGLPKVM:NDA-NHz 
Pacifastacus leniusculus6 
Procambarus clarkil, Orconectes immunis6 , Orconectes NSELINSILGLPKVMNEA-NHz 
limosus8 
Penaeus aztecul, Penaeus vannamei iO 
Pandalus jordani3 
Penaeus vannamei Ilo 
Penaeus japonicus III 
Penaeus japomcus IJll 
Callinectes sapidus Ii 
fusect PDFs: 
NSELINSLLGJ:PKVM:NDA-NH2 
NSELINSLLGLPKVMTDA-NH2 
NSELINSLLGLP~rnDA-NH2 
NSELINSLLGJ:PKVMTDA-NH2 
NSELINSLLGLPKFMIDA-NH2 
NSELINSLLGISALMNEA-NHz 
Periplaneta americana12 NSELINSLLGLPKVLNDA- NHz 
Acheta domesticus6 NSEJ:INSLLGLPKVLNDA-NH2 
Romolea microptera13 NSEJ:INSLLGLPKLLNDA-NHz 
Carausius morosu!4 NSELINSLLALPKVLNDA-NHz 
!Femlund, 1976; 2Raoetal., 1989; JRaoetal., 1985; 'XleinhoIzetal., 1986; 5j(jeinetal., 1994; iiRao 
and Riehm, 1993; 1McCallum et al., 1991; SOe Kleijn et al., 1993; !'phillips et al., 1988; 
llloesmoucelles-Carette et ai., 1996; lIYang et aI., 1999; 12Mohrherr et al., 1991; 13Rao et aZ., 1987; 
14Mohrherr et aZ., 1994. 
Preprohormone structures of crustacean PDHs have been characterised in C. maenas 
(Klein et at, 1992), the crayfish Orconectes limosus (De Kleijn et ai., 1993), 
Callinectes sapidus (Klein et al., 1994) and the 'white shrimp Penaeus vannamei 
(Desmoucelles-Carette et al., 1996). All of these preproPDHs consist of a signal 
peptide, a PDH-precursor-related peptide (pPRP) and the PDH peptide (Fig. 1). As in 
the case of preproRPCH, the physiological role of the precursor-related peptide of 
preproPDHis also unknown (De Kleijn and Van Herp, 1995) .. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
RPCH Signal peptide (25) I RPCB (8) G K RPRP (74) R 
I 
K 
AKH Signal peptide (19-22) AKH (8-10) G R APRP (34-63) 
! 
PDH Signal peptide (21-23) PPRP (32-34) 
K 
PDB (18) lG R 
I 
cHH Signal peptide (24-26) , CPRP(J5-38) K cHH (72-73) G R 
i 
. NITHI~ __ S_i~ __ al_p_ep_t_id_e_(2_5_-3_5)~1 _______ NITH __. _(_77_-7_8_) ______ ~ 
vrnl 
Morn I (Capa) 
ITP 
Morn 
(Liem) 
I 
Signal peptide (29-31) I 
Signal peptide (35) 
Signal peptide (23) 
Signal peptide (26) 
vrn (78-83) 
MOrn (78) 
IPRP (30) K ITP (72) G R 
MPRP (34) K MOrn (72) G 
R 
Fig. 1. Schematic diagram of the preprohormone structures of various decapod 
crustacean neuropeptides from the X-organ, as well as from an isopod and 
insects. The number of amino acid residues is indicated in brackets. One-letter 
code for amino acids is used to denote the dibasic cleavage site (K = lysine; R 
arginine) and the amidation signal (G = glycine). Capa = Cancer pagurus; 
Liem = Libinia emarginata 
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1.3.2. Crustacean hyperg(vcaemic hormone (eBB) 
The injection of crude extracts of eyestalks into C. sapidus by Abramowitz et al. 
(1944), gave rise to an increase in blood glucose concentration, and this effect was 
ascribed to the presence of a "diabetogenic factor" in crustacean eyestalks. This 
hyperglycaemic factor was later shown to be a peptide neurohormone, which 
primarily mobilises glycogen from the hepatopancreas and abdominal muscle tissue to 
result in an elevated blood glucose concentration (Sedlmeier, 1985). Because of the 
relative ease with which hyperglycaemic bioassays can be conducted in vivo and the 
high abundance of cHH in the sinus gland (see Keller and Wunderer 1978), this 
peptide became the most extensively studied of the crustacean hormones in a number 
of different species. Comparative immunological and biological studies of cHH in 
different decapod crustaceans have provided evidence that this hormone exhibits 
specificity of activity within certain groups of crustaceans (Kleinholz and Keller 
1973). Differences in the electrophoretic mobility of cHH from different taxonomic 
groups '(Keller 1977), and results from immunodiffusion, immunoelectrophoresis and 
cross-injection studies (Leuven et al. 1982) all pointed towards group-specificity of 
cHH at the level of superfamily. This was further investigated with a more sensitive 
method, viz. tissue immunocytochemistry (Gorgels-Kallen et al. 1982), in which a 
positive immunoreaction was shown in several astacideans (crayfish and clawed 
lobsters), a palinuran (spiny lobster) and a caridean (shrimp) with anti-Astacus 
leptodactylus (crayfish) cHH serum. They could, however, not demonstrate a stable 
and clear immunoreaction in brachyuran (true crab) tissue; but their study nonetheless 
showed that cHH is not strictly group-specific on an immunological basis. 
The primary sequence of a cHH was first determined from the crab, C. maenas (Kegel 
el al., 1989). Since then, the amino acid sequence of cHH has been determined from 
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11 decapod crustacean species and one isopod species; a high degree of identity exists 
between the different cHHs (see Fig. 2). In all the decapod crustacean species studied 
to date, cHH is present in multiple forms as a 72 amino acid long peptide. The 
different isoforms of cHH may result either from genetic variation, post-translational 
modifications, or a combination of both. In the case of brachyurans, the two isoforms 
differ only by one residue at the N-terminus: a pyroglutamate (pGlu) versus a 
glutamine (GIn) residue in the other (Chung and Webster, 1996; Chung et aI., 1998). 
In all the astacideans investigated, thus far, the cHH isoforms are N-terminally 
blocked by pGlu (Kegel et aI., 1991; Huberman et al., 1993; De Kleijn et aI., 1994a) 
and, in most species, differ from each other in conformation only; that is, the L-Phe3 
residue undergoes stereoinversion to a D-Phe3 residue (Aguilar ef ai" 1995, Van Herp, 
1998). Two exceptions are the American lobster, Homanls americanus, and the 
swamp crayfish, Procambarus clarkii, where two sets of two isoforms of cHH have 
been reported. In the former species, two distinct cHHs are 90 % identical to each 
other and result from two different genes; each of these cHH isoforms undergo 
stereoinversion to give rise to a further two cHH isoforms (Tensen et aI., 1991a; 
Soyez et aI., 1994). In the case of P. clarkii, the two cHH isoforms apparently differ 
only at the N-terminus by pGlu versus GIn (as wa~ observed in brachyurans); each of 
these isoforms then undergo stereoinversion (as is observed with all other astacurans) 
(Yasuda et aI., 1994; Yasuda, 1997). Information on the cHH sequence from penaeids 
(prawn) shows the occurrence of 5 distinct cHH isoforms in the Kuruma prawn, 
Penaeus japonicus, each with a different primary sequence and arising from different 
genes (Yang et al., 1995; 1997); 2 different cHH structures have also been reported in 
Metapenaeus ensis (Gu et al., 2000). All the penaeid cHHs known to date have a free 
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Hoam eHH-A1 pEV_F_DQA_C_K_G_V _Y_D_RN_L_FK_K_L_D RVCEDCYNLY RKPFVATTCR ENCYSNWVFR D ~IDEYVSNV_Q MV-NH;; 
Hoam eHH-B] pEVFDQACKGV YDRNLFKKLN RVCEDCYNLY RKPFVIVTCR ENCYS~RVFR QCLDDLLMID ~IDEYVSNVQ MV-NH? 
Prbo eHH**2 pEVFDQACKGI YDRAIFKKLD RVCEDCYNLY RKPYVATTCR QNCY~SVFR QCLDDLLLIQ VVDEYI~GVQ TV-NH~ 
Cama eHH-II 3 pEIYDTSCKGV YDRALFND~E HVCDDCYNLY ~TSYVASACR SNCYSNLVFR QCMDDLLMMQ EFDQIARKVQ ____ ~ 
Capa eHH-II 4 pEIYQTSCKGV YDRGLFSDLE HVCDDCYNLY RNSYVASACR SNCYSNVVFR QCMEE~LMMD EFDKIARAVQ MV-NH2 
Peja eHH-VI s LVFDPSCAGV YDRV~LGKLN RLCDDCYNVF REPNVATECR SNCFY~LAFV QCLEYLLPPS LHEEYQANVQ MV-NH2 
Peja eHH-III s SLFDPACTGI YDRQ~LRKLG RLCDDCYNVF REPKVATGCR SNCYHNLIFL DCLEYLIPSH LQE~HMAAMQ TV-NH2 
Maro eHH 6 
Pemo 
Meen eHHBH 
Pesc eHH 9 
Arvu ~urtlO 
LMWPll 
Seq ITpl2 
AILQQSCKGI FDRELFKKLD RVCDDCYNLY RKPYVAIDCR RGCYQ~LVFR QCIQD~Q~MD DLDEYANAVQ TV-NH2 
SLSFRSCT§A YDRE~LVRLD RVCEDCYNVI ~DVGVAAECR SNCFH~EVFL YfVQYMFRPR QRNQ!RAALQ RL-NH2 
SLFDPSCTGV KDRELLGRLN RVCDDCYNVF ~E~KVATECR SHCFLNPAFI QCLEYIIFEV LHEEYQANVQ LV-NH2 
ANFDPSCTGV YDRELLGRLS ~LfDDCYNVF REPKVATECR SNCFYNPVFV QCLEY~IPAD LHEEYQAH~G 
RIFDTSCKGF YDRGLFAQLD RVCEDCYNLY RKPHVAAECR RDCYTTEVFE SCLKDLMMHD FINEYKEMAL MVS-NH? 
ISPADIG~TDI -SQADIDE~N NNCIKfGEDG FGEEMVNRCR DKCFTDNFYQ SCV-DLLNKV YEEKDTPPVQ E 
SFFDIQCKGV YDKSIFARLD RICEDCYNLF RE~QLHSLCR SDCFKSPYFK GCLQALLLIQ EEEKFNQMVE IL-NH2 
Fig. 2. Comparison of the amino acid sequences of cHHs from three different decapod crustacean infraorders, viz. Astacidae: II lomarus american us (Tensen et aI., 
1991a) and 2Procambarus bouvieri (A,!,'1lilar et a/., 1995 ); Brachyura: 3Carcinus maenas (Kegel et al., 1989) and 4Cancer pagurus (Chung et 01., 1998), and 
Penaedae: 5Penaeusjaponicus (Yang et al., 1997), 6Machrobrachium rosenbergii (Sithigorngul et ai., 1999a,b), 7Penaeus monodon (Udomkit et a/., 20(0), 
8Metapenaeus ensis (Gu et al., 2000; # deduced from nucleotide sequence) and 9Penaeus schmitti (Huberman et 01., 20(0); and an isopod species: IOArmidillidium 
vulgare (Martin e/ a/., 1993). Aligned with the cHH sequences are related sequences from other non-crustacean arthropods: II Low molecular weight protein 
(Gasparini et ai., (994) and 12Schistocerca gregaria ion-transporting peptide (Meredith et al., 1996). Similarities between all the different sequences are underlined. 
"''''TIle cHH sequence of P. houvieri is identical to that of Procambarus clarkii, and cHH from Orconectes Iimosus differs from Otis by only one residue 
c 
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N-terminus and a blocked C-terminus; (Sefiani et al., 1996; Yasuda, 1997; 
Sithigorngul et al., 1999a; Udomkit et al., 2000; Huberman et al., 2000). 
Characteristically, cHHs have (i) 6 cysteine residues at conserved positions with three 
disulfide bridges assigned between them: C7_C43 , C23_C39 and C26_C52 ; (ii) a chain 
length of 72 amino acid residues and, (iii) a molecular mass of between 8000 and 
9000 Da (see Van Herp, 1998). The application of molecular biological techniques, 
such as cDNA cloning and PCR, has resulted in the elucidation of the preprohormone 
structure of several cHHs. Reports on preprocHH from C. maenas (yVeidemann et aI., 
1989), 0. limosus (De Kleijn et al., 1994a), H. americanus (De Kleijn et aI., 1995), P. 
japonicus (Ohira et aI., 1997a) have shown a common structural organisation of a 
signal peptide flanked by a cHH-precursor-related peptide (CPRP), followed by the 
cHH peptide (Fig. 1). CPRPs were also isolated from sinus glands of C. maenas, 0. 
limosus, H. americanus (T ensen et aI., 1991 b) and the edible crab Cancer pagurus 
(Chung et al., 1998). Despite attempts to functionally characterise the CPRPs, their 
physiological relevance is still not understood. 
In recent studies, it has been shown that the eyestalk is not the sole source of cHH in 
decapod crustaceans. cHH gene expression in the ventral nerve cord of H. americanus 
(De Kleijn et aI., 1995) and cHH immunoreactivity in the brain, thoracic ganglion and 
pericardial organs of C. maenas (Keller et al., 1985; Dircksen and Heyn, 1998) were 
reported. More recently, cHH and CPRP immunoreactivity was detected in gut 
endocrine cells of C. maenas (yVebster et al., 2000), and in a pair of cells in the 
suboesophageal ganglion and in the thoracic ganglia of H. americanus (Chang et al., 
1999). The function of this extra-eyestalk cHH in C. maenas appears to be related to 
ecdysis; a transient surge of cHH (also observed in eyestalk-ablated animals) has been 
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recorded during the initial stages of ecdysis and is very likely stimulating the uptake 
of water (Chungetal., 1999). 
1.3.3. Moult-inhibiting hormone (MIH) 
From the early, classical physiological experiments, such as eyestalk ablation and 
implantation, it was observed that eyestalk ablation often but not always resulted in a 
shortened intermoult period and hence, in a precocious ecdysis (see Chang, 1995). It 
was thus concluded that the eyestalk, and specifically the XO-SG complex, is the 
source of a moult-inhibiting factor, which is effective in suppressing the 
synthesis/secretion of moulting hormones (ecdysteroids) from the moulting glands (Y-
organs; Passano, 1953). Despite this early discovery of a putative moult-inhibiting 
hormone, it took many decades to isolate and charac:terise an Mill due to the paucity 
of reliable, convenient and sensitive biological assays. The development of an in vitro 
bioassay, which measured the inhibition of ecdysteroid synthesis by isolated Y-organs . 
after the addition of crude extracts of sinus glands, was a crucial event for progress in 
the isolation of Mill (Soumoffand O'Connor, 1982). Isolation, characterisation and 
sequence elucidation of Mill from C. maenas was eventually realised 0N ebster, 1986; 
Webster and Keller, 1986; Webster, 1991). Before this, a peptide with Mlli activity 
from H amertcanus was reported (Chang et aI., 1987, 1990). This sequence, however, 
was later found to be incomplete and the "MIH" peptide is now considered to be one 
of the lobster's hyperglycaeroic hormones, viz. cHH A (Tens en et al., 1991a; Chang, 
1995). 
Because the H american us cHH also had MI!f biological activity and, the absence of 
a unique peptide with sole Mill activity in the lobster, this led to the idea that only 
brachyurans possessed distinct cHH and MIH molecules (Chung et al., 1996). During 
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the past decade, however, several reports have been published on the pnmary 
structure of lvlIH from different crustacean species and infraorders (Aguilar et aI., 
1996; Yang et at., 1996; Nagasawa et al., 1996; Chung et al., 1996) The different 
MIH peptides are homologous in structure to one another, and also to dill peptides 
(see Fig. 3). Despite the structural similarities,. however, none of the isolated :t\fIH~ 
could induce hyperglycaemia, whereas the corresponding cHH molecules were 
capable of suppressing ecdysteroid titres in in vitro bioassays (yl ebster and Keller, 
1986; Chung et al., 1996; Yang, et al., 1996). 
Characteristic of most of the MIHs to date, is (i) the presence of 6 cysteine residues 
and their connecting disulfide bridges: C7_C44, C24_C40, C27_C53; (ii) a molecular mass 
of more than 9000 Da and, (iii)' a chain length of more than 72 amino acid residues 
(see Webster, 1998 for review). Of the 5 isolated and sequenced MIH neuropeptides, 
one, viz. MIH from the Mexican crayfish Procambarus bouvieri, has the primary 
structure which is characteristic of the cHH peptides (compare Fig. 2 with Fig.3). This 
MIH.is 90 % homologous to the cHH from P. bouvieri, yet it is claimed not to display 
any hyperglycaemic activity (Aguilar et al., 1996). Several putative MIH peptide 
sequences have also been deduced from nucleotide sequences following cDNA 
cloning, for example MIH from C. maenas (Klein et al., 1993b), P. vannamei (Sun, 
1994), C. sapidus (Lee et al., 1995), P. japonicus (Ohira et al., 1997b), the sand 
shrimp Metapenaeus ensis (Gu and Chan, 1998), the crab Charybdisferiatus (Chan et 
al., 1998) and the Dungeness crab Cancer magister (Umphrey et al., 1998). All of 
these preproMIHs, except one, showed the same organisation, viz. a signal peptide 
followed by the MIH peptide, thus lacking a precursor-related peptide (see Fig. 1). 
The exception to this rule, viz. the MIH of P. vannamei, consists of a signal peptide, a 
precursor-related peptide and the putative MIH sequence (Sun, 1994). Since the MIH 
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RYVFEECPGVMGNRAVHGKVTRVCEDCYNVFRDTDVLAGCRKGCFSSEMFKLCLLAMERVEEFPDFKRWIGILNA-NHz 
Casa 2 *: RVINDDCPNLIGNRDLYKKVEWICDDCANIYRSTGMASLCRKDCFFNEDFLWCVRATERSSDLAQLKQWVTILGAGRI 
Cama 3 : RVINDECPNLIGNRDLYKKVEWICEDCSNIFRKTGMASLCRRNCFFNEDFLWCVHATERSEELRDLEEWVGILGAGRD 
Capa 4 : RVINDDCPNLIGNRDLYKKVEWICEDCSNIFRNTGMATLCRKNCFFNEDFLWCVYATERTEEMS QLRQWVGI LGAGRE 
*: RVINDDCPNLMGNRDLYKKVEWICDDCANIYRI TGMAS LCRKDCFFN FDFLWCVRATFRS FD MTQLKQWVRILGAGRI 
Camag6 *: RVINDDCPNLIGNRDLYKRVEWICEDCSNIFRNTGMATLCRKNCFFNEDFLWCVYATERTEEMSQLRQWVGILGAGRE 
Peja 7 : SFIDNTCRGVMGNRDYNKKVVRVCEDCTNIFRLPGLDGMCRNRCFYNEWFLICLKA-NREDEIEKFRVWISILNAGQ 
Meen8 *: SYIENTCRGVMGNRDIYKKVVRVCEDCTNIFRLPGLDGMCRDRCFNNEWFLVCLKAANRDDELDKFKVWISILNPGL 
Prbo9 : pEVFDQACKG-IYDRAIFKKLELVCDDCYNLYRKPKVATTCRENCYANSVFRQCLDDLLLINVVDEYISGVQIV-NH2 
Peva 10 *: DTFDHSCKG-IYDRELFRKLDRVCEDCYNVFREPKVATECKSNCFVNKRFNVCV-ADLRHDVSRFLKMANSALS 
Fig. 3. Comparative alignment of the peptide structure of putative MIHs from tlle different decapod crustacean infraorders. Astacidae: I 
Procambarus clarkii (Nagasawa et al., 1996), and 9p. bouvieri (Aguilar et af., 1996); Penaediae: 7Penaeusjaponicus (Yang et al., 1996), 
8!.!etapenaeus ens;s (Gu and Chan, 1998) and lOp. vannamei (Sun, 1994); and Brachyura: 2Callinectes sapidus (Lee et al., 1995), 3Carcinus 
maenas (Webster, 1991), 4Cancer pagurus (Chung et ai., 1996), 5Charybdisjeriatus (Chan et al., 1998) and 6Cancer magister (Umphrey et aI., 
1998). Identical amino acid residues, Witll reference to the brachyuran MlHs, are shown in bold. TIle (-) indicates tlle gap(s) introduced into the 
amino acid sequence to align tlle Cys residues and to allow for maximal identity. Amidation is shown by: -NH2• Note: not all of the primary 
structures have been obtained from purified peptides; some have been deduced from nucleotide sequences (*) only. 
.j.. 
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peptide of P. vannamei was never isolated from the sinus glands and, therefore, has 
also not been functionally characterised, it may be argued that this preprohormone 
sequence represents a cffrI and not MlH. 
The purification of MlH peptides made it possible to generate very specific antisera 
with which to investigate the neurosecretory system immunocytochemically. Antisera 
raised against MlH of C. maenas localised MlH-producing cells in the X-organ of 5 
brachyuran crab species (Dircksen et al., 1988). Double-staining techniques w.ith 
antisera against MlH and cffrI of C. . maenas did not show co-localisation of these 2 
peptides in the brachyuran species studied but demonstrated 2 distinct neurosecretory 
pathways within the XO-SG complex (Dircksen et aI., 1988). This was confirmed by 
in situ hybridisation studies with cRNA probes for C. maenas cffrI and -r...1IH which 
clearly showed that cffrI mRNA did not co-localise with MlH mRNA in the XO of C. 
maenas (Klein et aI., 1 993a). In P. japonicus, however, some neurons of the XO 
showed co-localisation of cffrI and MlH peptides (Shih et al., 1998). For this 
immunocytochemical study, the specific cffrI and MlH antisera were raised against 
synthetic partial peptide sequences corresponding to the C-terrninal decapeptide 
sequences of the cffrI and MlH, respectively, of P. japonicus due to the low sequence 
ide~tity of the 2 peptides in this region of the molecule (Shih et al., 1998). 
1.3.4. Vitellogenesis-inhibiting hormone (VIR) 
The control of reproduction in crustaceans has mostly concentrated on the regulation 
of female reproduction, specifically, the process of vitellogenesis. Various stages in 
the development of the oocytes in female crustaceans have been described (see Van 
Herp and Soyez, 1997). Briefly, previtellogenic oocytes arise from cell divisions 
(mitotic and meiotic) of undifferentiated gonia. During previtellogenesis (or primary 
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vitellogenesis), ribosomes accumulate and the rough endoplasmic reticulum develops 
in the growing oocyte, which is surrounded by follicle cells. Fully-grown 
previtellogenic oocytes enter a vitellogenesis cycle (secondary vitellogenesis) during 
the reproductive season by the development of microvilli. Secondary vitellogenesis 
involves the accumulation of yolk proteins into the oocytes, which will sustain the 
developing embryollarva after hatching. The lipoprotein, vitellin (Vt), is a chief 
component of the yolk (Browdy et al., 1990) and a relatted protein, vitellogenin (V g), 
has also been detected in crustaceans during ovarian development (Shafir et ai., 
1992); the hepatopancreas is capable of produCing this extra-ovarian source of yolk 
protein (Quackenbush, 1999). At this time, the follicle cells form a network that 
supports the massive uptake by the oocytes of V g from the haemolymph via 
endocytosis. The absorbed Vg is transformed to Vt; in penaeid prawns, there is also 
an intra-ovarian source of vitellin (Fainzilber et al., 1992; Khayat et al., 1994). The 
disappearance of the microvilli marks the end of vitellogenesis. This is followed by 
the breakdown of the germinal vesicle, resumption of meiosis and a period of 
maturation which culminates with egg-laying (see Van Herp and Soyez, 1997). In 
many instances, eyestalk-ablation experiments resuitl;!d in accelerated secondary 
vitellogenesis in female crustaceans (see Adiyodi and Adiyodi, 1970). It was, 
therefore, concluded that the eyestalk housed a vitellogenesis-inhibiting hormone. 
Like MIH, the isolation and characterisation of VIH has been' severely hampered by 
the absence of suitable, rapid and sensitive biological assays. The first VIH was 
isolated from sinus glands of H. americanus by using a heterologous in vivo assay 
which measured the retardation of oocyte growth in the shrimp Palaemonetes varians 
after injection of HPLC-purified fractions (Soyez et al., 1987). Vitellogenesis is 
prolonged in most large decapod crustaceans with egg-laying occurring once on an 
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annual basis only, it is, therefore, not easy to develop an ill vivo assay in homologous 
systems of lobsters and crayfish; a much shorter reproductive cycle occur in prawns 
and shrimps. The primary structure of Vlli from H. americanus was elucidated by 
conventional microsequencing and found to be a peptide with remarkable homology 
to .M1H and cHH from other crustaceans (Soyez et al., 1991). H. americanlls Vlli is a 
78 residue peptide with a molecular mass of more than 9000 Da and 6 cysteine 
residues with at positions 10, 27, 30, 43, 47 and 56 (see Fig. 4). Like H. americanlls 
cHH, the lobster vrn was found as 2 isoforms of identical sequence and mass, but 
only one of these isoforms had Vlli biological activity (Soyez et al., 1991). A sinus 
gland neuropeptide, isolated from P. bOllvieri also demonstrated vrn capabilities in 
the prawn Penaeus setiferus as· measured in vitro by the inhibited incorporation of 3H-
labeled leucine into yolk proteins after treatment with sinus gland fractions (Aguilar et 
al., 1992). This bioactivity was, however, obtained with an unphysiologically high 
dose of 10 SGE; the primary structure of P: bouvieri vrn is omy partially elucidated 
(Fig. 4) with a molecular mass of 8388 Da; the position of the Cys residues are 
identical to the arrangement in the cHH molecules. A vrn peptide has recently been 
functionally characterised and fully sequenced from the isopod Armidillidium vulgare 
(Greve et al., 1999). The functional characterisation of the isopod vrn was based on 
(i) an in vitro vitellogenin immunoprecipitation assay and, (ii) an in vivo bioassay 
based on the delay of the onset of vitellogenesis as determined by the nature of the 
moult (normal versus parturial moult, i.e. with egg laying observed in the breeding 
pouch of the latter moult). The isopod vrn is an 83 residue peptide with a molecular 
mass of 9485 Da and 6 Cys residues at positions 15, 32, 35, 48, 52 and 61; this 
peptide did not induce hyperglycaemia in vivo, nor did it prolong the intermoult 
period after conspecific injections (Greve et aI., 1999). 
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Hoam VIH1: ------ASAWFTNDECPGVMGNRDLYEKVAWVCNDCANI FRNNDVGVMCKKDCFHTMWFLWCVYATERHGEI DQFRKWVS ILR 
Arvu VIH2: YNIPLGWGRRDMPGCLGVLGNRDLYDDVSRICSDCQNVFRDKNVESKCRSDCFSTSYFETCIMALDLAEKISDYKLHASILKE 
Prbo VIH3: ----------pEVFDQACKGIYDRAI FKKLELV* * * *YN* * * * * * VAT TCRENCYAN 
Fig. 4. Comparative amino acid sequences of vitellogenesis-inhibiting hormone (VIH) isolated from IHomarus 
americanus (Soyez et al., 1991), 2Armadillidium vulgare (an isopod; Greve et al., 1999) and the partial sequence 
from 3Procambarus bouvieri (Huberman et al., 1995). The 6 Cys residues are indicated in bold; the asterisk (*) 
shows the incomplete sequence; gaps (-) have been introduced to align the sequences for maximal sequence 
identity and identical residues between Hoam and Arvu VIH are also indicated by bold letters. 
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Information on the preprohormone structure of Vlli has also been obtained. cDNA 
which encodes Vlli in H american us has been cloned and sequenced. The structure 
of prepro Vlli consists of a signal peptide and the Vlli peptide itself (De Kleijn et al., 
1994b), thus showing the same organisation as the MlH preprohormones. This 
organisation of a Vlli preprohormone (Fig. 1) was also reported for a putative Vlli 
from M ensis, where the signal peptide consisted of 29 amino acid residues and the 
mature peptide of 78 residues (Gu and Chan, 1999). 
Several immunocytochemical studies have been carried out in crustaceans with 
antisera against VIH. Vlli was shown to be localised in the XO-SG complex of H 
american us with a specific antibody to H american us Vlli (Meusy et al., 1987) and 
also with a cRNA probe (Laverdure et al., 1992). The antibody to H american us Vlli 
also cross-reacted with sinus gland extracts of the marine shrimps P. varians and 
Palaemon serratus, the giant freshwater prawn Machrobrachium rosenbergii, and C. 
maenas, and with brain extracts (with the attached sinus gland) of the woodlouse 
(isopod) Porcel/to dilatatus, but did not cross-react with sinus gland extracts of the 
crayfish A. leptodactylus and 0. limosus, nor with the spiny lobster Jasus paulensis 
(Meusy et al., 1987). Co-localisation of cHH and Vlli in the XO of H american us 
was demonstrated by antisera against H american us Vlli and A. leptodactylus cHH 
(Kallen and Meusy, 1989). Only a small subset of the immunoreactive neurons, 
however, showed co-localisation of the 2 peptides. A similar partial co-localisation of 
cHH and Vlli peptide, was observed with specific antisera raised against H 
american us peptides (Meusyand Soyez, 1991; Rotllant et aI., 1993), and was also 
reflected at the mRNA level in Homarus gammarus larvae with cRNA probes 
directed against H american us cHH and Vlli (Rotllant et az', 1993). The same was 
found with partial co-localisation of cHH and Vlli mRNA in H american us (De 
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Kleijn et al., 1992). In another astacidean, the NOlWay lobster Nephrops norvegicus, 
no co-localisation was observed with antisera directed against A. leptodactylus cHH 
and H. american us Vlli (Guilianini et al., 1998). The physiological relevance of co-
localisation and thus, co-secretion of the cHH family peptides is not clear at this stage. 
Although Vlli has been predominantly studied and characterised in female 
crustaceans, there is evidence that this hormone is also present in male specimens (De 
Kleijn et a!., 1992). Vlli is hence, also referred to as GIH (gonad-inhibiting hormone) 
and is considered to have a different, and as yet unknown, role in the male crustaceans 
than in their female counterparts. \ 
1.3.5. Mandibular organ-inhibiting hormone (A10IH) 
The mandibular organs (MO) of decapod crustaceans synthesise and secrete methyl 
farnesoate (MF), a sesquiterpenoid (Laufer et ai." 1987). The exact physiological 
relevance ofMF, however, is still undefined (see Webster, 1998). The fact that MF is 
the unepoxidised precursor of the so-called juvenile hormone ill (JH ill) in insects has 
led to the assumption that, like JH ill, MF also plays a role in reproductive 
development and growth (Laufer et aI., 1993). Indeed, there are some studies that 
support this hypothesised role of MF in crustaceans, whereas others do not (see 
Homola and Chang, 1997; Abdu et aI., 1998). What has been clearly demonstrated 
from eyestalk-ablation studies and injection of extracts of sinus glands, is that 
synthesis of MF by the MO is negatively regulated by a neuropeptide hormone from 
the XO-SG complex. Using an in vitro bioassay to measure the synthesis of MF (by 
incorporation of 3H-methyl methionine) after incubation with sinus gland fractions, 
two peptides with Morn activity were isolated from the edible crab Cancer pagurus 
(Wainwright et al., 1996). The C. pagurus MOIRs consisted of 78 residues with 
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molecular mass of more than 9000 Da and 6 Cys residues with their connecting 
disulfide bridges arranged in the characteristic manner of the 'MIH molecules (Fig. 5) 
These two C. pagurus MOIHs differed from one another by only one substitution at 
position 33. Three peptides from the sinus gland of the spider crab Lihinia emarginata 
were also characterised as MOIHs (Liu and Laufer, 1996). The complete primary 
structure of one of these peptides have been elucidated (Liu et al., 1997b) and it 
resembles cHH more than it does 'MIH or the C. pagurus MOIHs. In addition, the L. 
emargtnata MOIH candidates displayed significant hyperglycaemic effects (Liu and 
Laufer 1996). The difference in peptide structure also extends to the preprohormone 
structure (Fig. 1): preproMOIHs of C. pagurus have the same organisation as 
prepro'MIHs, i.e. signal peptide and hormone sequence (Tang et al., 1999), whereas L. 
emarginata preproMOIH is organised like preprocHHs with signal peptide, PRP and 
hormone sequence (Liu et a!., 1997a). 
1.4. The cHHIMIHIVlH peptide family 
As the primary structure of several neuropeptide hormones from the sinus glands of 
decapod crustaceans became known, it was apparent from sequence homology that 
the cHH, 'MIH, VIH, and later also the MOIH molecules, were all members of one 
peptide hormone family (Keller, 1992; Webster, 1998). For some time, this peptide 
family was considered to be a novel group. of crustacean peptides, until the primary 
structure of a low molecular weight protein (LMWP) was elucidated from venom of 
the black widow spider, Latrodectus mactans tredecimguttatus (Gasparini et a!., 
1994). This LMWP is a 70 amino acid residue peptide with 6 Cys residues and 3 
disulfide bridges that can be aligned with that of cHH (Fig. 2). Although LMWP co-
eluted with the main neurotoxin from the spider venom, it has no toxic effect and its 
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Liem MOIH1 : QIFDPSCKGLYDRGLFSDLEHVCKDCYNLYRNPQVTSACRVNCYSNRVFRQCMEDLLLMEDFDKYARAIQTVGKK 
Capa MOIH2 : RRINNDCQNFIGNRAMYEKVDWICKDCANIFRKDGLLNNCRSNCFYNTEFLWCIDATENTRNKEQLEQWAAILGAGWN 
Fig. 5. Amino acid sequences of mandibular organ-inhibiting hormone (MOIH): I, from Libinia emarginata (Liu et 
al., 1997b) and 2, Cancer pagurus (Wainwright et al., 1996). The 6 Cys residues are indicated in bold; not~ tllat a 
second Capa MOIH is idt;:ntical to the one shown here, except for the substitution ofK33 (underlined) by Q33. 
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function is, as yet, unknown (Gasparini, et al., 1994). More recently, the amino acid 
sequence of an ion transport peptide (ITP), isolated from the neurohaemal organs 
(corpora cardiaca) of the desert locust Schistocerca gregaria, was determined by a 
combination of micro sequencing and molecular biological techniques (Meredith et al., 
1996; Philips et at., 1998). The S. gregaria ITP consists of 72 amino acid residues, a 
mass of 8564 Da, with 6 Cys and 3 disulfide bridges at positions typical for cHHs 
(Fig. 2). The preprohormone of S. gregaria ITP has also been investigated and this is 
organised in the same way as preprocHHs (Philips et at., 1998) (Fig. 1). Comparative 
information gained about the preprohormones of members of the cHHIMIHIVIH 
peptide family, leads to the grouping of the peptides into 2 subsets: (i) cHHfITP and 
(ii) MIH!Vll:I (Lacombe et at.,· 1999). In the first group, the preprohormones are 
organised as a signal peptide, followed by a precursor-related peptide (PRP) and then 
the sequence of the mature peptide. The preprohormones of the second group, on the 
other hand, have only a signal peptide and the mature peptide sequence (see Fig. 1). 
The arrangement of MOIH into the subgroups is equivocal at this stage, since the 
primary structures of two MOIH peptides closely resemble that of the MIHsNIHs 
r:w ainwright et al., 1996), but another putative MOm has the primary structure of the 
cHH peptides (Liu et at., 1997b). The preprohormone structure of the former Mom 
matches that of the MIH!Vll:I subgroup (Tang et at., 1999), while the latter 
preproMOIH is organised in the same manner as peptides belonging to the cHH 
subgroup (Liu et al., 1997a). Until information becomes available on the sequences of 
MOIH peptides from other crustaceans, and their preprohormone structures, it is 
tempting to dismiss the L. emarginata MOIH as primarily being a cHH, especially 
since cHH has been shown to be multifunctional in many crustaceans, e.g. MIH 
activity (Chang et aI., 1990), gonad-stimulating activity (specifically, stimulation of 
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oocyte growth; Tensen et al., 1989), MOIH activity (i.e. inhibitory effect on l'v1F 
synthesis by the MO; Laufer et al., 1994), secretagogue activity (Sedlmeier, 1988), 
inhibition of protein and mRNA synthesis in ovaries of vitellogenic females (Khayat 
et al., 1998) and involvement in osmoregulatory processes (Charmantier-Daures et 
al., 1994). 
Although not all the isolated members of the cHH!MlHlVIH peptide family have been 
tested for different biological activities, it can be expected from the literature to date, 
that some, if not all, of these peptides are multifunctional. Furthermore, it might be 
possible to speculate about the evolutionary dIstance between different crustacean 
groups, based on the degree of structural homology and functional cross-activities of 
the cHH!MlHlVIH peptide family. 
1.5. Scope and aims of the present study 
Lobsters belonging to the family Palinuridae are called spiny lobsters because of the 
many spines on the carapace and basal segments of the long second antennae (Fig. 
6A,B), and are also referred to as rock lobsters because of their preference to inhabit 
rock crevices on the sea floor. Unlike clawed (true) lobsters, spiny lobsters lack claws 
and live gregariously in relatively shallow waters, 'where rocks are present for shelter 
(Phillips et aI., 1980). Commercially, spiny lobsters are highly valued seafood and 
form the hub of extremely important fisheries in certain countries (Booth and Phillips, 
1994). Due to the ever-increasing demands from the seafood market, however, most 
fisheries are overexploited and to meet these demands, ventures into aquaculture are 
being undertaken; this is, however, not an uncomplicated task and the successes are 
slow in coming (Kittaka and Booth, 1980). 
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Fig. 6. Photographs of adult spiny lobsters, A. Jasus lalandii and B. 
Palinurus gilchristii. C. Distribution ofthe 3 genera of spiny lobsters 
in the oceans surrounding the Republic of South Mrica (RSA); 1= J 
lalandii ; 2= P. gilchristii and 3= Panulirus homarus. 
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South Africa is one of the countries that supports the commercial and subsistence 
fishing of spiny lobsters. Here, the rock lobster industry is largely dependent on the 
exploitation of Jasus lalandii (H. Milne-Edwards), which predominates in the cold 
waters (10-18 DC) of the Atlantic Ocean along the west coast of South Africa (hence, 
this species is also known as the west coast rock lobster; Heydom, 1969). Because of 
its economic importance (export of frozen tails, whole frozen lobsters, whole cooked 
lobsters, and live lobsters to overseas markets: ca 3700t per annum; Pollock 1986), J 
lalandii and the associated lobster industry is locally referred to as "red gold". It is 
believed that the west coast rock lobster fishery is currently valued in excess of R145 
million per annum and provides employment for more than 400 people (Mr P. Foley, 
West Coast Rock Lobster Sea Management Association, pers. comm.). 
Two other spiny lobster species occur in South African waters: (i) the east coast rock 
lobster Panulirus homarus (Linnaeus), which is found in the shallow warm waters of 
the Indian Ocean (20-30 DC), is not of commercial interest and is only fished 
recreationally under strict legislation; (ii) the deep water rock lobster Palinurus 
gilchristii (Stebbing; Fig. 6B) is commercially fished, but on a smaller scale than the 
west coast rock lobster. Because they occur at depths of 100-500 m in the sea, it is not 
ailowed to fish P. gilchristii for recreational or subsistence purposes (Heydom, 1969 
and Cockcroft and Payne, 1997). Figure 6C shows the distribution of these three 
South African spiny lobster species. 
Despite the commercial interest in South African spiny lobsters, there is a severe 
paucity of physiological and biochemical information since most of the research on J 
lalandii has been conducted at an ecological level (see for example Heydom, 1969; 
Griffiths and Seiderer, 1980; Goosen and Cockcroft, 1995; Barkai et aI., 1996). It is 
with this in mind, that the spiny lobster J lalandii has been selected as the 
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experimental animal in the present study. It is hoped that the current study will initiate 
further interest on the cellular, biochemical and molecular levels which will form the 
cornerstones for more applied aspects of research on this valued decapod crustacean. 
The present study has three main objectives. The first is to compile, as complete as 
possible, an inventory of the neuropeptide hormones found in the XO-SG complex of 
the South African spiny lobster species Jasus lalandii, based on HPLC fractionation 
and subsequent biological and immunological assays. The. second objective is to 
characterise the isolated peptides by mass spectrometry and to elucidate their primary 
structures by Edman degradation, in conjunction with enzymatic cleavages and other 
chemical treatments. The third objective is to lay the groundwork for future research 
on this topic at the molecular biology level, It is hoped that comparative 
endocrinologists can use this inventory of XO-SG neuropeptides from 1. la/andii as a 
representative of the Palinuf(l (spiny lobster) infraorder, since other studies have 
focused on Brachyura (true crabs), Astacidea (clawed lobsters and crayfish), Caridea 
(shrimps) and Penaeidae (prawns; classification is according to Bowman and Abele, 
1982). In the present study, brief comparisons with the other South African spiny 
lobsters are also made, with reference to the histological and biochemical aspects of 
the neuroendocrine complex in the eyestalk. 
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2 .. MATERIALS AND METHODS 
2.1. Animals 
Live crustaceans were obtained along the coasts of South Africa, transported on ice to 
the laboratory where they were held in large tanks containing recirculating sea water. 
The ambient temperature in the aquarium was 12-14 °c with a photoperiod of 12 h 
light: 12 h dark. Lobsters and crabs were fed maximally twice a week with pilchards 
and mussels, whereas shrimps were fed ad libitum with dried fish flakes and pieces of 
mussel tissue. Adult and juvenile specimens of Jasus lalandii CJala) (both sexes) 
were collected from various sites in the Atlantic Ocean off the west coast of South 
Africa. Adult specimens of Panulirus homarus (Paho) were collected from the Indian 
Ocean off the east coast of South Africa and were kindly supplied by Dr. P. Fielding 
of the Oceanographic Research Institute in Durban. P. homarus specimens were not 
held under the aquarium conditions described above; their eyestalks were immediately 
ablated on their arrival in Cape Town and prepared for immunocytochemistry (see 
below), the animals were sacrificed thereafter. Carcinus maenas (Cama) were 
collected in baited traps set at the Alfred and Victoria Waterfront harbour in Cape 
T own. Marine shrimps, Palaemon pacificus, were collected with hand-held nets from 
beds of Zostera capensis (eelgrass) in the Langebaan. Lagoon in the vicinity of Cape 
Town. For large-scale preparation of sinus glands to obtain sufficient peptides for 
1 The nomenclature is according to that proposed by Raina and Gade (1988) for insect neuropeptides. 
However, I prefer at least a 4-letter denomination for the Crustacea (2 letters for the genus and 2 or 
more letters for the species) to prevent confusion with the insect nomenclature. For example, Cam 
denotes the stick insect, Carausius morosus, but could also mean Carcinus maenas. Therefore, I 
propose Cama for the latter. However, to abbreviate Cancer magister, a 5-1etter denomination is 
required for clarity, i.e. Camag. 
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purification and sequencing, eyestalks were ablated from live specimens of 1. lalandii 
and Palinurus gilchristii (Pagi) at lobster factories in Cape Town and Hout Bay. Live 
prawns, Penaeus semisulcatus (Pese) , were collected from Haifa Bay (Israel). They 
were kept in 3 m3 aerated tanks in Haifa, Israel, under natural light conditions with a 
continuous supply of sea water and a regulated temperature of 25°C. The prawns 
were fed daily with a mixture of frozen shrimp, frozen squid and food pellets. 
2.2. Preparation of sinus glands and purification of peptides 
Freshly-ablated eyestalks from adult 1. laland/.i, P. homarus, P. gilchristii and C. 
maenas were excised from the exoskeleton and the sinus gland (SG) was carefully 
dissected with the aid of a binocular microscope and placed into ice-cold 10 % acetic 
acid. Batches of 25 SG in 400 III acetic acid (for preabsorption, immunocytochemical 
experiments) or 50-100 SG in 800 III acetic acid (for peptide purification! seque~ncing) 
were homogenised in a glass homogeniser for 5 min at 85°C. The homogenate was 
then cooled on ice and centrifuged at 24 200 x g (Sorvall centrifuge) for 15 min at 4 
0c. The resulting supernatant was stored on ice; the pellet was re-extracted with 400 
III 10 % acetic acid on ice and centrifuged. The combined supernatants were dried in a 
Bachoffer vacuum concentrator. 
The dried SG extracts of J. lalandii, P. gilchristii and C. maenas were redissolved in 
50 III 10 % acetic acid and for peptide separation, were injected onto a Nucleosil C-18 
column (5 11m particle size, 25 cm length x 0.46 cm internal diameter). The 
chromatographic equipment was a Gilson high pressure gradient system with UV 
detection at 214 nm and a flow rate of 1 mlImin. The solvents were: A= 0.11 % 
trifluoroacetic acid (TF A) in Milli-Q water, 0.1 % TF A in 60 % acetonitrile. 
Peptides of the cHHIMIHIVIH family were separated from the crude extracts by a 
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gradient from 20-60 % B in 10 min, followed by a linear increase to 80 % B in 50 
min. Peak fractions were collected manually and aliquots were immediately tested in 
an ELISA (see 2.3.4.), while the remainder was dried in vacuo and used either in 
biological assays (see 2.4.), or pooled for structural elucidation (see 2.5.). To 
minimise the loss of cHHlMIHlVlli peptides by adhesion to Eppendorf tubes, these 
peptides were collected into silanated tubes (briefly, the tubes were coated for a few 
minutes at room temperature with 5 % dimethyl silane in toluene, followed by 3 rinses 
with toluene and a final rinse with methanol; the tubes were then heated at 50°C for 3 
h). 
2.3. Comparative immunocytochemical studies 
2.3.1. Tissue preparation 
Live adult specimens of J. lalandii, C. maenas, and P. homarus were anaesthetised on 
ice and their eyestalks were ablated. After removal of the exoskeleton, the eyestalks 
were fixed in Bouin's fixative overnight at room temperature for tissue 
immunocytochemistry. The fixed material was dehydrated in a graded ethanol series, 
cleared in xylene and then embedded in Paraplast. Serial sections (5 flm thick) were 
cut on a Reichert-Jung microtome and every 11 th section was routinely stained with 
haematoxylin and eosin, and viewed with a light microscope to assess the 
morphology, quality and appropriateness of the tissue area for immunocytochemical 
staining. 
2.3.2. Primary antisera 
Primary antisera used in this study were obtained as gifts. Anti-Homarus americanus 
(Hoam) elm and -VIH were provided by Dr. D. Soyez (CNRS, Paris, France) and 
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were raised in guinea pIgS against purified lobster cHH and VIH fractions, 
respectively (Meusy and Soyez 1991). Antiserum raised in rabbits against Hoam VIH 
was also supplied by Dr. Soyez. Anti-Cancer pagurus (Capa) cHH and -MJH were 
provided by Dr. S. Webster (University of Wales, Bangor, Wales) and were raised in 
rabbits against purified crab cHH and MIH fractions, respectively. Anti-ProcQ,rubanls 
bouvieri (Prbo) cHH was supplied by Dr. A. Huberman (INN, Mexico City, Mexico) 
and was raised in rabbits against purified crayfish cHH. For each primary antiserum, 
optimal concentration was tested in a dilution series for each investigated spf~cies by 
tissue immunocytochemistry and by enzyme-linked immunosorbent assay (ELISA, 
see 2.3.4. below). Anti-Hoam cHH serum was tested over a concentration range of 
. 1 :2000-1: 10000, anti-Prbo cHH ranged from 1 :2000-1 :5000, anti-Capa cHH and anti-
Capa MlH ranged from 1:2000-1:6000, and anti-Hoam VIH serum was tested over a 
concentration range of 1 :500-1 :2000. The following dilutions were decided upon for 
use in the indirect peroxidase immunocytochemistry procedure: anti-Hoam cHH 
1:5000, anti-Prbo cHH 1:5000, anti-Capa cHH 1:4000, anti-Capa MIH 1:2000 and 
anti-Hoam VIH 1 :500. Higher concentrations of antisera were selected for use with 
the immunofluorescence technique (see 2.3.3.2.). 
2.3.3. Tissue immunocytochemistry 
2.3.3.1. The indirect peroxidase procedure 
Paraplast sections on glass slides were deparaffinised and rinsed in distilled water. To 
inhibit the activity of endogenous peroxidase, tissue sections were incubated with 1 % 
H202 in methanol (30 min at room temperature) followed by a 5 min washing step 
under running tap water. Before the application of anti-Hoam cHHl-VIH to tissue 
sections, non-specific binding was blocked by incubating the sections with 20 % 
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application of anti-Capa :M1HI-cHH and anti-Prbo cHH, sections were first incubated 
with 10 % normal swine serum (NSS, Sigma). Tissue sections were then incubated 
overnight at 4 °c with 20 III primary antiserum diluted in 0.01 M phosphate-buffered 
saline (PBS, 14 mM NaCI, 3 mM KCI, 8 mM Na2HP04, 2 mM KH2P04), pH 7.6, 
washed 3 x 5 min in PBS at room temperature and then incubated at room temperature 
for 1 h with the respective secondary antiserum, viz., 1: 150 rabbit anti-guinea pig 
conjugated to horse radish peroxidase (RAGp-HRP, Dako), or 1:50 swine anti-rabbit 
conjugated to HRP (SAR-HRP, Dako). This was followed by PBS washes and a final 
5 min rinse in Tris-buffered saline (0.1 M NaCl in 0.05 M Tris-HCl, pH 7.6). For 
visualisation of the immunoreactions, the sections were incubated for 5 min with 2 mg 
3,3'-diaminobenzidine (DAB) per 4 m1 of 0.05 M Tris-HCI buffer, pH 7.6 and 0.001 
% H20 2, followed by a tap water rinse. The immunostained sections were mounted in 
veronal-buffered glycerol (equal amounts of glycerine and veronal buffer [0.1 M 
NaCl and 0.04 M sodium veronal], pH 8.6) and coverslipped. 
2.3.3.2. Immunofluorescence and double-staining procedure 
bewaxed, rehydrated serial sections of Jala eyestalk tissue were double-stained as 
follows. Non-specific reactions were blocked by incubating the sections with a 
mixture of 1:5 NRS and 1: 10 NSS for 1 h at room temperature. Cocktails of primary 
antisera, viz. (i) rabbit anti-Capa cHH 1 :500 + guinea pig anti-Hoam VIH 1 :250, (ii) 
rabbit anti-Capa MIH 1:500 + guinea pig anti-Hoam cHH 1: 1000, (iii) rabbit anti-
Capa MIH 1 :500 + guinea pig anti-Hoam VIH 1 :250, and (iv) rabbit anti-Hoam VIH 
1 :250 + guinea pig anti-Hoam cHH 1: 1000, were applied to the sections and left to 
incubate overnight at 4 0c. Thereafter, the sections were rinsed 3 x 5 min in PBS and 
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the first secondary antibody, 1 :20 SAR conjugated to TRITC (tetramethylrhodamine 
isothiocyanate, Sigma) with 1:20 normal guinea pig serum (NGpS), was applied to the 
sections and left to incubate for 1 h at 4 Dc. Excess antisera were removed by 3 x 5 
min rinses in PBS. The second secondary antibody was then applied, viz. 1 :20 RAGp 
conjugated to FITC (fluorescein isothiocyanate, Sigma) + 1: 10 NRS + 1: 10 NSS, and 
incubated at 4 DC for 1 h. TRITC- and FITC-Iabeled secondary antisera were kindly 
supplied by Prof B. B. Rawdon (Anatomy and Cell Biology Department., University 
of Cape Town, Rondebosch, South Africa). The incubation with secondary antisera 
was followed by PBS washes and the sections were mounted in veronal-buffered 
glycerol, coverslipped and viewed with a Leitz fluorescent microscope. 
2.3.3.3. Specificity controls 
Controls for the specificity of the immunocytochemical staining included (1) omission 
of primary antiserum to check unspecific binding of secondary antibody and other 
compounds applied later in the procedure, (2) substitution of primary antiserum with 
normal serum to show specificity of the primary antiserum, (3) application of 
preabsorbed antisera-peptide complexes to illustrate the specificity of the primary 
antisera to one particular antigen. Preabsorption of 50 pmol of purified Capa MIH or 
Capa cHH (gifts from Dr. S. Webster, University of Wales, Bangor, Wales) per III of 
1 : 1 0 anti-Capa MIH or 1: 10 anti-Capa cHH eliminated all specific immunostaining 
completely. 
Preabsorption of antisera with Hoam cHH, Hoam VIH and Prbo cHH could not be 
carried out because of insufficient amounts of the specific, purified Hoam and Prbo 
peptides. As it is known that the anti-Hoam VIH n~cognises Hoam cHH to some 
extent (Meusy and Soyez 1991), specificity tests were carried out by preabsorbing 
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putative cHH fractions from J. lalandii and putative MlH from C. maenas in the 
following way: sinus gland extracts were prepared fromJ. lalandii and C. maenas, the 
peptide content of the crude extracts was separated on RP-HPLC as described in 2.2. 
and these peptide fractions were subjected to ELISA using antisera raised against anti-
Hoam cHH and anti-Capa MIH. Those HPLC fractions with strong cHH and MlH 
immunoreactivity were then used to preadsorp the anti-Hoam VIH serum. These 
peptide-antisera complexes were then tested for immunoreactivity on the putative Jala 
cHH and Cama MlH fractions in ELISA studies and on tissue sections of Jala 
eyestalks. 
2.3.3.4. Microscopy and photomicrography 
Immunostained tissue sections were examined with a Nikon microphot light 
microscope with bright field transmitted light. Micrographs were also taken on a Wild 
Photomakroskop M400 (bright field and oblique) and a Leitz Diaplan M400 
(Hoffman's modulation contrast). Immunofluorescent sections were examined with a 
Leitz Labolux K microscope with transmitted fluorescence illumination and filters for 
rhodamine and FITC. The immunofluorescence was recorded on Fujichrome Sensia 
(400 ASA, daylight) colour film, whereas the DAB reactions were photographed on 
Kodak (50 ASA) monochrome film. It was not possible to take double-exposure 
photographs on the available equipment, therefore, the immunofluorescence results of 
double-staining were photographed separately with the different filters in place (FITC 
has an excitation wavelength of 495 nm and emission at 525 nm; TRITC is excitatory 
at 552 nm and emission occurs at 570 nm). 
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2. 3. 4. Enzymatic-linked immunosorbent assay (ELISA) procedure 
Direct ELISA was carried out on Nunc Maxisorp plastic microtiter plates with flat 
wells (Nunc, Denmark) coated either with 0.25 sinus gland equivalents (SGE) of 
crude SG extracts from J. lalandii, P. homarus and C. maenas for determining 
optimal working dilutions of the available primary antisera, or coated with 0.25 SG 
equivalents of HPLC-purified fractions from J. la landii, C. maenas and P. gilchristii 
SG extracts to identify putative cHH, MlH and VlH peptides in these species. 
Alternatively, 25-50 J..I.I aliquots from 1.5 m1 HPLC fractions were coated directly onto 
the microtitre plate without concentrating the sample beforehand. The ELISA method 
followed is that of Sefiani et a1. (1996) with the use of alkaline phosphatase 
conjugated secondary antisera (Sigma). Briefly, the antigens were dried in the wells 
either under vacuum or by heating at 37 Dc. Coating buffer (0.1 M sodium carbonate 
buffer, pH 9.6) was then added in a volume of 100 J..I.l per well, and the plate was 
incubated for 2 h at 37 DC or overnight at 4 DC. The coating buffer was then discarded 
and the plate rinsed 3x for 5 min with 0.02 M PBS, pH 7.4, containing 0.1 % Tween-
20 and 0.02 % sodium azide. The appropriate primary antibody (100 J..I.I pe~r well), 
diluted in PBS containing Tween, sodium azide and normal goat serum (NGS; Sigma) 
to a final volume of 1 %, was added to the microtitre wells and were incubated for 1.5 
h at 37 DC. Excess amounts of antibody were washed off by 3 x 5 min rinses in 
PBSfTween!sodium azide solution. The appropriate secondary antibody (100 J..I.I per 
well), also diluted in PBSfTween!sodium azide/NUS solution was then applied to the 
wells and incubated for 1.5 hat 37 Dc. The secondary antibodies were 1:10 000 goat 
anti-guinea pig IgG conjugated with alkaline phosphatase (Sigma) and 1:10000 goat 
anti-rabbit IgG conjugated with alkaline phosphatase (Sigma). After a 3 x 5 min rinse 
in PBSfTween solution, the enzymatic activity was assessed by the addition of para-
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nitrophenyl phosphatase disodium (Sigma) in 0.1 M sodium carbonate buffer, pH 9.6. 
The optical density was determined every 10-20 min at 405 nm using a Titertek 
Multiskan Plus reader. 
2.4. Functional characterisation of members of the cHHIMIHIVlH peptide family 
in Jasus lalandii 
2.4.1. Biological assay for hyperglycaemic activity 
A homologous in vivo assay using live juvenile rock lobsters was established. HPLC 
peak material (peaks 1-5, Fig. 24) which gave positive immunochemical reactions to 
cHH!MIHJVIH antisera in ELISA, were tested for a hyperglycaemic effect in juvenile 
specimens of J. lalandii (average weight 65 g, carapace length 4.5 cm) which had 
been starved 2-4 days prior to use. Individual animals were identified by means of 
numbered tags, which were glued onto the dorsal surface of the tail. The test animals 
were allowed to move freely in 20 x 50 x 60 cm assay chambers (width x length x 
depth), which were constructed from transparent perspex material. These chambers 
were fully submersed, but held afloat, in a large reservoir of recirculating sea water in 
the aquarium room. In this way, haemolymph sampling and injections could be 
carried out in the aquarium room under the prevailing temperature regime of 12-14 
DC, and individual animals could easily be identified and removed from the chamber 
for sampling purposes without submitting them to undue stress. Sampling and 
injections were usually achieved within 1 min. In pilot experiments, animals were 
randomly included in the bioassays. However, due to huge variations in the initial 
glucose concentrations between individual juveniles, the resulting data were not 
statistically comparable. Therefore, in subsequent experiments, 50 1-11 haemolymph 
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samples were withdrawn from 30 animals and immediately processed to determine the 
initial glucose concentration (see below). On the basis of these values, individuals 
were then grouped into subsets and injected with a test substance. For each test 
substance, the assay was done at least twice with n == 4-10 animals. 
Dried HPLC-derived peak material was redissolved in sterile sea water and injected in 
50 III volumes at concentrations of 1-2 SGE through the arthrodial membrane of the 
fifth walking leg. As control substances, 50 III sea water and 0.5-1 SGE of crude 
extracts of Jala sinus glands were included in the assays. Two hours after injection, a 
second haemolymph sample was taken to determine the concentration of glucose. 
2.4.1.2. Determination o/glucose tUres in haemolymph samples 
Before injection of the test substance into juvenile lobsters and 2 h after injection, 50 
III ofhaemolymph was sampled with a Hamilton syringe, ejected into 50 III of 0.03 N 
perchloric acid and immediately vortexed. The syringe was repeatedly rinsed with 10 
% sodium citrate to delay clotting of the haemolymph. Haemolymph samples were 
centrifuged at room temperature for 8 min at 20 000 x g and the glucose concentration 
in the supernatant was analysed with a commercially 'available kit (510 A kit, Sigma). 
The kit consisted of the following reagents: (i) PGO enzyme capsules (each capsule, 
when dissolved in 100 ml distilled water, contains 500 units of glucose oxidase from 
Aspergillus niger, 100 purpurogallin units of horseradish peroxidase and buffer salts); 
(ii) 50 mg o-dianisidine dihydrochloride which is reconstituted in 20 ml distilled 
water and then used as the colour reagent; and (iii) 1mglml J3-g1ucose in 0.1 % 
benzoic acid solution which served as the stock solution for reference amounts of 
glucose. An enzyme-colour reagent solution was prepared by combining 100 ml of 
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enzyme solution and 1.6 ml colour reagent solution. The Sigma procedure (Procedure 
No. 510) is based upon the following coupled enzymatic reactions: 
Glucose Oxidase 
---------.... ~ Gluconic Acid + H20 2 
Peroxidase 
----------~....... Oxidised o-Dianisidine 
(Colourless) (Brown) 
The intensity of the brown colour measured at 425-475 nm is proportional to the 
glucose concentration. 
The glucose concentration in the haemolymph samples was determined as follows: 50 
III supernatant was pipetted into a glass tube with 1 ml enzyme-colour reagent 
solution (blank samples consisted of 50 III 0.03 N perchloric acid with 1 ml enzyme-
col.our reagent). After mixing, the tubes were incubated at 37°C for 30 min. The 
optical density of the samples was measured in a glass cuvette at 436 nm on a 
Vitatron IFP spectrophotometer and the concentration of glucose was calculated from 
a standard curve prepared with glucose standard solutions, viz. 8 dilutions with 
perchloric acid, ranging from 0-25 mg/ml. Determination of glucose concentrations 
were later modified for microtitre plates: 10 III haemolymph supernatant + 200 III 
enzyme colour reagent solution, in duplicate, and the optical density was then read at 
450 nm with a Bio-Rad 550 microplate reader. The average difference in the glucose 
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concentrations after injection for each test substance was statistically compared to the 
difference caused after injection of sea water with the use of the Student's t-test. 
2.4.2. Biological assay for moult-inhibiting activity 
2.4.2.1. Characterisation of circulating ecdysteroids in 1. lalandii and ecdysteroid 
quantification 
2.4.2.1.1. Haemolymph sampling and extraction of ecdysteroids 
Haemolymph samples were collected on 2 different occasions from the ventral sinus 
of adult and juvenile male lobsters (n==5 in both cases) using disposable syringes. Pure 
methanol was added to the haemolymph (4: 1 v/v; the minimum volume of 
haemolymph withdrawn from an individual was 1 ml, whereas the maximum was 15 
ml and the total volume collected was 51 ml). The haemolymph samples were then 
centrifuged at 4 °c for 10 min at 24 000 x g and the supernatants were pooled and 
kept on ice. One volume of methanol was added to the pellets which were extracted 
twice more. The pooled supernatants were dried by evaporation and then redissolved 
in a smaller volume of methanol for separation of the ecdysteroids. 
2.4.2.1.2. Chromatographic separation of ecdysteroids 
An aliquot of the methanolic extract of haemolymph was applied to a normal phase 
(NP) column (Hypersil, Zorbax) attached to a Waters HPLC system with UV 
detection at 250 nm. The ecdysteroids were separated isocratically with 
dichloromethane/isopropanol!water (125:30:2; v/v/v) at a flow rate of 1 ml!min for 42 
min. Fractions of 0.5 ml were collected by a fraction collector for ecdysteroid 
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quantification in an enzyme immunoassay (EIA, see 2.4.2.1.3. below). Both batches 
of methanolic extracts were separated on NP-HPLC at least 3 times. The following 
synthetic ecdysteroids were also applied to NP-HPLC as references: ecdysone (E), 20-
hydroxyecdysone (20E), 3-dehydroecdysone (3 dE), ponasterone A (PoA), 2-
deoxyecdysone (2dE) and 2-deoxy-20-hydroxyecdysone (2d20E; all generousJy 
provided by Prof. R. Lafont, ENS, Paris, France). 
2.4.2.1.3. Ecdysteroid quantification 
An enzyme immunassay (EIA) was used to quantitate ecdysteroids in fractionated 
extracts of haemolymph and in the incubation medium of in vitro assays with Y-
organs (YOs). The method,a competitive EIA, has been adapted from the one 
described by Porcheron et al. (1989) (see below) by using goat anti-rabbit IgG 
(Sigma) as secondary antiserum and a different enzymatic tracer: 2-succinyl-20-
hydroxyecdysone coupled to peroxidase (a generous gift from Dr IP. Delbeque, 
CNRS, Bordeaux, France). The principle of the EIA is, briefly, (see Fig. 7): the rabbit 
anti-ecdysteroid antibodies (primary antisera) are immobilised to microtitre plates by 
goat anti-rabbit IgG (secondary antiserum). During a 3 h incubation period the 
ecdysteroid sample and tracer (peroxidase-labeled ecdysteroid) compete with each 
other for binding sites on the immobilised primary antisera. After plate washing, the 
remaining peroxidase is assayed by a colour reaction using ortho-phenyldiamine as 
substrate and the absorption is measured at 450 nm. In greater detail, each well of the 
microtitre plates (96 F, NunclDenmark) were coated for 24 h at room temperature 
with 0.25 Ilg secondary antiserum in 200 III 50 mM EIA buffer (0.1 M potassium 
phosphate buffer pH 7.4, 0.4 M NaCl, 1 mM EDTA and 0.1 % bovine serum albumin, 
BSA). Thereafter, 0.3 mg BSA in 100 III distilled water was added to each well. The 
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1. Coating microtitre well with goat anti-rabbit IgG 
2. Immunological reaction: 
o ecdysteroids in sample 
a-o 20E-peroxidase (=tracer) 
Y rabbit anti-ecdysteroids 
3. Revelation of enzymatic colour reaction <* ) 
Fig. 7. Schematic representation of the competitive enzyme immunoassay (EIA) used to determine the titre of 
ecdysteroids in haemolymph samples and in tissue culture medium in which Y -organs had been incubated. 
+-
Un
iv
rsi
ty 
of 
Ca
pe
 To
wn
plates were stored at 4 °c and were ready for use 12 h later. Before use, the plates 
were extensively washed in washing buffer (0.01 M potassium phosphate buffer, pH 
7.4 with 0.05 % Tween-20). In the determination of ecdysteroid quantities in YO-
incubated medium, all the washing steps were manually carried out, whereas, for EIA 
analyses of the HPLC-separated ecdysteroids, all the washing steps were carried out 
by an automatic plate washer. 
For the quantitation of ecdysteroids in NP-HPLC fractions, the tracer and primary 
antibodies were diluted in EIA buffer, and the HPLC fractions from Jala haemolymph 
were redissolved in 0.5 ml EIA buffer. Each fraction was plated in duplicate (50 Ill) 
for EIA. Reagents were applied to the microtitre plates, final volume of 150 III per 
well, in the following order (see Fig. 8): tracer, EIA buffer, ecdysteroid standards, 
samples and finally, the primary antibody. To determine the degree of non-specific 
binding, blanks were prepared in which the primary antibody and the ecdysteroid 
standard were omitted from the well. The degree of maximal possible binding (Bo), 
i.e. the enzymatic activity of the tracer bound in the absence of competitor molecules, 
was assessed by omission of ecdysteroid standards. All measurements were made in 
duplicate for blank samples, and in quadruplicate for Bo. The polyclonal antibody, AS 
4919 , (a gift from Prof P. Porcheron, University of Paris XI, Paris, France) was used 
(1:100 000) in the EIA with haemolymph fractions because the antibody recognises a 
broad spectrum of ecdysteroids (Porcheron et al., 1989). Calibration curves were 
constructed using synthetic 20E (Sigma) as standard ecdysteroid (range: 15.6-2000 
fmoles in EIA buffer). 
For the determination of ecdysteroid titres in the incubation medium after in vitro 
incubations of YOs from 1. lalandii, 2-50 III incubation medium was plated for EIA. 
In these EIAs, the solutions of synthetic ecdysteroids for construction of a standard 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
B. 
Blank 
Bo 
Standard 
Sample 
A. 
Blank (non-specific binding) 
Bo(maximal binding) 
Standards 
Samples 
Tracer 
50 111 
50 fll 
50 111 
50 111 
Tracer 
50 fll 
50 fll 
50 fll 
50 fll 
Medium* 
50 fll 
50 fll 
-
0-48fll 
EIA buffer 
100 fll 
50 fll 
-
-
EIA buffer 
50 fll 
-
-
-
Standard Sample Primary Antibody 
- - -
- - 50 fll 
50 fll - 50 fll 
- 50 fll 50 fll 
Standard Sample Primary Antibody 
- - -
- - 50 fll 
50 fll - 50 111 
- 2-50 fll 50 fll 
Fig. 8. Plating scheme and volumes for EIA reagents, synthetic ecdysteroid standard solutions and, in A, NP-HPLC-derived fractions from 
extracts ofhaemolymph, in B, samples of tissue culture medium after in vitro incubations ofYOs from J. lalandii. 
* denotes fresh culture medium. 
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curve were prepared in culture medium (M199, Sigma) and the final volume of 150 
Ill/well was attained by the addition of culture medium (see Fig. 8). The polyclonal 
antibody, RUD 2 (a gift from Dr D. Sedlmeier, University of Bonn, Bonn, Germany) 
was used in these EIAs to obtain direct quantification of E and 3DE in samples (Von 
Gliscynski et aI., 1995). Each determination was made in duplicate. Calibration 
curves were constructed using either synthetic E (Sigma) or 3DE (range: 15.6-2000 
finoles; gift from Prof R. Lafont). 
In a routine ErA, the plates were incubated for 3 h at room temperature under constant 
but gentle agitation. Alternatively, the plates were incubated at room temperature for 
2 h, incubated overnight at 4 °c and then incubated for a further hour at room 
temperature the following day. After incubation, the plates were washed with washing 
buffer. For manual washings, the reagents were flicked off from the plate, washing 
buffer was added at 250 Ill/well with a multichannel pipette, and the plates were 
gently agitated for 5 min; this was repeated 3 times. The enzymatic activity of the 
tracer was measured using ortho-phenylenediamine (Sigma) as substrate. This was 
prepared by dissolving a 5 mg tablet in 12.5 m1 0.05 M phosphate citrate buffer, pH 5 
with 2 III 30 % H202 added just before use. The plate was incubated in the dark at 
room temperature, with constant agitation and the optical density was measured 
periodically at 450 nm with a microplate reader (either the Titertek Multiskan Plus, or 
the Bio-Rad 550 model). Standard curve fitting was done with a computer using a 
linear log-logit transformation (Rodbard et al., 1968; software program was kindly 
supplied by Dr. D. Soyez) and the EIA measurements of the samples were calculated 
from the standard curve by computer. Results are expressed as BlBo x 1 00 as a 
function of the log dose, where B represents the absorbance measured on the bound 
fraction in the presence of competitor molecules. 
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2...1.2.2. In vitro incubations ofY-organsfrom J. lalandii 
The Y-organs (YO) of J. lalandii are located anteriorally near the epimeral attractor 
muscle, the maxillary epimera and the base of the second maxilla as described by 
Paterson (1968). Adult lobsters were anaesthetised by chilling in a mixture of ice and 
sea water. The paired YOs were dissected under sea water and placed into small glass 
dishes· on ice, containing 1 ml of sterile incubation medium. One litre of medium 
consisted of 11 g M199 culture medium powder (Sigma), 20 mM Hepes, 330.2 mM 
NaCI, 11.7 mM CaCh.2H20, 17.9 mM MgCh.6H20, 15 mM Na2S04, 6.6 ml\.1 KCI, 
0.06 g penicillin and 0.13 g streptomycin. The pH was adjusted to 7.4 and the medium 
was sterilised by filtration through 0.22 Ilm filters C~\l1illipore) and stored in sterile 
vials at 4 Dc. After rinsing the YOs in the cold incubation medium, the medium was 
removed from the dish and replaced with 1 ml of fresh medium for one hour at room 
temperature. This medium was collected for EIA analyses and replaced with fresh 
medium: one organ from each pair of YOs was incubated as the· control tissue in 
incubation medium, while the other organ was incubated in medium supplemented 
with a particular test substance. This substance was either a crude extract of Ja/t.J SGs 
or HPLC-purified peptide material, redissolved in M199 medium. The results were 
expressed as % inhibition of ecdysteroid synthesis relative to the control YO. 
Crude extracts of Jala SGs were applied to YOs from intermoult animals during a 6 h 
incubation period to assess the inhibitory responses and the sensitivity of the organ 
assay. HPLC peaks 1, 3 and 4 (see Fig. 24 for elution profile), which correspond to 
truncated cHH-I, MlH and cHH-I of J. lalandii, were tested at doses of 1 SGE during 
overnight incubations. The glass dishes containing the YOs were covered with 
parafilm to minimise evaporative loss of media, and incubated at room temperature 
(21 -25°C), under constant but gentle agitation. After incubation, the medium was 
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transferred to tubes and stored at -20°C until the ecdysteroid titre could be quantified 
by EIA Pieces of YO tissues (halves and quarters) were also used in in vitro 
incubations after pilot experiments showed that the glands could be cut into 
representative tissue pieces of equal productivity. 
2.4.2.2.1. Tissue specificity o/the YO assay 
Non-YO tissues of the branchiostegal region, such as muscle, epidermis, gill and 
hypodermis were incubated in vitro with M199 or crude extracts of sinus glands to 
show that only YO tissues produced ecdysteroids and that only these tissues were 
affected by extracts of sinus glands. Tissues were trimmed to approximately the same 
size as the YOs and were incubated overnight. 
2.4.2.2.2. Production dynamics ofYOs in vitro 
The release of ecdysteroids from Jala YOs in vitro was assessed: YOs were incubated 
in 1 ml M199 for a total period of 21 h. All the media was removed and replaced with 
1 ml of fresh M199 after 1, 3, 6 and 15 h of incubation. The collected samples were 
stored at -20°C until EIA analyses. 
2.4.2.2.3. Determination of the moult stages and the inhibitory effect of sinus glands 
during the moult cycle 
Adult J lalandii specimens were destalked; 25 ~l haemo)ymph was withdrawn with a 
Hamilton syringe from the base of the 5th pair of walking legs of these animals before 
eyestalk ablation and at various periods thereafter. The haemolymph samples were put 
into tubes containing 25 JlI of 0.03 N perchloric acid and vigorously vortexed. These 
tubes were then centrifuged at room temperature for 8 min at 20000 x g and 15 ~l of 
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the supernatant was analysed, in duplicate, in a competitive EIA with AS 4919 as 
primary antibody. Levels of circulating ecdysteroids were correlated with the different 
stages of the moult cycle by observing the destalked lobsters and noting the day of 
ecdysis, as well as by morphological changes, such as hardness of the exoskeleton. 
Haemolymph samples were withdrawn up to maximally 3 weeks following ecdysis. 
These post-ecdysis animals were then sacrificed and their YOs were incubated in 
vitro. 
YOs from lobsters undergoing different stages of the moult cycle, l.e. intermoult, 
premoult and postmoult, were incubated with 1 SGE of crude extracts of lala SGs for 
6 h and overnight incubation periods. Selection and classification of animals into 
these groups were made on the basis of their ecdysteroid titres in the haemolymph. 
2.4.3. Biological assay to measure the inhibition of de novo protein synthesis 
In contrast to the other biological assays described above, here a heterologous assay 
was used. 
2.4.3.1. Dissection and in vitro incubations of ovaries from Penaeus semisulcatus 
Female shrimps were collected from the tanks, decapitated with a pair of scissors and 
the dorsal carapace of the thorax and abdomen was removed. The ovaries, which 
extend under the dorsal carapace as a coiled, green mass were carefully removed, 
leaving the heart behind, and placed into ice-cold tissue culture medium. This 
methionine- and cysteine-free medium was similar in composition to M199 (Sigma) 
but was custom-made in 75 % sea water (Biological Industries Co., Beit Hamek, 
Israel) and the following components were added to 1 1 medium before use: 3.1 mg 
cysteine, 1.5 mg methionine, 12 g Hepes and 150 mg (250 000 U) penicillin. The pH 
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of the medium was then adjusted to 7.43. The developmental stage of each ovary was 
microscopically assessed by viewing the oocytes from a small tissue biopsy and 
measuring the average diameter of the oocytes. Suitable ovaries were those which 
contained oocytes larger than 350 flm and were devoid of cortical rods. The latter 
contains precursors for the jelly layer cover of eggs and is, therefore, indicative of the 
final developmental stage before spawning (Shlagman et al., 1986). The selected 
ovaries were cut into small pieces with a sterile scalpel blade. Each piece was 
weighed and 45-55 mg tissue pieces were randomly placed into wells of a 24-well 
tissue culture plate (Corning Incorporation) containing 0.5 ml medium, on ice. Dried 
peptides, generated from RP-HPLC-separation of crude extracts of sinus glands from 
J lalandii (peaks 1-6, Fig. 37), were redissolved in culture medium and added to the 
wells (1 SGE in 10 fll); each substance was tested in duplicate. A dose-response curve 
was also created by incubating ovarian tissue pieces in duplicate with 5 different 
concentrations of crude extracts of sinus glands fromJ. lalandii (range: 0.001-2 SGE). 
A positive control consisted of the incubation of ovarian tissues with crude extracts of 
sinus glands (0.1 SGE) from P. semisulcatus. Other controls were (1) non-treated 
ovarian tissues in which SG-derived material was omitted from the incubation, (2) 
sh9rt incubations of non-treated ovarian tissues, i.e. non-treated tissues were removed 
after 15 min in culture, and (3) incubations without any ovarian tissues. 
Two fll corresponding to 30 flCi of radiolabeled amino acids (21 flCi 35S-methionine 
+ 9 flCi 3SS-Cysteine, Promix, Amersham) were mixed with 0.5 ml of culture medium 
and added to each of the culture wells. The tissue culture plates were incubated in an 
oxygenated chamber at 25°C for 6 h with gentle agitation. After 15 min of incubation, 
the "short incubation" controls of non-treated tissues were removed from the plates 
and immediately frozen and stored at -70 DC, and, following the full incubation period 
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of 6 h, the remaining tissue pieces were removed with forceps, put into marked tubes 
and also stored at -70 Dc. The incubated media was left at room temperature 
overnight to assess the presence of contaminating fungal or bacterial growth, 
2.4.3.2. Measurement of incorporated radio/abel 
Tissue pieces that h~d been stored at -70 DC subsequent to their incubation in vitro, 
were thawed on ice, Once thawed, 0.5 ml PBS, pH 7.4, containing a protease inhibitor 
(2 mM Pefablock, Boehringer Mannheim) was added to each sample and the tissues 
were homogenised in a glass homogeniser using a battery-driven pestle at room 
temperature. The homogenates were centrifuged for 10 min at 4°C, 15 000 x g. Ten 
J.ll of the resulting supernatants ,were spotted onto \¥batman No. 1 filter paper in 
duplicate and air dried. The remainder of the supernatants was stored at -70 DC for 
protein determinations and separations (see 2.4.3.3.). Incubation medium from the 
wells in which no tissue pieces had been incubated was also spotted on filter paper for 
protein precipitation. The filter paper containing the dried supernatant and media were 
placed into boiling 10 % trichloroacetic acid (TeA) for 10 min; rinsed twice in water, 
twice in methanol and twice in acetone, then dried with hydrogen gas (H2). Each filter 
was put into a numbered scintillation vial, 3 ml scintillation fluid (Ultima Gold, 
Packard) was added and the radioactivity was measured in a scintillation counter 
(Kontron). Results were expressed as dpm; each sample was read twice and the 
average count was calculated. Background levels of radioactivity were determined as 
the radioactivity count in the ovarian tissues that had been incubated for only 15 min. 
This background count was subtracted from the averagl~ count of all the other samples 
to correct for "noise". Percentage inhibition of protein synthesis was calculated as 
follows: (non-treated - treated)/non-treated x 100. 
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2.4.3.3. Determination ojprotein content, separation ojproteins by denaturing gel 
electrophoresis and transjer ojproteins to membranes 
Supernatants ofhornogenised ovarian tissue pieces were thawed on ice after storage at 
-70°C and the protein content was assessed in duplicate by using Bradford reagent 
(Bio-Rad) as follows. One J.lI of each sample was diluted with 799 J.lI distilled water 
and 200 J.lI Bradford reagent were added. Six different concentrations of 1 rng/ml 
BSA (range: 0-20 J.lg) served as a standard curve. The optical density of each sample 
was read on a spectrophotometer (Biochron) at 595 IlIl1, with 800 J.lI distilled water + 
200 J.lI Bradford reagent serving to zero the instrument. 
Amounts of protein in the ovarian tissue pieces were then calculated by extrapolating 
the data obtained from the best-fit curve (i.e. y ax) obtained with the protein 
concentrations of BSA. Thus, the concentration of the unknown sample (J.lg/J.lI) = 
(mean 00 of unknown) divided by a. 
After quantification of total proteins in the incubated tissue pieces, the homogenates 
were subjected to polyacrylamide gel electrophoresis under reducing conditions. 
Samples were thawed on ice, 30 J.lI Laemmli loading buffer (12 gil Tris pH 6.8, 0.6 gil 
EDTA,2 % SDS, 10 % glycerol, 0.2 gil bromophenol blue, 1 % p-mercaptoethanol) 
were combined with the equivalent of30 J.lg of proteins from each sample and boiled 
for 5 min. The samples were then loaded onto 12.5 % polyacrylamide gels (15 mm 
thick:, 10 lanes per gel), along with a prestained broad-range molecular weight marker 
[212 kDa (myosin) 7.2 kDa (aprotinin), Bio-Radl The proteins were allowed to 
migrate under 150 V for 2h. The gels were then stained with Coomassie Blue solution 
(0.5 g Brilliant blue R250, Sigma; 20 ml acetic acid, 90 ml methanol and 200 ml 
distilled water; the solution was filtered through Whatman No. 1 filter paper) for 45 
miri 'at room temperature under shaking conditions. Gels were destained overnight at 
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room temperature and with shaking in a solution containing 10 % acetic acid, 45 % 
methanol and 45 % distilled water. After recording the images by scanning, the gels 
were incubated for 2 h in running buffer supplemented with 0.1 % SDS and 6 M urea, 
this medium being changed every 30 min. Gels were then placed onto Whatman filter 
paper on the negatively charged transfer plate and covered with nitrocellulose 
membrane (0.45 /lm Transblot Transfer Medium Pure Nitrocellulose Membrane, Bio-
Rad) cut to the same dimensions as the gels and clearly marked. Both the filters and 
the membranes were first soaked in distilled water and then in transfer medium (25 
mM Tris, 192 mM glycine, 15 % methanol) before use. A "sandwich" was prepared 
by alternately stacking filter paper, followed by a de stained gel, a membrane and 
finally more filter paper, until all 4 gels were ready for transfer. The transfer of 
proteins from the gels onto the nitrocellulose membranes was carried out at 60 V for 
3.5 h and migration occurred from the negative to the positive pole in transfer 
medium. The membranes were then exposed to autoradiography films for 1 month (X-
ray film, super HR-G30, Fuji) and then automatically developed (RG II, Fuji). 
2.5. Sequence elucidation of members of the cHHlMIHlVlH peptide family in J. 
lalandii 
2.5.1. Reduction of S-S bonds of Jala cHH-/ 
Peptides belonging to this peptide family are known to have 6 Cys residues with 3 
connecting disulfide bonds. Four attempts were therefore made to linearise the Jala 
cHH-I molecule by reducing the S-S bonds and to prevent their reformation by 
alkylation (see Scheme in Fig. 9) before proceeding with sequence elucidation. 
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Fig. 9. Reduction and alkylation of a disulfide bond. The 
wavy lines symbolise the polypeptide in which the cross-
linked Cys residues are found. [xl indicates the increase in 
mass units brought about by the modification. 
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Approximately 300-600 pmot Jala cHH-I (corresponding to 25-50 SOs) were 
redissolved in 60 J!l reducing buffer (0.5 M Tris-HCI buffer, pH 8.5 containing 6 M 
urea). Fifty J!l 0.02 M dithiothreitol (DTT, Boehringer Mannheim) in reducing buffer 
was added. Oxygen in the sample tube was replaced by argon, an inert gas, and the 
mixture was incubated at 45°C for 1 h. Thereafter, 50 I.d 0.04 M iodoacetamide 
(Boehringer Mannheim) was added and the mixture was incubated for 20 min at 25 
°c. As a control, all the reagents were incubated without peptide materiaL The 
mixtures were separated on RP-HPLC. 
To determine the extent of peptide losses during this procedure, synthetic insuilin was 
reduced, alkylated and purified on HPLC; the combined peak heights of the reduced-
alkylated peptide chains were compared with the peak height of the same amount of 
non-reduced, non-alkylated insulin. 
Reduction/alkylation using DTT and iodoacetamide was also carried out on tryptic 
fragment T26 (amino acid residues 1-8 and 42-50) of Jala cHH-I, as well as on the 
synthetic octapeptides A VFDQSCK (with D-Phe3 and L-Phe3 conformation; custom-
synthesised by Dr. H. Echner, University of TUbingen, Tiibingen, Germany). These 
mixtures were also purified on HPLC. 
The success of reduction and alkylation was further monitored by removing aliquots 
of the peptide mixture after these different steps and analysing them by MALDI-TOF 
mass spectrometry (see 2.5.2.). 
2. 5.1.1. Reduction of disulfide bonds in peptide fragments for mass spectrometry 
After enzymatic digestions of peptides, those fragments containing disulfide bonds 
were reduced in silanated tubes, the mixtures were then analysed by MALDI. An 
aliquot of each fragment (approximately 16 SGE) was dissolved in 5 J!l reducing 
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buffer. An equal volume of 0.02 M DTT in reduction buffer was added and the 
samples were incubated for 1 h at 45°C under a layer of argon. After incubation, 
approximately 4 SGE of the samples were diluted 1: 10 with 30 % acetonitrile and 
0.01 % TFA and analysed by mass spectrometry. More recently, aliquots of the 
reduced samples were desalted by means of a ZipTip (Millipore). The ZipTipcl8 (C18 
spherical silica: 15 !lm, 200 A pore size) is a 10 III pipette tip with 0.5 III resin at the 
tip. To desalt and remove detergents from the samples for MALDI-mass 
spectrometry, the following procedure was carried out as recommended by Millipore. 
The ZipTip was equilibrated for sample binding by aspirating 10 III of 50 % 
acetonitrile in water into the tip, followed by 2 washes with 10 III of 0.1 % TF A in 
water. The reduced peptide fragments were then bound to the Zip Tip by aspirating 
and dispensing the sample 5-10 times, followed by 2 washes in 0.1 % TFA. Two to 4 
III of 50 % acetonitrile in water was pipetted into a clean sample tube using a standard 
pipette tip. To elute the peptides from the ZipTip, the acetonitrile solution was 
carefully aspirated and dispensed through the ZipTip at least 3 times. The desalted 
sample (0.7 Ill) was spotted directly onto a gold plate with 1 III of matrix and air-dried 
for mass spectrometric analyses (see 2.5.2. below). 
2.5.2. Mass spectrometry (MS) 
Matrix-assisted laser desorption/ionisation (MALDI) mass. spectra were first acquired 
on a time-of-flight (TOF) Voyager Elite Biospectrometry Workstation; this was later 
replaced by a MALDI-TOF Voyager-Pro DE (delayed extraction) instrument (both 
from PerSeptive Biosystems, Framingham, USA), equipped with a standard nitrogen 
laser. Data acquisition was performed by a Tektronix (TDS 520A) oscilloscope. 
Sinapinic acid and a-cyano-4-hydroxycinnamic acid (PerSeptive) were used as 
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matrices to analyse peptides in the range of 3000 - 10 000 Da and 500 - 3000 Da, 
respectively in the linear, positive ion, delayed extraction and reflectron modes. Dried 
peptides were redissolved in 30 % acetonitrile containing 0.1 % TF A. One III of 
matrix (10 mg/ml in acetonitrile and 3 % TFA) was applied to 0.7 III of sample 
solution on the target plate and dried. Samples containing peptide mixtures after 
digestions, cleavages or reduction, were not concentrated or dried in a vacuum 
concentrator, but were spotted directly from the reaction mixture after dilution with 
water or purification via ZipTip. 
The software package, General ProteinlMass Apalysis (GPMAW, Ver. 3.04) for 
Windows, was used to calculate the mass of peptide~s and to predict the cleavage 
patterns and masses of resulting fragments. 
2.5.3. N-terminal sequencing 
Sequence analysis was first achieved by automated Edman degradation perfornled on 
a gas-liquid solid phase sequencer (Brandt et al., 1984) linked to an on-line HPLC 
system, and later, on a liquid-pulsed sequencer (modlel 473A, Applied Biosystems). 
These analyses were performed by Assoc. Prof W. Brandt (Department of 
Biochemistry, University of Cape Town, Rondebosch, South Africa) and Dr. S. 
Stoeva (University of Til bingen, Tiibingen, Germany). 
2.5.4. Cleavages and separation of cleavage fragments 
2.5.4.1. Trypsin digestions 
Batches of trypsin (25 Ilg sequencing grade, Boehringer Mannheim) were 
reconstituted in 125 III 0.01 % TFA. Native, i.e. non-reduced peptides were 
redissolved in 0.1 M Tris-HCI buffer, pH 8.5: Jala cHH-I (125 SGE in 126 Ill), Jala 
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cHH-II (285 SGE in 125 Ill) and lata MIH (340 SGE in 80 Ill). Trypsin was added to 
the samples: 6 Ilg, 5.6 !lg and 4 !lg, respectively. A control reaction was always 
included in which no peptide was added to the incubation mixture. The digest was 
carried out at 37 DC for 18 h and thereafter terminated by the addition of 20 III 0.1 N 
HCI and subsequent storage at 4 DC. The digest mixtures were subjected to RP-HPLC 
using the same column and HPLC system as described in 2.2., but with a different 
gradient: a 5 min isocratic step at 0 % B and then an increase to 90 % B in 90 min. 
The resulting peak fractions were manually collected into silanated tubes, dried in 
vacuo and used for mass analysis and N-terminal sequencing. 
2.5.4.2. Endoproteinase-Asp N (endo-Asp N) digestions 
Batches of endo-Asp N (2 Ilg sequencing grade, Boehringer Mannheim) were 
reconstituted in 50 !ll Milli-Q water. Native, i.e. non-reduced peptides were 
redissolved in 50 mM sodium phosphate buffer, pH 8: lala cHH-I (150 SGE in 50 
!ll), lala cHH-II (550 SGE in 50 Ill) and lata MIH (350 SGE in 60 !ll). The enzyme 
was added to the 3 samples: 1.4 !lg, 1.4 !lg and 1.5 !lg, respectively. A control 
reaction was always carried out in which the peptide sample was absent. The digest 
was carried out at 37°C for 18 h, terminated by the addition of 20 III 0.1 N HCl and 
subsequent storage at 4°C, and the mixtures were purified on RP-HPLC as described 
for trypsin (see 2.5.4.1.). 
2.5.4.3. Cyanogen bromide (CNBr) cleavages 
Dried, native peptide material was redissolved in 70 % formic acid: 50 SGE lata 
cHH-I, 100 SGE lala cHH-II, 125 SGE lala MIH and 100 SGE truncated lala cHH-
I. CNBr (in formic acid) was added to a final concentration of 0.2 mg/40 !It The 
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sample mixtures were incubated in the dark under nitrogen gas for 18 h. The cleavage 
mixtures of Jala cHH-I and Jala cHH-II were not purified on HPLC, but dried in the 
vacuum concentrator and then redissolved for mass analyses and N-terminal 
sequencing. With the cleavage mixtures of Jala MIH and truncated Jala cHH-I, the 
CNBr was first evaporated from the samples and the mixtures were then applied to the 
HPLC for separation; the resulting peaks were collected. Only the purified C-terminal 
fragments (as identified by MALDI-TOF analyses) were dried and N-terminally 
sequenced. 
Partial cleavage of cHH-I material (3 SG equivalents) was also carried out by 
incubating the peptide for 30 min in 10 III 70 % TF A containing 3 mg/ml CNBr. The 
mixtures were dried for mass spectrometry and sequence analysis, and in the case of 
the partially cleaved products, also used for methylation (see 2.5.5. below). 
2.5.5. Methylation 
This is a reversible modification where free carboxyl groups (COOH) are converted to 
COOCH3 in the presence of methanol-chloride solution and is, therefore, a useful tool 
to investigate whether a polypeptide is C-terminally blocked. If the C-terminal 
carboxyl group is protected by an amide (NH2), there can be no formation of a methyl 
ester (CH2 = 14 mu). Methanol-chloride solution was prepared by bubbling HCI gas 
into pure methanol to a final concentration of 4-7 % gas. Peptides were redissolved in 
5 III pure methanol, and 5 III methanol-chloride solution was added to the tube. After 
25-40 min incubation at room temperature, the reaction was terminated by the 
addition of ice-cold Milli-Q water. The mixture was analysed by mass spectrometry, 
using a-hydroxy-cinnamic acid as matrix. Ten SGE of the following C-terminal 
fragments were methylated: MIH (D9), truncated cHH-I (CNBr 2) and cHH-I (015). 
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The synthetic nonapeptide DIWRSILKA-NH2 (custom-synthesised by Dr. H. Echner) 
and N-terminally deblocked RPCH (= des-pGlu-red pigment-concentrating hormone) 
were also subjected to methylation. A freeze-dried equivalent of 2 SGs of partial 
CNBr-cleaved cffif-I material (see 2.5.4.3.) was methylated at 18°C for 20 min in 5 
III methanol-chloride solution and analysed by mass spectrometry. 
As method controls, several known peptides with amidated or free C-termini were 
included in the methylation experiments: a hypertrehalosaernic hormone from 
Carausius morosus (code-named Cam-HrTH-II; Peninsula), an allatostatin from 
Periplaneta americana (Pea-Ast5; custom-synthesised by Dr. R. Kellner, Merck, 
Darmstadt, Germany) and a peptide mixture consisting of des Arg-bradykinin, 
angiotensin I and Glu-fibrinogen peptide B (Calibration mixture 1, PerSeptive). 
2.5.6. Determination of the ratio of truncated- and non-truncated cHH peptides 
Batches of five sinus glands were dissected into the following homogenisation 
buffers: (1) 10 % acetic acid; (2) 0.2 mM phenylmethylsulfonyl fluoride (PMSF, 
Boehringer Mannheim) in 10 % acetic acid; (3) 0.2 mM PMSF in distilled water; (4) 
0.1 % thiodiglycol (Fluka) in 10 % acetic acid; (5) 0.1 mglrnl trypsin inhibitor (from 
bovine lung, Serva) in 10 % acetic acid; and (6) 0.2 mglrnl ethylenediaminetetraacetic 
acid, pH 8 (EDT A, Boehringer Mannheim) in water. The sinus glands were stored in 
solution at -20 DC and later, homogenised in a glass homogeniser for 5 min at 85 Dc. 
The extracts were dried in vacuo, redissolved in 10 % acetic acid and applied to the 
HPLC system for peptide separation (as in 2.2.). Peaks, defined by their retention time 
as truncated and non-truncated cffifs, were integrated and the peak area calculated by 
means of Gilson's Unipoint software (ver. 1.65). This set of experiments was also 
repeated with batches of 10 sinus glands. 
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2.6. Purification and characterisation of non-cHH-like (less-hydrophobic) peptides 
from J. laland;; 
2.6.1. Initial purification on RP-HPLC 
With every HPLC separation of crude extracts of SGs from J. lalandii (see 2.2.), 
material eluting between 0 and 20 min were continuously collected as 2 ml fractions. 
These fractions were immediately dried down and stored at -20°C until further 
purification. The fractions were redissolved in 50 ~l of 25 % acetonitrile, pooled into 
1 tube for drying and again separated by HPLC in batches of 100-400 SGE of 
fractions (total amount repurified = 1060 SGE). 
Peptides were separated on the RP-HPLC system and column, described in 2.2. 
. Solvents were: A = 0.115 % TF A in water, B = 100 % acetonitrile with 0.1 % TF A 
and a gradient was applied (4 min isocratic step at 25 % B and increasing to 40 % B in 
50 min). Peak fractions were collected manually and dried. Aliquots were analysed by 
MALDI-TOF spectrometry to assess the purity of the peak material. 
2.6.2. Subsequent purifications on RP-HPLC 
Peak fractions from separate runs that corresponded to peaks 1-5 (Fig. 61), based on 
comparisons of the chromatograms, were pooled in batches of350 SGE and subjected 
to a second purification step using the same HPLC system as described in 2.2. but 
with solvents: A = 0.13 % HFBA (heptafluorobutyric acid) in water, B = 100 % 
acetonitrile with 0.13 % HFBA. A gradient was applied from 30-60 % B in 100 min. 
Resulting peak fractions were manually collected; identical peaks from different runs 
were pooled and dried. 
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Those peaks that were not fully resolved, were subjected to a third purification step 
with different solvents: A = 0.05 % TFA in water, B = 100 % acetonitrile with 0.05 % 
TF A and a different gradient: 6 min isocratic step at 25 % B and increase to 40 % B in 
50 min. Aliquots of the purified material were analysed by mass spectrometry. 
2.6.3. Heterologous biological assays for RPCH and PDH activities 
For the red pigment-concentrating hormone (RPCH) assay, shrimps (Palaemon 
pacificus) were adapted to dark coriditions by being confined in a darkened aquarium 
in tanks lined with black plastic for at least 2 days before the assay. 
For the PDH (pigment-dispersing hormone) assay, shrimps were adapted to light 
conditions by being kept under white light in white plastic containers in the aquarium 
for at least 2 days before the assay. 
The assays were carried out at room temperature. The condition of the 
chromatophores was assessed with a Nikon dissecting microscope at the start and at 
regular intervals during the assay: 5 min for RPCH and 10 min for PDH. Dark-
adapted shrimps were individually kept in sea water in small, black dishes for the 
duration of the assay, whereas light-adapted animals were isolated in white containers. 
T ~n III of test substances were injected through the lateral carapace and the animal 
was returned to its dish. For microscopic monitoring of the chromatophores, the entire 
dish was placed onto the microscope stage so that the shrimps were not subjected to 
undue stress of prolonged handling outside sea water. 
Substances for injection were dissolved in sea water. These substances were: 1 SGE 
of HPLC fractions 1-5 (Fig. 61), synthetic RPCH (Peninsula), synthetic f3-PDH (a 
kind gift from Prof K. R. Rao, University of West Florida, Pensacola, Florida, United 
States of America) and sea water (n = 5-6); the assays were repeated at least 4 times. 
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A further control included non-injected animals which were regularly monitored to 
see whether their chromatophoric behaviour was affected by the laboratory 
environment during the assay period. 
2. 7. Structural elucidation of non-cHH-like (less-hydrophobic) peptides 
All the purified peptides were N-terminally sequenced, except the peak identified as 
RPCH. 
2.7.1. Deblocking the N-terminus oj RPCH 
The suspected pGlu residue at the N-terminus of RPCH was removed by cleaving 
with a Pfu pyroglutamate amino peptidase (Takara Shuzo Co., Japan). This enzyme, 
purified from Pyrococcus Juriosus, has an optimum temperature of 95-1 00 °c, with 90 
% confirmed activity at 75°C. Therefore, the cleavage reaction can be carried out for 
a shorter time compared with other pGlu peptidases. 
The lyophilised enzyme was reconstituted in 50 III buffer (supplied, and diluted in 
water according to the manufacturer's instructions). To establish optimum conditions 
for cleavage of Jala RPCH, 300 SGE of the pure peptide was redissolved in 45 III 
buffer and 2.5 III of the reconstituted enzyme was added. The mixture was incubated 
at 65°C for a maximum period of 135 min.·The equivalentof30 SGs was withdrawn 
45 and 135 min after incubation and run on HPLC. Based on these results, 900 SGE 
RPCH was then incubated with 5 III enzyme at 65°C for 3 h. Aliquots of the 
deblocked peptide, i.e. des-p Glu-RP CH, were subjected to mass analyses and to 
methylation experiments (see 2.5.5.). The remainder of the deblocked material was 
subjected to N-terminal sequencing. 
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2.7.2. Tryptic digestion ojCPRPs 
The putative cHH precursor-related peptides (300 SGE dissolved in 50 III of 0.1 M 
Tris-HCI buffer, pH 8.5) were digested with 1 Ilg trypsin in 0.01 % TFA (sequencing 
grade, Boehringer Mannheim) for 18 h at 37°C and purified by HPLC. The same 
column, solvents and gradient system as outlined in 2.5.4.1. were used. The resulting 
fractions were collected manually; aliquots were retained for mass spectrometry and 
the rest of the fractions were dried for N-terminal sequencing. 
2.7.3. Endo-Asp N digestion ofCPRP-l and-2 
The dried peptide, consisting of a mixture of the two peptides (150 SGE), was 
redissolved in 50 III sodium phosphate buffer, pH 8, digested with 0.3 Ilg 
endoproteinase-Asp N (sequencing grade, Boehringer Mannheim) for 18 h at 37°C. 
The mixture was purified and analysed as in 2.5.4.1. 
2.7.4. CNBr cleavage ofCPRP-l and-2 
The dried peptide (180 SGE) was redissolved in 50 III of 25 % acetonitrile, a small 
crystal of CNBr was added and brought into solution. The reaction was carried out 
overnight in the dark at room temperature and purified on HPLC under the same 
conditions as in 2.5.4.1. 
2.8. Molecular biological aspects 
2.8.1. RNA isolation 
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Thirty XOs were dissected from freshly-ablated eyestalks of adult 1. lalandii under 
sterile and RNAase-free conditions. The XOs were immediately frozen in liquid 
nitrogen and stored at -80 DC until the RNA could be extracted. Total R.J'.rA was 
isolated with a standard phenol/guanidine thiocyanate method using peqGOLD 
TriFast (PEQLAB) and following the manufacturer's instructions. Briefly, frozen 
XOs were transferred to a sterile 1.5 ml tube, 0.5 ml Trifast solution was added and 
the XOs were manually homogenised with a sterile, teflon-ended pestle. A further 0.5 
ml Trifast was added and the sample incubated at room temperature for 5 min. 
Thereafter, 200 III chloroform was added, the sample was vortexed, incubated at room 
temperature for 10 min and then centrifuged for 5 min at 4 °c and at 14 000 rpm on a 
Sorvall RMC14 (Du Pont). The top (aqueous) phase was carefully transferred into a 
fresh tube, and the lower layers were discarded. To the aqueous phase, 500 III 
isopropanol was added to precipitate the RNA, and left at room temperature for 15 
min. The sample was centrifuged at 4 °c for 10 min at 14 000 rpm. The sup<~rnatant 
was discarded and the pellet was rinsed (at least twice) with 1 ml 75 % ethanol, 
followed by a 5 min centrifugation step at 4°C, 14 000 rpm. The pellet was 
redissolved in 10 III DEPC (diethyl pyrocarbamate)-treated water and aliquots were 
quantified in quartz cuvettes on a UVIKON 710 spectrophotometer at wavelengths of 
230, 260 and 280 nm. The amount of RNA in the sample was calculated as: 
Absorbance @ 260 run x dilution factor of sample 
30 
(where 30 is the RNA factor). The quality of the RNA was checked by electrophoresis 
on an ethidium bromide/agarose/formaldehyde gel: 1.5 I1g and 3 I1g RNA were loaded 
alongside a marker (RNA B) and the gel was run for several hours at 100 V. The 
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RNA bands were visualised under UV light and recorded photographically. R.~A 
samples in DEPC-treated water were stored at -70°C. 
2.B.2. Construction of a cDNA library 
A cDNA library was constructed with the use of a SMART™ eDNA library 
construction kit from CLONTECH (User Manual PT3000-1); a flowchart of the 
protocol is shown in Fig. 10. The protocol utilizes the SMART IIITM (Switching 
Mechanism At 5' end of RNA Transcript) oligonucleotide in the first-strand synthesis 
.to generate high yields of full-length double strand (ds) cDNA. 
2.B.2.1. First-strand synthesis 
The following reagents were combined in a sterile 0.5 ml centrifuge tube with 
deionised water to a final volume of 5 ~1: 1 ~g RNA extracted from Jala XOs, 1 ~l 
SMARTIIFM oligonucleotide and 1 ~l CDS IIV3' PCR primer. The contents were 
mixed and incubated for 2 min at 72 DC, then cooled on ice. The following was then 
added to the tube to make a 1 0 ~l reaction: 2 III 5x First-strand buffer, 1 III DTT (10 
mM), 1 III dNTP mix (10 IlM) and 1 III Superscript II reverse transcriptase (Life 
Technologies). The mixture was incubated for 1 h at 42 DC in a thermal cycler 
(GeneAmp 480, Techne). The tube was then cooled on ice before proceeding with 
cDNA amplification; the remainder of the sample was stored at -20 °C. 
2.B.2.2. cDNA amplification by LD (Long Distance) PCR 
The following components were added to a fresh 0.5 ml tube: 2 III first-strand cDNA 
(see above), 80 III deionised water, 10 III 10 x eDNA PCR buffer, 2 ~l dNTP mix, 2 
!-tI5' PCR primer, 2 !-tt CDS IIV3' PCR primer and 2 !-t150 x Advantage® cDNA 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
SMART 
cDNA S'{I\thesis 
SMART 
lTriplEx2 Ugation 
: 
-
65 
PolyA+RNA 
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Fig. 10. Flow diagram showing the main steps involved in the SMART cDNA library 
construction protocol (from CLONTECH Laboratories, Inc.). 
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polymerase mix. The contents were gently mixed and then placed in the preheated 
thermal cycler and a thermal regime selected: 95 DC for 1 min, followed by 20 cycles 
of a 15 s denaturing step at 95 DC and a 6 min combined annealing/extension step at 
68 Dc. A 5 ~l sample of the PCR product was mixed with 1 ~l 5x DNA Blue Run dye 
and analysed on a 1.1 % agaroselEtBr gel, alongside with 1 kb DNA size markers 
(250 ng of Lambda DNA digested with HindUl or a double digest with HindIlVEco 
RI, :MEl Furmentas). The bands were visualised under UV light. The remainder of ds 
cDNA was either digested with proteinase K, or stored at -20 Dc. 
2.8.2.3. Proteinase K digestion 
Fifty ~l of the amplified ds cDNA was combined with 2 III proteinase K (20 ~g/1l1) in 
a sterile 1.5 m1 tube. The contents were briefly mixed and incubated for 20 min at 45 
Dc. Deionised water (50 ~l) was added and the sample denatured by the addition of 
1 00 ~l phenol/water/chloroform solution (nucleic acid purification grade, Applied 
Biosystems) and mixed continuously for 1-2 min by gentle inversion. The tube was 
centrifuged for 5 min at 14 000 rpm to separate the phases. The top ( aqueous) layer 
was transferred to a clean tube, while the interface and lower layers were discarded. 
To the aqueous layer, 1 00 ~l chloroform was added and the sample was gently mixed 
again for 1-2 min followed by a 5 min centrifugation step to separate the phases. The 
top (aqueous) layer was once again transferred to a clean tube and the other layers 
were discarded. The following was added to the aqueous layer: 10 III 3M sodium 
acetate pH 5.2, 1.3 ~l glycogen (20 ~g/IlI) and 260 ~l of 100 % ethanol at room 
temperature. This mixture was immediately centrifuged at 14 000 rpm for 20 min at 
room temperature and the supernatant was carefully removed and discarded. The 
pellet was washed with 1 00 ~l 80 % ethanol and centrifuged for 5 min. The pellet was 
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air-dried for 15-20 min to evaporate the residual ethanol and was then resuspended in 
79 ).11 deionised water. 
2.B.2.4. SftI digestion 
The following components were combined in a fresh 0.5 ml tube: 79 ).dcDNA. after . 
proteinase K digestion, 10 ).11 lOx Sft buffer, 10 J.LI Sft I enzyme and 1 J.Ll 100x BSA to 
give a final reaction volume of 100 J.L1. This was mixed well and incubated at 50°C 
for 2 h. 
2.B.2.5. eDNA sizejraetionation by CHROMA SPIN-400 
Sixteen 1.5 ml tubes were labeled and arranged in a rack.The CHROMA-SPIN-400 
column (CLONTECH) was prepared for the drip procl~dure as follows: (i) the column 
was warmed at room temperature for 1 h, then inverted several times to resuspend the 
gel matrix; (ii) air bubbles were remov;ed from the column and the bottom cap was 
removed to let the column drip; (iii) the column was then attached to a ring stand and 
the drainage buffer could flow out under gravity; (iv) when the surface of the gel 
beads in the column matrix was visible and the flow rate was about 1 drop/40-60 s, 
the column was deemed ready. When the storage' buffer stopped dripping out, 700 ).11 
of column buffer was gently added and allowed to drip out completely (15-20 min), 
Only then was 100 J.ll of the Sft I -digested cDNA carf:fully added to the top centre of 
the matrix; the sample was allowed to be fully absorbl~d into the surface of the matrix 
before 100 ).11 column buffer was added. This buffer was allowed to drain out of the 
column until there was no liquid left above the resin. The rack of 16 tubes were then 
placed under the column outlet and after the addition of 600 J.Ll column buffer to the 
column, the single-drop fractions (30-40 J.lI) were sequentially collected. Three ).11 of 
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fractions 7-16 were electrophoresed on a 1.1 % agaroselEtBr gel. The gel was run for 
2 min at 150 V and the bands visualised under UV light. The fractions that contained 
the cDNA were pooled into a clean 1.5 ml tube. The following reagents were added to 
the pooled fractions: 1110 vol. 3 M sodium acetate pH 5.2, 1.3 III glycogen (20 
mg/ml) and 2.5 vol. 100 % ethanol. The contents were mixed by gently rocking the 
tube back and forth and the tube was kept overnight at -20°C. Thereafter, the tube 
was centrifuged at 14 000 rpm for 20 min at room temperature. The supernatant was 
carefully removed and discarded; the tube was recentrifuged, all the liquid was 
carefully removed and the pellet was air-dried for 10 min. The dried pellet of cDNA 
was then resuspended in 7 III deionised water. 
2.8.2.6. Ligation of eDNA to the vector 
The quantity of Jala eDNA recovered after size fractionation was estimated by the 
ethidium bromide plate assay (following instructions from Stratagene). In a clean 0.5 
ml tube, the following reagents were added and mixed well: 1 III eDNA (= 50 ng), 1 
III A TriplEx2 vector (= 500 ng/Ill), 0.5 III lOx ligation buffer, 0.5 III ATP (10 rnM), 
0.5 III T4 DNA ligase and 1.5 III deionised water. The tube was incubated overnight at 
1'6 Dc. A A-phage packaging reaction was carried out according to the protocol for the 
Gigapack III Gold Packaging kit (Stratagene). Briefly, 4 III DNA (containing ligated 
Jala XO cDNA) was added to the Gigapack III packaging extract and mixed well 
with a pipette tip. The tube was then pulsed for 3-5 s in a centrifuge and incubated at 
room temperature for not more than 2 h. SM buffer (500 Ill) was added to the tube, 
followed by 200 III chloroform. After mixing gently, the tube was briefly spun to 
sediment the debris. The supernatant containing the phage was then ready for titre 
determination. 
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2.8.2.7. Determining the titre a/the un amplified library 
E. coli XL 1-Blue bacteria were grown overnight at 37°C. The bacterial culture was 
centrifuged for 5 min at 5000 rpm, the supernatant was discarded and the pellet was 
resuspended in 7.5 mIlO mM MgS04. The unamplified phage lysate (see above) was 
diluted in 1 x lambda dilution buffer to 1:5 and 1 :20. One III of the diluted phage 
solution was added to 200 III of the viable E. coli XLI-Blue overnight culture and the 
phage was allowed to adsorb for 10-15 min at 37°C. Two ml of melted 50°C 
LB(Lourier broth)lMgS04 top agarose was added, quickly mixed by inversion and 
immediately poured onto 90 rnrn LB agar plates prewarrned to 37°C. The plates were 
cooled at room temperature for 10 min, inverted and incubated at 37 °c for 6-18 h. 
The resulting phage plaques, appearing as light spots in the bacterial lawn, were 
counted on a light box with the use of a manual counter and a marker pen. The titre of 
the phage was calculated as follows, where pfu refers to "plaque forming units": 
Titre of phage (pfulml) = 
2.8.2.8. Library amplification 
no.of plaques X dilution factor X 103 /-Il/ml 
vo\. of diluted phage plated 
E. coli XLI-Blue bacteria, grown overnight at 37°C, were centrifuged for 5 min at 
5000 rpm, the supernatant was discarded and the pellet was resuspended in 7.5 mIlO 
mM MgS04. Into 20 tubes of 4 ml volume, 500 III of the bacterial suspension and 20 
III of Jala cDNA library lysate were added. The tubes were incubated at 37°C for 15 
min. Thereafter, 4.5 ml of molten 50°C LBIMgS04 top agarose was added to each 
tube. The tubes were quickly inverted and the bacteria/phage/agar mixture was poured 
onto 15 em agar plates that had been preheated to 37°C. The plates were cooled at 
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room temperature and later inverted, stacked onto each other and incubated at 37°C 
overnight. To prepare an amplified library lysate, 10 ml 1 x lambda dilution buffer was 
added to each plate and the plates were incubated at room temperature for 8-9 h on a 
platform shaker. With a sterile 5 ml pipette, the lambda phage lysates were transferred 
into a sterile beaker. This was well mixed and poured into sterile 50 ml polypropylene 
screw-:cap tubes; 10 ml of chloroform was added to each tube and mixed by hand. 
This was followed by a 10 min centrifugation step at 7000 rpm. The supernatant was 
collected into fresh tubes. An aliquot was used for titre determination and blue/white 
screening, while the remainder was dispensed into 10 ml tubes with 7 % DMSO (i.e. 
7.5 ml amplified cDNA library + 525 III DMSO, dimethyl sulfoxide). This was stored 
at -70°C. 
2.8.2.9. Determining the percentage of recombinant clones and titre determination of 
the amplified cDNA library 
To determine the efficiency of the recombination and the success of the ligation, 
blue/white screening was carried out, i.e. E. coli XLI-Blue bacteria were transduced 
with the phage containing the lala cDNA insert and the plate was screened for blue 
plaques on medium containing IPTG (isopropyl beta-D-thiogalactopyranoside) and X-
gal (5-bromo-4-chloro-3-indolyl beta-D-galactopyranoside). To perform blue/white 
screening, the same procedure was followed as described in 2.8.2.7., except that X-gal 
and IPTG solutions were added to the molten top agarose before plating the 
phagelbacteria mixture. After incubating the plates at 37°C overnight, the ratio of the 
white (recombinant) to the blue (non-recombinant) plaques were calculated. 
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To titre the amplified cDNA library, 10 ml of the library lysate was diluted 1110 000 
in Ix lambda dilution buffer. One III of this was added to 200 III bacterial cells and 
cultured overnight at 37 DC. 
2.8.3. Primersfor peR amplification of lola eBB eDNA 
From the known amino acid sequence of lola cHH-I (see Fig. 41), two non-
degenerate primers were designed (using the codon usage of Drosophila 
melanogaster) for use in PCR: an upstream sense primer, lola cHH pos (5' -
GCCCTGTTCGAYCAGAGCTGCAAGGGCGT - 3'), encoding the N-terminal 
region of the cHH peptide A VFDQSCKGV, and a downstream anti-sense primer, 
lola cHH neg (5' - CACCATCTGCACSGAGGCCACGTACTC - 3'), encoding the 
C-terminal region of the cHH peptide VDEYV ASVQMV. 
2.8.4. peR cloning of the coding region of lola eBB eDNA 
RNA was extracted from 30 lala XOs from male specimens with Trifast; first strand 
cDNA was synthesised and ds eDNA was amplified according to the protocol 
supplied with the SMARTTM kit from CLONTECH (see 2.8.1. and 2.8.2. above). In 
the same way, RNA was also extracted from 10 XOs from female lola specimens and 
ds cDNA was amplified. PCR reaction mixtures (total volume 50 Ill) contained 5 III 
ds lala cDNA, 5 III lOx eDNA PCR buffer*, 5 III dNTP mix,S III each of lala cHH-
pos and -neg primers (10 pmoVIll) and 0.2 III Taq DNA polymerase* and sterile 
water. The addition of 10 III 5x Q-Solution* was also included in some of the reaction 
mixes (products marked with * were obtained from the QIAGEN Taq PCR Kit; Q 
solution is an agent which consists predominantly of DMSO and Mg ++ and which 
modifies the melting behaviour of DNA in a PCR reaction). As a control, reaction 
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mixtures without cDNA template were included. PCR was performed with the 
following temperature profile: 96 DC for 1 min, followed by 30 cycles of a 45 s 
denaturing step at 96 DC, a 1 min annealing step at 55 DC and an elongation step at 72 
DC for 1 min; a final extension step of 10 min at 72 DC concluded the cycling in a 
GeneAmp 480 cycler. 
2.8.5. Gel extraction of specific peR products 
The PCR products from the male RNA samples were pooled and run on an 
agaroselEtBr gel. The same procedure was carried out with the specific PCR products 
from female RNA samples. The gels were briefly viewed under blue light, the DNA 
bands were excised from the gel with clean scalpel blades and put into preweighed 
Eppendorf tubes. The weight of each excised band was then determined and the DNA 
was extracted from the gel, following the QIAGEN QIAquick Gel Extraction protocol 
using the reagents supplied with the kit. Briefly, 3 volumes of QG buffer were added 
to each gel piece. The tubes were incubated at 50 DC for 10 min, with periodic 
vortexing. To each 100 mg of gel slice, 100 III isopropanol was added. The mixture 
was applied in volumes of 800 III to a QIAquick spin column that was fitted into a 2 
m1 collection tube. The column was then centrifuged for 1 min at room temperature, 
14000 rpm in an Eppendorf 5415C centrifuge. After the centrifugation step, the buffer 
from the collection tube was discarded; the DNA was bound to the column. In an 
additional step to remove traces of agarose, 500 III QG buffer was added to the 
column and centrifuged for 1 min. The column was then washed with 750 III PE 
buffer and allowed to stand for 2 min before centrifuging for 1 min (this step is 
important for blunt-ended ligations). The centrifugation step was repeated and, finally, 
30 III elution buffer (10 mM Tris-HCI, pH 8.5) was added to the column to elute the 
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bound DNA. The quantity of the recovered DNA was estimated from the intensity of 
the bands on an EtBr agarose gel, relative to that from known quantities of DNA in 
commercially available molecular weight markers. 
2.8.6. Cloning oj lala-specific PCRproducts 
The PCR products were cloned into pCR®-TOPO® vector (Invitrogen) with EcoR I 
restriction sites (see Fig. II for a detailed map of the TOPO® vector). The efficient 5 
min, one-step cloning strategy was carried out according to the protocol supplied with 
the Invitrogen TOPO T A Cloning Kit. This strategy enables the direct insertion of 
Taq polymerase-amplified PCR products into a plasmid vector, as illustrated in Fig . 
. 12: the plasmid vector pCR® 2.1-TOPO®, is supplied Iinearised with (i) single 3'-
Thymidine (T) overhangs for T A cloning, and (ii)' T opoisomerase I covalently bound 
to the vector. Taq polymerase has a terminal transferase activity that adds a single 
deoxyadenosine (A) to the 3' ends ofPCR products. This allows PCR inserts to ligate 
efficiently with the vector and occurs spontaneously within 5 min at room 
temperature. Thus, for the cloning reaction, 2 J!1 PCR product (approximately 100 ng) 
was mixed with 0.5 III vector (i.e. 5 ng plasmid DNA in 50 % glycerol, 50 mM Tris-
HCI pH 7.4, 1 mM EDTA, 1 mM DTT,O.l % Triton X-IOO, 100 Ilg/ml BSA and 
phenol red). The cloning reaction was carried out for 5 min at room temperature and 
the reaction was stopped by the addition of 0.5 III 6x TOPO® Cloning Stop Solution 
(0.3 M NaCI, 0.06 M MgCh), mixed for 10 s at room temperature and placed on ice. 
The stop solution creates conditions that favour dissociation of topoisomerase from 
the DNA. The TOPO® Cloning Reaction was then transformed into chemically-
competent cells in the following manner: 2 J!1 of the cloning reaction was added to a 
vial containing 50 J!l of One Shot® cells (Le. E. coli Top 10 strain, Invitrogen). The 
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lacZaATG Hind 111 Kpnl Sac! BamHI S,oe I M13 Reverse Primer I I I I I I 
CAG GA.l< ACA G~-'-. ACe ATG A ... .,. ACG eCA AGC .... u GTA CCG AGC .,..,'''''':-.~" '''' . CCA C::A G"'''' CT7 TGr eGA TGG TAC TAA TGC G"''' '-1. TCG AAe CAT GGC TCG AGC C::;.. G~-". GAr 
BstX I EcaR I EcoR I 
I I : 
GrA ACG GCC GCC AGT GTG CTG GM TTC Gee CTJ'}4 ... jihffiIft#PG GGC GA.l< TTC TGC 
CAT TGC CGG CGG TCA CAC GAC crr MG eGG G~iI. ' ....... TTC eeG crr AAG ACG 
-' 
EcoR V BstX I Not I Xha I Nsi I Xoa I A,oa I 
I I I I II 1 
74 
AGA TAT CCA TCA CAe TGG CGG CCG CTC GAG CAT GCA TCT AGA GGG ecc ~~T TCG cce TAT 
T:::r ATA GCT AGT GTG Ace GCC GGe GAG CTC GTA CGT AGA TCT cce GGG TTA AGC GGG ATA 
+ 
17 Promoter M13 Forward (-20) Primer M13 Forward (-401 Primer 
ACT GAG TCG TAT l' 
TCA eTC AGC ATA A 
Comments for pCR®2.1-TOPO® 
3908 nucleotides 
LacZa. fragment: bases 1-571 
AAT TCACTG GCC GTe OTT TTA CAA cm CGT GAe TGG GA}\. MC 11 426 
T1'A AG1'iGAC CGG CAG CM AAT grT Ger GCA CTG ACC CTT TTG. 
pCR®2.1-TOPO® 
3.9 kb 
M 13 reverse priming site: bases 205-221 
Multiple cloning site: baSes 234-357 
T7 promoter/priming site: bases 364-383 
M13 Forward (-20) priming site: bases 391-406 
M 13 Forward (-40) priming site: bases 411-426 
fl origin: bases 548-962 
Kanamycin resistance OR.F: bases 1296-2090 
Ampicillin resistance OR.F: bases 2108-2968 
pUC origin: bases 3113-3786 
Fig. 11. Restriction map of the plasmid vector pCR® 2.I-TOPO® (supplied by Invitrogen) 
used for cloning the Ja/a-specific PCR products. 
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"Activated" TOPOti Cloning Vector 
3' 
Taq·amplified PCR product 
with 3'·A overhangs 
... 
. . . . ..... 
3' S' 
5 minutes at room temperature 
Ugation complete-
ready for transformation 
75 
Fig. 12. A diagrammatic overview of the principle of TO PO TA Cloning (from 
Invitrogen). The plasmid vector is supplied with single 31 thymidine (T) overhangs for 
TA cloning and with covalently-bound topoisomerase I (the "activated" vector). Taq 
polymerase has a non-template-dependent terminal transferase activity that adds a single 
deoxyadenosine (A) to the 31 ends ofPCR products. Thus, PCR inserts ligate efficiently 
with the vector. The ligation activity oftopoisomerase I is exploited by this system to 
allow efficient and spontaneous ligations within 5 min at room temperature. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
76 
mixture was incubated on ice for 30 min, followed by a 30 s heat-shock at 42 Dc. The 
tubes were then immediately transferred onto ice and 250 III of room temperature 
SOC medium (2 % tryptone, 0.5 % yeast extract, 10 mM NaCl, 2.5 mM KCI, 10 mM 
MgCh, 10 mM MgS04 and 20 mM glucose) was added. The tubes were then shaken 
horizontally at 37 DC for 30 min. From each transformation, 50 III was spread onto 
ampicillin plates. The plates were incubated overnight at 37°C and positive clones 
were picked for further analyses. 
2.8.7. Analysis ofpositive clones and sequencing 
T en ampicillin-resistant, white colonies were cultured overnight in LB medium 
containing 50 Ilglrnl ampicillin. Plasmid DNA was isolated by carrying out a mini-
prep (plasmid mini purification) using a kit and protocol from QIAGEN. The 
plasmids were then analysed for the insert by restriction analysis (i.e. digestion with 
EcoR I). Clones with inserts of the expected length were sequenced from both sides 
using an automated sequencer. 
2.8.8. Preparation of Jala XO cDNA library for screening 
XLI-blue coli cells were resuspended in 7.5 ml 10 mM MgS04 . Two III of the 
unamplified Jala eDNA library (approximately 10.64 x 103 pfu) were added to 500 III 
of resuspended bacterial cells and the tubes were incubated for 15 min at 37 ° C. Five 
rnl top agarose was added to the bacterial solution and rapidly poured on the surface 
of 15 cm MgS04 agar plates. A numbered nylon filter was deposited on the top agar 
for 2 min (QIABrane nylon membranes,~ 132 mm, QIAGEN). The filter was 
carefully peeled off and the plate returned to 4 0c. The filter was then placed in DNA 
denaturing solution (1.5 M NaCl, 0.5 N NaOH) for 5 min, then into neutral ising 
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solution (1.5 M NaCl, 0.5 M Tris-HCI, pH 8) for 5 min and finally, into 2x SSC 
solution (20x SSC stock consisted of 3 M NaCl, 3 N sodium citrate.2H20, pH 7) for 2 
min. The filters were then blotted on Whatmans filter paper and the DNA was fixed to 
the filter by UV cross-linking. The filters were wrapped in foil, labeled and stored at -
20 DC until screening with a digoxygenin-labeled RNA probe (ROCHE Dig labeling 
kit). 
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3. RESULTS 
3.1. Comparative immunocytochemistry: localisation of cHHlMmNm peptides 
in eyestalks of two spiny lobster and one crab species 
3.1.1. Morphology of crustacean eyestalks 
Longitudinal sections through the eyestalks of 1. lalandii, P. homarus and C. maenas 
were stained with haematoxylin, counterstained with eosin and examined with a light 
microscope. Figure 13a shows the typical histological features of a decapod 
crustacean eyestalk: the retina, 4 optic ganglia, SG, xo and optic nerve. The retina 
contains the photoreceptor units, the ommatidia, each of which contains 7 retinular 
cells arranged in a characteristic pattern which appears flower-like when viewed in 
cross-section (Fig. 13c). The optic ganglia consist of the lamina ganglionaris (distal to 
the retina), the medulla externa, the medulla interna and the medulla terminalis. The 
sinus gland, a neurohaemal organ, is located on the eyestalk just beneath the 
exoskeleton and adjacent to the optic ganglia: the gland is comprised of axon 
terminals surrounding a blood sinus. The axons arise from neurosecretory cells of the 
medulla terminalis ganglionic X-organ (abbreviated MTGXO, or simply referred to as 
X-organ) and can be seen as a definitive tract leading into the sinus gland (Fig. 13b). 
From several morphological reports on other decapod crustaceans, it seems that the 
location of the sinus gland is different in the spiny lobster. Figure 13a shows that in 
the spiny lobster the sinus gland is situated at the transition of the medulla interna and 
the medulla terminalis rather than at the transition of the medulla extema and the 
medulla interna. The XO is located laterally to the medulla terminalis and is evident 
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Fig. 13. Consecutive histological sections of the eyestalk of P. homarus: a, c stained with 
haematoxylin and eosin to show its morphology and b immunostained with anti-Hoam 
cHH to illustrate components of the neurosecretory system. c The retina in cross-section, 
showing the floral-like arrangement of the retinular cells of the ommatidia. 
(1 ommatidia, 2 lamina ganglionaris, 3 medulla externa, 4 medulla interna, 5 medulla 
terminalis, 6 optic nerve, M muscle, S blood sinus, curved arrow sinus gland, arrow X-
organ, open arrow sinus gland tract 
Scale bar 1 mm 
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as a cluster of cells with large nuclei . In Fig. 13b, only the components of the XO-SG 
complex are illustrated after immunocytochemical staining with an antibody raised 
against a dill molecule. 
3.1.2. Enzyme-linked immunocytochemistry: establishing optimal dilutions of primary 
antisera 
The donors of the different antisera had recommended the following dilutions (pers. 
comm.) as optimal for the specific antigens against which the antisera had been 
raised: anti-Hoam dill and anti-Hoam vrn 1: 10 000 and 1 :500, respectively, anti-
Capa cHH and anti-Capa :MIH 1: 4000, and anti-Prbo cHH at least 1 :500 (as tested in 
a dot blot assay) . To ascertain whether the antisera would at all recognise epitopes on 
eyestalk material from other crustacean species, ELISAs were carried out on crude 
extracts of sinus glands from J. lalandii, P. homarus and C. maenas. Positive 
immunoreactions were obtained with all the antisera on 0.25 SGE extract. Crude 
extracts of sinus glands from each of the 3 species were used as antigens with serial 
dilutions of all 5 antisera to determine an optimal dilution. Table 3 shows that anti-
Hoam cHH strongly recognised lala and Cama epitopes, even at antibody dilutions of 
1: 10 000 and 1: 8000, respectively, but a more concentrated antibody solution (1:2000) 
was necessary to produce the same result in Paho. Similarly, anti-Prbo cHH did not 
recognise Paho epitopes as well as it did those of lala and Cama. Both antisera raised 
against crab (Capa) antigens were most reactive with Cama material, followed by 
lata antigen in the case of anti-Capa cHH serum. Anti-Capa :MIH, however, only 
weakly recognised epitopes on lala and Paho sinus gland material. With the anti-
Hoam vrn serum, the most intense reaction was against sinus glands from Cama with 
an antibody solution of 1 : 1000 required to obtain a clear positive result. 
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Table 3. Serial dilution of primary antisera (see text for abbreviations) as tested in ELISA with crude extracts of sinus glands from spiny lobster (.J. lalandii 
- - - - - - - -- -- --- - - -_. ted. 
Anti-Hoam cHH Anti-Prho cHH Anti-Capa cHH Anti-Capa MIH Anti-Hoam VIH 
I: 10000 1:8000 1:6000 1 :4000 1 :2000 1:5000 1:2000 1 :6000 1 :4000 1 :2000 1 :6000 1 :4000 1 :2000 1 :2000 1: 1000 1:500 
lata 0.45 0.56 0.68 0.95 1.17 0.62 1.95 0.33 0.49 0.80 
- -
0.19 
-
0.\3 0.43 
0.25 SGE 
Paho 
- -
0.12 0.20 0.50 0.22 0.40 
-
0.13 0.20 0.17 0.24 0.29 0.1 0.22 0.5\ 
0.25 SGE 
Cama 0.26 0.45 0.50 0.70 0.94 0.49 0.51 0.52 0.66 1.40 1.12 1.30 1.58 0.14 0.35 0.60 
0.25 SGE 
L-_ I 
- IS used where absorbance values were below 0.1. 
00 
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3.1.3. Tissue immunocytochemistry: peroxidase and immunofluorescence techniques 
In an three species, an immunocytochemical reaction was observed in the sinus gland, 
a number of neurosecretory cens of the X-organ and, in some cases, in part of the XO-
SG tract (Figs. 14-16). Only in the case of anti-Capa Mill was non-specific, 
background staining observed. This background immunoreaction was visible in 
striated muscle tissue and other neural tissue and was not eliminated by blocking 
endogenous peroxidases in the tissue sections nor by preabsorption of anti-Capa MJH 
with Capa MJH peptide (Fig. 17). In all instances large immunoreactive perikarya 
formed a distinct group at the lateroventral part of the medulla terminalis, clearly 
defining the shape of the X-organ. In the perikarya the immunoreaction was visible as 
clumps of granular material scattered around the nucleus, whereas in the sinus gland 
the "Herring body" -like axonal endings are stained. In all cases, the immunoreaction 
was more intensive in the sinus gland than in the perikarya. In the case of P. homarus 
with anti-Hoam cHHlVIH and anti-Capa MIH, parts of the axonal tract between the 
sinus gland and the X-organ were also immunostained (see for example, Fig.13b). The 
serial dilutions of primary antibodies were also carried out on tissue sections and the 
staining results were co-incident with those obtained from ELISA experiments (see 
above). However, although a visible immunoreaction was obtained in the sinus gland 
with the very dilute antibody solutions, the perikarya of the XOS were negative. 
Therefore, the antisera were used at a dilution where both components of the XO-SG 
complex were immunostained, viz. anti-Hoam cHH 1:5000, anti-Prbo cHH 1 :5000, 
anti-Capa cHH 1 :4000, anti-Capa MIH 1 :2000 and anti-Hoam VIH 1 :500. The 
immunostained axonal swellings in the sinus gland of the two spiny lobster species 
were indistinguishable from each other after the application of different primary 
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Fig. 14. Immunocytochemical staining of the neurosecretory system (sinus gland a-c, g and h; 
X-organ d-f, i and j) on consecutive sections (except h,j) of J lalandii with the following 
primary antisera: anti-Hoam cHH (a,d), anti-Capa MIH (b,e), anti-Hoam VIH (c,f), anti-Capa 
cHH (g, i); (h,j) immunostained with anti-Prbo cHH. 
Scale bar 50 f.!m 
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Fig. 15. Immunocytochemical staining of the neurosecretory system (sinus gland 
a-c, g; X-organ d-f, h and i) on consecutive sections of P. homarus with the 
following primary antisera: anti-Roam cHH (a,d), anti-Capa MIH (b,e), anti-
Roam VIH (c,t), anti-Capa cHH (g,h); (i) immunostained with anti-Prbo cHH. 
Scale bar 50 ~m 
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Fig. 16. Immunocytochemical staining of the neurosecretory system 
(sinus gland a-c, g and h; XO d-f, i) on consecutive sections of C. 
maenas with the following' primary antisera: anti-Hoam cHH (a,d), 
anti-Capa MIH (b,e), anti-Hoam VIH (c,!), anti-Capa cHH (g, i); (h) 
immunostained with anti-Prbo cHH. 
Scale bar 50 J.lm 
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Fig. 17. Adjacent longitudinal sections through the eyestalk of P. homarus immunostained with a. anti-Capa 
MIH serum and b. anti-Capa MIH serum preabsorbed with Capa MIH peptide. Arrow marks position of the 
sinus gland. Note the presence of background staining in both a. and h. Scale bar 70 11m 
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antisera. In contrast, selectivce staining patterns . could be observed in the axon 
.-
terminals of the sinus gland of. C. maenas after ., t,he application of different antisera 
(Fig. 16). 
In all three investigated speCIes, immunostaining with anti-cHH was consistently 
strong, whereas with anti-MIH, staining was strongest in C. maenas tissue; fainter 
staining was mostly obtained with anti-VIH in all species. Staining consecutive 
sections of the three crustacean species with anti-cHH, anti-MIH and anti-VIH 
showed immunoreactivity to all these antisera III the same perikarya, i.e. co-
localisation (Figs. 14-16). However, a number of cells showed an immune response 
with only one antiserum, which could indicate that a subpopulation of cells produces 
only one neuropeptide. Alternatively, it could be speculated that the neuroendocrine 
cells are in different stages of secretion. 
To further examine the idea of co-localisation of the clffi!MIH/VIH peptides in the 
same neuronal cell bodies, tissue sections were double-stained with mixtures of 
primary antisera and each different antiserum could be visualised by a fluorescent 
marker (either FITC or TRITC). In general, the staining intensity of the fluorescent-
labeled secondary antisera was not satisfactory and was related to the old age of these 
antisera (used well after the expiry date of the product). Nevertheless, in Fig. lSa-d, 
co-localisation of MIH and cHH is evident in the axon terminals of the SG, as well as 
in one neuron of the XO in 1. lalandii tissue. Co-localisation of MIH and VIH is 
shown in Fig. lSe-h. 
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Fig. 18. A pair oflongitudinal sections through the eyestalk of 1. lalandii double-stained with (i) 
anti-Capa Mill (TRITC label: a,c) and anti-Hoam cHH (FITC label: b,d) and (ii) anti-Capa Mill 
(TRITC label: e,g) and anti-Hoam VIH (FITC label: f,h). a and b, and e and f show overlapping 
immunoreactions in the sinus gland, whereas c and d, and g and h, show co-localisation of 
immunoproducts in cell bodies of the X-organ. Scale bar 30 flm 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
89 
3.1. 4. Preabsorption experiments and other controls 
To determine whether the apparent co-localisation of neuropeptides might be due to 
cross-reactivity of the antisera at the dilutions used, preabsorption experiments were 
carried out. The preabsorption of anti-Capa cHH serum with Capa cHH peptide, and 
anti-Capa Mill serum with Capa Mill peptide completely abolished the staining of 
cHH- and Mill-immunoreactive structures (Fig. 19). The non-specific background 
staining that is evident in the optic ganglia with anti-Capa Mill is not removed by the 
application of the antiserum preabsorbed with its antigen (Fig. 19i, j). 
To establish whether anti-Hoam Vlli cross-reacted with cHH or Mill, anti-Hoam 
Vlli serum was preabsorbed independently with Capa cHH peptide and with Capa 
Mill peptide and then applied to J lalandii tissue sections. These antigen-antibody 
complexes did not eliminate specific staining (Fig. 20). This issue was further 
investigated in a preliminary ELISA investigation. Putative cHH and Mill peptides 
were identified in HPLC peak fractions from crude sinus gland extracts of J lalandii 
and C. maenas using anti-Hoam cHH and anti-Capa MIH antisera. These fractions 
were then preabsorbed with anti-Hoam Vlli and tested for immunoreactivity on the 
putative lala cHH and Cama MIH fractions. Figure 21 A,B shows a typical elution 
pattern of the fractionation of J lalandii and C. maenas sinus gland extract on HPLC 
under the given chromatographic conditions. Of the J lalandii peak fractions, 
numbered 1-12 (Fig. 21 A), peaks 7-9 showed the highest cHH immunoreactivity (Fig. 
21 C). Fractions 7 and 9 also tested positive with anti-Vlli serum; after preabsorption 
with these fractions, Vlli immunoreactivity was reduced between 2- and 4-fold (Fig. 
2IE). Concerning the C. maenas fractions numbered 1-12 (Fig. 21B), peak 9 showed 
the highest Mlli immunoreactivity (Fig. 21 D) and was also immunopositive to the 
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Fig. 19. Pairs of adjacent sections through the sinus glands of 1. lalandii (a, b, g, h), P. hornarus 
(c, d, i, j) and C. maenas (e, f, k, I) immunostained with anti-Capa cHH (a, c, e), anti-Capa cHH 
preabsorbed with Capa cHH (b, d, f), anti-Capa MIH (g, i, k) or anti-Capa MIH preabsorbed with 
Capa MIH (h, j, I). 
Scale bar 50 ~m 
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Fig. 20. Pairs of adjacent sections 
through the sinus gland of J 
• lalandii irnmunostained with (a, 
c) anti-Hoam VIH, (b) anti-Hoam 
VIH preabsorbed with Capa cHH 
and (d) anti-Hoam VIH 
pre absorbed with Capa MIH. 
Scale bar 50 ~m 
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Fig. 21. HPLC profile of extracts of A. 12 sinus glands from J lalandii and B. 6 sinus glands from C maenas. 
The gradient is indicated by dotted lines; solvent A= 0.11 % trifluoracetic acid (TF A) in water, solvent B= 0.1 
% TF A in 60 % acetonitrile. C. Identification of Jala cHH in HPLC fractions in A by ELISA with anti-Hoam 
cHH. D. Identification of Cama MIH in HPLC fractions in B by ELISA with anti-Capa MIH. E. 
Immunoreactivity of anti-Hoam VIH antiserum on putative Jala cHH and Cama MIH before and after 
preabsorption with the respective cHH or MIH peptides as shown by ELISA. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
92 
anti-Roam VIH serum. After preabsorption of anti-Roam VIH serum with peak 9 
material, the resultant immunoreactivity showed a 4-fold reduction. To determine 
whether different peptides of the spiny lobster are indeed reacting with different 
antisera, peak fractions obtained from HPLC separation of J lalandii crude extracts of 
SG were tested by ELISA using anti-Roam elm, anti-Roam VIH, anti-Capa elm and 
anti-Capa MIH antisera. The HPLC fractionation pattern obtained (not shown) was 
similar to that of Fig. 21A and the eluted peaks were numbered identically as in Fig. 
21A. Fig. 22 shows that anti-Capa elrrl recognises the same two peaks as anti-Roam 
cHH, viz. peaks 7 and 9. However, an additional major peak (peak 5) is strongly 
recognised by anti-Capa cHH. This peak 5 is, however, the sole peak recognised by 
anti-Capa MIH. In contrast, anti-Roam VIH did not recognise a unique peak but 
weakly cross-reacted with the three major HPLC peaks, 5, 7 and 9 (Fig. 22). 
In all cases of tissue immunocytochemistry or ELISA, substitution of the primary 
antisera with PBS or normal sera did not result in specific staining (results not 
shown). 
3.2. Purification and characterisation of cHHlMffiIVffi family peptides from J. 
lalandii 
3.2.1. Sinus gland preparation, peptide separation and characterisation by antisera 
and mass spectrometry 
The sinus gland of J lalandii was easily visible, even with the naked eye, as a pale-
blue disc on the eyestalk, lying just beneath the exoskeleton and adjacent to the optic 
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Iii anti-Hoam cHH 
0 anti-Capa cHH 
• anti-Capa MIH 
l1li anti-Hoam VIH 
Peak No.5 Peak No.7 Peak NO.8 Peak No.9 
Fig. 22. Immunoreactivity, as shown by ELISA, of anti-Hoam cHH, anti-Capa 
cHH, anti-Capa MIH and anti-Hoam VIH on HPLC-separated peak fractions from 
crude extracts of sinus glands from J lalandii (see Fig. 21 A for a typical elution 
profile). 
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ganglia (Fig. 23). Sinus glands could only be dissected whole from freshly-ablated 
. .' . D 
eyestalks; when older material was used (stored at 4 C or frozen) the gland was 
visibly disintegrated and the peptide yield was markedly reduced . Therefore, SGs ' 
. were quickly dissected from fresh material and kept in ice-cold homogenisation 
solution. In pilot experiments, 0.1 N HCI was used with 3 different homogenisation 
techniques: (1) the tissue was disrupted by short bursts of sonication, heated for 5 min 
at 85 DC, cooled on ice and then stirred for 1 h at room temperature. The homogenate 
was centrifuged at 14 000 rpm for 20 min at 4 DC and the supernatant collected and 
dried (see Soyez et aI., 1990). (2) The tissues ,vere sonicated on ice, centrifuged at 
room temperature for 20 min; supernatant was collected and re-extracted twice more 
(see Soyez et aI., 1987). (3) The tissues were sonicated very briefly on ice and 
centrifuged at 4 DC for 15 min; the supernatant was collected and the pellet was re-
extracted . . Sinus glands were also prepared in 10 % acetic acid and homogenised in 
the same manner as for samples in 0.1 N HC!. The success of each method was 
assessed by the reproducibility of the chromatogram and the peptide yield (by 
comparing the peak height of identical peaks). The validity of pre-separation of crude 
extracts over a C 18+ Sep-Pak column was also assessed. 
Under the same chromatographical conditions, 10 % acetic acid was found to be the 
better medium for the preparation of 1. lalalldii SinUS gland material and 
homogenisation in hot acetic acid resulted in the most reproducible HPLC 
chromatograms with the highest peptide yields (results not shown). The method of 
homogenisation described in 2.2., using a glass homogeniser without sonication, 
became the method of choice for preparing crude extracts of sinus glands from 1. 
lalalldii. Different HPLC gradients were also tested in pilot experiments to obtain the 
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Fig. 23. The eyestalk of J lalandii 3. encapsulated in the exoskeleton and b. removed of its 
exoskeleton. The sinus gland is seen as a pale blue disc (arrow) on the white neural tissue of 
the optic ganglia. 
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best resolution of the more-hydrophobic material in the sinus glands. A gradient from 
20-62 % B in 10 min, followed by a linear increase to 80 % B in 50 min, resulted in a 
good separation of the late-eluting, more-hydrophobic peak material. Figure 24 shows 
the typical HPLC chromatogram of an extract of 100 SGs from J lalandii. Fractions 
of one ml were collected, aliquots thereof were tested in ELISAs with antisera raised 
against Hoam cHH, Hoam VIR, Capa cHH and Capa MIH to identify similar 
peptides in J lalandii. From Fig. 25A, B it is clear that all 5 peak fractions are 
recognised by the cHHlMlHlVIH antisera. Fractions corresponding to peaks 1, 2, 4 
and 5 were strongly reactive with anti-Hoam cHH (Fig. 25A) and anti-Capa cHH 
(Fig. 25B). These fractions were also all recognised by anti-Hoam VIR, so that no 
unique peak was identified by this antiserum (Fig. 25A). Anti-Capa cHH antiserum, 
in addition to recognising fractions of peaks 1, 2, 4 and 5, reacted also with fractions 
that corresponded to peak 3 (Fig. 25B). Peak fraction 3, however, was the sole peak 
clearly recognised by anti-Capa MIH antiserum (Fig. 25B). Mass analyses of peaks I-
S by MALDI-TOF, revealed the following [M+Hf data: 7666.41, 7613.53, 9007, 
8381 and 8358, respectively. 
3.2.2. Biological activity: hyperglycaemia 
A homologous assay, using live juvenile specimens of J lalandii, was established to 
measure glucose concentration in haemolymph samples in response to injected 
substances. Dried material ofHPLC peaks 1-5 (Fig. 24) were redissolved in sea water, 
injected at 1 SGE/50 III and its effect on glycaemia was measured 2 hr after injection. 
No significant increase in glucose concentration was obtained after the injection of 
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Fig. 24. A typical RP-HPLC fractionation of an acetic acid extract of 100 sinus glands from J lalandii 
on a Nucleosil C-18 column. Gradient (indicated by dotted lines) with solvents A: 0.11 % TFA in 
water and B: 0.1 % TF A in 60 % acetonitrile. Peaks were labeled in order of elution. 
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Fig. 25. Immunoreactivity, as shown by ELISA, of A anti-Hoam cHH 
and anti-Hoam VIH, and B anti-Capa cHH and anti-Capa Mill sera on 
aliquots ofHPLC-separated fractions from crude extracts of sinus 
glands from J. lalandii (see Fig. 24 for HPLC elution profile). 
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sea water and peaks 1-3 (Fig. 26). Significant increases in the glucose concentration 
were consistently obtained after the injection of crude extracts of lala sinus glands 
and peaks 4 and 5 (Fig. 26). On the basis of their hyperglycaemic activities in vivo, 
peaks 4 and 5 are referred to as lala cHH-I and lala cHH-II, respectively. 
3.2.3. Biological activity: effects on ecdysteroid synthesis 
The biological activity of a putative moult-inhibiting peptide was deduced from the 
.indirect evidence of ecdysteroid synthesis in the V-organs (YOs), dissected from adult 
specimens of 1. lalandii and incubated in vitro. The ecdysteroid titre in the incubation 
medium was determined by EIA. 
3.2.3.1. Characterisation of circulating ecdysteroids 
To establish a meaningful EIA for the quantitative assessment of the biological 
significance of lala MIll on ecdysteroid production, the ecdysteroids present in the 
haemolymph of 1. lalandii specimens were firstly identified. Ecdysteroids extracted 
from haemolymph were separated by normal-phase (NP) HPLC (Fig. 27 A); aliquots 
of the collected fractions were assayed by EIA using the antiserum AS 4919. Four 
immunoreactive compounds were detected (Fig. 28). Their retention times on HPLC 
were compared with those of known synthetic ecdysteroids to establish their identity 
(Fig. 27B). The major immunoreactive compound had the same retention time as 20E 
and a minor peak had the same retention time as E. In haemolymph samples from 
adult specimens, the concentration of 20E was more than 5050 pg/ml, whereas 
samples from juvenile specimens had a much higher concentration, viz. 72 ng/ml. No 
compound co-migrating with ponasterone A was detected, and the 2 less-polar 
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Fig. 26. Effects of peaks 1-5 on glycaemia in juvenile J. lalandii. Before injection, 
50 III ofhaemolymph was withdrawn (blank bar), and then again 2h after injection 
(black bar) of sea water (SW; n=5), 0.5 SGE of crude extracts of sinus glands (SO; 
n=8), or 1 SOE of peak material from HPLC peak 1 (n=10), peak 2 (n=10), peak 3 
(n=12), peak 4 (n=lO) and peak 5 (n=11). Average values are indicated ± SD. 
**Significant difference (p<0.05) when compared with the injection of sea water, 
using the Student's Hest. NS, not a significant difference. 
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Fig. 27. A. Profile of the compounds extracted from 5 ml 
haemolymph of adult (intermoult) J. lalandii and separated by 
NP-HPLC over a Hypersil column. A flow rate of 1 ml/min with 
the isocratic mixture of dichloromethane/isopropanol/water 
(125:30:2) was maintained. B. Retention times of synthetic 
ecdysteroids in a reference run using the same NP-HPLC system, 
column, solvents and isocratic conditions as in A. Reference 
compounds used: ecdysone (E), 20-hydroxyecdysone (20E), 
Ponasterone A (PoA), 2-deoxyecdysone (2dE) and 2-deoxy-20 .. 
hydroxyecdysone (2d20E). 
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Fig. 28. EfA profile of ecdysteroid compounds separated from haemolymph of J lalandii specimens by NP-HPLC (see Fig. 27A for 
typical profile). NP-HPLC fractions of 0.5 ml were collected and analysed in the assay with AS 4919 as antiserum. EIA activity is 
expressed as pg equivalents of 20E. Arrows indicate the retention time of reference ecdysteroids: ecdysone (E), 20-
hydroxyecdysone (20E), 3-dehydroecdysone (3DE), 2-deoxyecdysone (2dE) and 2-deoxy-20-hydroxyecdysone (2d20E). 
Unidentified, immunoreactive compounds are labeled as "X" and "Y". 
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immunoreactive compounds did not correspond to any of the known ecdysteroids 
(Fig. 28). For the purpose of designing an EIA for the in vitro incubation ofYOs of 1. 
lalandii, however, 20E was considered to be the major circulating ecdysteroid and, 
hence, it is assumed that either E or 3DE or both, are secreted by the YOs of the 
spiny lobster. 
3.2.3.2 In vitro incubations ofY-organs 
3.2.3.2.1. Location and dissection ofYOs 
The anatomy of the neuroendocrine system of the spiny lobster is not particularly 
well-documented and the lack of such an atlas/dissecting guide is sorely felt. 
Paterson (1968) describes the position of the YO in 1. lalandii as follows: " .. .it is 
generally located near the ventral body wall and has been interpreted by Gabe as a 
thickening of the hypodermis." (page 204). And "It lies almost horizontally near the 
anterior limit of the epimeral attractor muscle and is also close to the maxillary 
epimera and the base of the second maxilla." (page 204). Further, " ... the lateral 
diverticulum of the dorsal lobe of the digestive gland bulges into the anterior part of 
the branchiostergite." (page 205). With this information, many dissections were 
carried out in an attempt to locate the YOs. The successful dissection is initiated by 
removing the lateral carapace and the underlying tissue of the cephalothoracic region, 
i.e. the branchiostergite (Fig. 29A). With a blunt-bladed knife, the exoskeleton is 
carefully removed from the underlying tissue and discarded. With the epidermis-side 
down in a dissecting dish, the second maxilla can be sl~en with its broad basal plate 
(scaphognathite) onto which the hepatic (digestive) gland protrudes (Fig. 29B). 
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Fig. 29. Location and dissection of the Y-organ (YO) of J lalandii. A. Lateral view of an 
adult specimen showing the branchiostergite, the area removed for further dissection 
(demarcated by dotted line) and the general position of the YO (indicated by arrow). B. 
The underlying tissues of the branchiostergite wall : H=hepatic gland, S=scaphognathite, 
M=2nd maxilla, arrowhead pointed at interdigitations. C. The YO (arrow) partially 
dissected from the scaphognathite. D. The YO removed from other tissues and 
illuminated from below to show internal structures. Scale bar 10 mm 
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Behind the interdigitation on the scaphognathite lies the YO, arranged in a slight 
crescent to follow the contours of this ridged area. The convoluted ridges of the sac-
like YO are pale-yellow in colour in freshly-killed animals and can be seen as a 
thickening of the inner epidermal wall (Fig. 29C). In adult specimens of 1. lalandii 
(carapace length 9.2 em) the YO was 10 mm long and approximately 5 mm high 
(Fig. 29D). Because of the relatively large size of the YOs, these tissues could not be 
incubated in wells of a microtitre plate, but were incubated in glass block (embryo) 
dishes (diameter of well= 25mm with maximum volume capacity of 2 ml). For in 
vitro incubations, either the whole YO was used with the contralateral organ as the 
control tissue or, the YO was bisected through the vertical axis and the halves were 
incubated or, the halved YO was further bisected through the horizontal axis to 
produce quarters for incubation. In the latter case, the two upper pieces were 
compared with each other, and the two lower pieces were directly compared with 
each other, due to the crescent arrangement of the YO tissue (as shown in Fig. 30). 
3.2.3.2.2. In vitro incubations of YO and related tissues 
Because the YO is such a diffuse structure in the spiny lobster, it was not always 
easy, at first, to cleanly dissect out only YO tissue for incubations. Thus, other 
surrounding tissues such as muscle, gill, epidermis and hypodermis were incubated in 
tissue culture medium to assess whether these tissues produced anything that would 
interfere with the EIA and thereby, influence the interpretation of the results. Non-
YO tissues were incubated from the branchiostergal regions of6 adult lobsters, thus n 
= 12 for each tissue type; no ecdysteroids were detected by EIA in the incubation 
medium from all these samples and the absorbance values were identical to that of 
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Fig. 30. Scheme showing the further dissections of the YO of J. lalandi; for in vitro 
incubations. M199, tissue culture medium; M199 + S, tissue culture medium 
supplemented with a test substance, such as crude extracts of sinus glands or purified 
peptides . 
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Fig. 3 L Rates of ecdysteroid secretion from 3 pairs of whole YOs (marked with *) and 9 
pairs of halved YOs fromJ. lalandii shown as paired bars 4-12. 
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medium that were incubated without any tissue pieces (results not shown). The 
influence of surrounding tissues was also investigated by incubating a YO with the 
surrounding epidermis still intact, and comparing this with its contralateral YO from 
which the surrounding tissue had been removed. Comparable amounts of 
ecdysteroids were measured in these samples (results not shown) To determine the 
variability between YOs, pairs of YOs were cultured in M199 overnight. Fig. 31 
shows that there is mostly little variation between ecdysteroid secretions ofYOs from 
the same pair, but much more variation in ecdysteroid titre between glands from 2 
different specimens. Further, halved organs were generally also representative with 
regards to equal ecdysteroid secretion (Fig. 31). Quartered YOs (derived as shown in 
Fig. 30) similarly demonstrated equivalent production of ecdysteroids (results not 
shown). As a rule, all YO tissue pieces and whole YOs were incubated for 1 h at 
room temperature in M 199, this medium was removed and replaced with fresh 
medium containing the substances to be tested. In this way, the initial rates of 
ecdysteroid secretion could be compared and, where these preincubation values 
varied by more than 20 %, the data was discarded. 
The time-course pattern of ecdysteroid secretien in vitro was established by 
withdrawingall the culture medium after a specified time of incubation and replacing 
it with fresh medium. Maximum secretory .rates were observed during the first 3 h 
and, thereafter, the rate of secretion was lowered; after 6 h of incubation there was 
not much further increase in ecdysteroid secretion (Fig. 32). However, for 
convenience, some of the YO incubations were carried out overnight, i.e. for more 
than 6 h. 
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Fig. 32. Time-course profile of ecdysteroid secretion by the YOs of J. lalandii in vitro. 
Five YOs were incubated in 1 ml medium M199 for a total of 21 h. Medium was 
removed and replaced after 1 h, 3 h, 6 h and 15 h of incubation and subjected to EIA to 
determine the titre of ecdysteroids. Results are expressed as ng ecdysone per ml of 
incubation medium. 
Table 4. Ecdysteroid titre of individual lobsters before and after eyestalk ablation as 
determined by EIA analyses on haemolymph samples. 
Ecdysteroids (equiv. of20E ng per ml) 
Before Post- ablation (days) 
Animal i 5 23 31 36 48 80 
1 10 0.2* 0.33 0.30 - - -
(d. 12) 
2 39.41 n.s. 1.39* 0.29 - - -
(d. 30) 
3 0.11 n.s. 0.74 0.89 1.10 2 4.25 
4 0.09 n.s. 0.42 0.67 0.61 0.62 0.65 
5 34* n.s. 0.26 0.19 - - -
(d. 12) 
6 0.69 n.s. 2.35 3.26 4A2 8.74 210 
7 0.07 n.s. 0.29 0.27 0.31 0.52 0.28 
8 0.1 n.s. OAI 0.42 0.27 0.57 l.41 
9 188.07 118.55 2.16* - - - -
(d. 27) 
.. 
*Indicates the last sample taken before ecdYSIS; the exact day of ecdYSIS is mdicated In 
bold letters; n.s. = no samples taken; - means animal sacrificed. 
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3.2.3.2.3. Ecdysteroid production and inhibition in relation to moult stage 
It is not easy to distinguish the different moult stages in the spiny lobster by virtue of 
external parameters, except in the cases of pre- and post-ecdysis when the 
exoskeleton is extremely soft. The circulating ecdysteroid titre was therefore, useQ as 
an additional indicator of the moult stage, with dissection as confirmation. However, 
the study did not lend itself to accurately sub-divide moulting stages, for example as 
early-, mid-, or late-premoult, therefore, the animals were broadly classified into 
intermoult, premoult and postmoult groups. 
Haemolymph samples were analysed in EIAs with AS 4919 as antiserum. In this EIA 
system, it was found that animals in intermoult exhibited on average 15.14 ± 10.34 
ng 20EI1 0 ml haemolymph, 98 ± 174 ng 20E/ml haemolymph for premoult animals, 
and an average of 2 ± 1 ng 20E/I0 ml haemolymph was measured in postmoult 
animals (values are presented as mean ± SD and n=lO in each case). In the case of 
premoult animals the developmental stage could be confirmed by dissection and 
looking at the formation of the new cuticle. Confirmation for postmoult and 
intermoult stages came from obseIVations of the lobsters held for months in the 
aquarium (noting when the animal had previously moulted) and by the condition of 
the carapace (postmoult lobsters were generally blemish-free). Nine adult male 
specimens of J. lalandii were also destalked. Haemolymph samples were collected 
before destalking and periodically thereafter. Ecdysteroid titres were determined until 
the specimens were maximally 2 weeks post-ecdysis. From this data (Table 4) and its 
correlation with ecdysis, it is apparent that a broad classification of the moulting 
stage, on the basis of circulating levels of 20E, can indeed be made. What is further 
noticeable is that there is a dramatic and significant decline in ecdysteroid titres 
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before ecdysis (Table 4); the decline is so pronounced that ecdysteroid levels which 
are normally measured for intermoult or postmoult animals were recorded at this 
time. Animals 1, 2, 5 and 9 were already in the premoult phase at the time of 
destalking, whereas all the other animals were in the postmoult (or post-ecdysis) 
phase of the moult cycle (as seen by their ecdysteroid titres in Table 4). 
Lobsters from different moult stages were sacrificed and their YOs incubated with 
crude extracts of sinus glands of J. lalandii for 6 h to determine the effect of putative 
inhibitory peptide(s) during development. The results are depicted in Fig. 33 . 
. Animals in inter- or premoult were, thus, preferred for YO incubations with purified 
peptides (see below), because their tissues responded to MIH, whereas those from 
postmoult animals did not. With respect to postmoult YOs, no inhibition of 
ecdysteroid synthesis was recorded for 3 out of 5 pairs of organs after 6 hr, whereas 
the other 2 pairs showed 32 and 3 % inhibition, respectively, which accounts for the 
average value of 7 % inhibition in Fig. 33. It should be noted that the same 
experiments were performed, in parallel to these above, but with an overnight 
incubation period of approximately 18 hours. With this longer incubation, the 
observed inhibition increased (not significantly) in intermoult YOs to 62 ± 13 % 
(n=10) and decreased slightly but not significantly in pre:moult YOs to 49.25 ± 16 % 
(n=4). When post-moult YOs were incubated overnight with crude extracts of sinus 
glands, 3 out of 5 pairs showed no inhibition of ecdysteroid secretion, whereas 2 
pairs showed 59 and 24 % inhibition, respectively, which accounts for an average 
value of 16.6 ± 26 % inhibition. 
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Fig. 33. Inhibition of ecdysteroid production in YOs dissected from adult J lalandii 
specimens at different stages of the moult cycle. Pairs of halved YOs were used and 
crude extracts of sinus glands (1 SGE) were applied in each case. Values are expressed 
as a percentage of inhibition ± SD (n=8, 5 and 5, respectively for intermouIt, premoult 
and postmoult groups). 
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Fig. 34. Percentage of inhibition (± SD) of ecdysteroid synthesis in vitro by YOs 
from intermouIt J. lalandii as effected by different concentrations of crude extracts of 
sinus glands, n= 5, 7, 7, 5, 5 and 8, for the respective doses from 0.001 to 1 SGE. 
The lower doses (0.001 to 0.025 SGE) are shown in the insert for clarity. 
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3.2.3.2.4. Dose-dependent inhibition of ecdysteroid synthesis by crude extracts of 
sinus glands 
The inhibitory effect induced by crude extracts of sinus glands on YOs from 
intennoult 1. lalandii specimens was examined at doses between 0.001 and 1 SG 
equivalents over a 6 h incubation period. Figure 34 shows that a typical saturation 
curve was obtained, with 1 SGB producing an inhibition of 53 % and the lowest dose 
of 0.001 SGB did not have an inhibitory effect. The first dose to give a significantly 
different effect to 1 SGB was 0.025 SG, which produced an inhibition of25.4 %. 
3.2.3.2.5. Inhibition of ecdystetoid synthesis in response to various Jala peptide 
neurohormones 
RP-HPLC-derived peak material from 1. lalandii sinus glands were examined for an 
inhibitory effect on the synthesis of ecdysteroids from YOs. Pairs of YOs were 
dissected from adult lobsters and incubated overnight with 1 SGB of peak fractions 1, 
3 and 4 (see Fig. 24 for HPLC trace). Figure 35 shows that peak fractions 3 and 4 
significantly inhibited the ecdysteroid titre compared with peak fraction 1. Whereas 
peak fraction 4 (Jala cHH-I) was nearly as efficient as the putative MIH (peak 
fraction 3) in suppressing the ecdysteroid synthesis (no significant difference 
between the effect of Jala cHH-I and Jala MIH), the truncated fonn of Jala cHH-I 
(peak fraction 1) had no effect in this assay. Based on its ability to suppress the 
ecdysteroid output from YOs in vitro, HPLC peak fraction 3 is henceforth referred to 
asJa/aMIH. 
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Fig. 35. Percentage inhibition (± SD) of ecdysteroid production iIi vitro by J. lalandii 
YOs when treated with peptides purified from Jala SGs by HPLC. The YOs were 
incubated overnight with 1 SGE ofHPLC peak fractions (see Fig. 24 for profile): 1 
(n=8),3 (n=12) and 4 (n=lO); the medium was analysed by EIA. 
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Biological activity: inhibition of de novo ovarian protein synthesis 
3.2.4.1. Inhibition of de novo protein synthesis in prawn ovaries by extracts of JaZa 
SGs 
Vitellogenic ovaries, dissected from Penaeus semisulcatus (Pese), were successfully 
used in a heterologous assay with peptide material fromJ. lalandii. A dose-response 
curve for inhibition of total protein synthesis was generated by incubating pieces of 
Pese ovary with increasing doses of crude extracts of Jala SGs. The concentration 
ranged from 0.001-2 SGE. As a reference, ovary tissue pieces were also incubated 
with homologous SG extract, viz. 0.1 SGE of crude extracts of SG from Pese. 
Background incorporation of radiolabeled amino acids was estimated from the tissues 
incubated for a short time only (15 min; typically 15.29 dpm/Ilg protein) and the 
normal level of synthesis was assessed from incubating pieces of ovary tissue in 
medium containing only radiolabeled amino acids, i.e. no treatment with SG extracts 
(typically 152.52 dpm/Ilg protein), The crude extracts of Jala SGs induced a dose-
dependent inhibition of total protein synthesis (Fig. 36). The maximum inhibitory 
effect of 57 % inhibition of protein synthesis was achieved with 2 SGE crude Jala 
extracts, whereas an inhibitory effect of 52 % was achieved with only 0.1 SGE of a 
crude extract from Pese sinus glands (Fig. 36). 
3.2. 4. 2. Protein synthesis in ovaries incubated with peptides purified from J. lalandii 
sinus glands 
Pieces of ovary tissues were incubated with 1 SGB ofHPLC peak material obtained 
by fractionating extracts of sinus glands from J. lalandii (see Fig. 37 for HPLC 
trace). A peak with [M+Ht of 8400 Da was only purified from a few batches of Jala 
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Fig. 36. Effects of increasing doses of crude extracts of J. lalandii (Ja/a) sinus glands 
on protein synthesis in ovaries from Penaeus semisllicatlls (Pese); 1 dose of 
homologous extract, i.e. 0.1 SGE Pese was also administered as a positive control. 
Results are expressed as mean percentage inhibition ± SD (n=4 from 2 ovaries with 
mean oocyte diameters of353 /lm and 431 /lm, respectively). 
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Fig. 37. An atypical chromatogram showing the RP-HPLC fractionation of 80 sinus gJands of J. lalandii on a Nucleosil C-18 
column. The same column, HPLC and solvent system were used as in Fig. 24. Six peaks are labeled according to order of elution. 
The 4th peak (indicated in bold letters), with protonated mass 0[8400 Da, does not typically appear with fractionation ofJala sinus 
glands. The effect of these 6 peak fractions on de novo protein synthesis in ovaries were tested at 1 SGE each (see Fig. 38). 
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SGs and this peak 4 was included in the in vitro assay, along with the cHHs (peaks 5 
and 6, Fig. 37), Mill (peak 3, Fig. 37) and the 2 peaks with cHH immunoreactivity 
(peaks 1 and 2, Fig. 37). Figure 38 shows that peak fractions 1 and 2 did not inhibit 
protein synthesis in the ovaries, whereas peak 6 and peak 4 caused 48.59 ± 7.02 % 
and 33.51 ± 8.87 % inhibition, respectively. Peak material of fractions 5 and 3 
produced an inhibition of20.23 ± 14.16 % and 14.90 ± 13.26%, respectively (values 
are mean ± SD, n = 4). 
An electrophoretic profile of the proteins occurring in the ovary of a vitellogenic 
prawn is depicted in Fig. 39. A number of prominent bands are visible in the 
Coomassie Blue-stained SDS gel of ovarian homogenates, which relates to the 3 sub-
units of vitellin (VT) with a molecular weight of200, 120 and 80 kDa, respectively; a 
less abundant protein with molecular weight of around 33 kDa corresponds to the 
shrimp ovarian peritrophin-like protein (SOP, Fig. 39A). The inhibition of de novo 
protein synthesis in the ovary, as measured by the incorporation of radiolabeled 
amino acids following their 6 h incubation with various substances (see above), was 
also reflected in the electrophoretic profile of ovarian proteins, as visualised on 
autoradiographed gels (Fig. 39 B, C). After the protein content of each homogenate 
(from the ovary pieces) had been determined, total protein loaded per lane could be 
standardised to facilitate direct comparisons between samples; the intensity of the 
bands on the autoradiograph reflects the abundance of the radiolabeled proteins. 
Figure 39B shows a clear increase in the intensity of the protein bands with the 
decreasing dose of crude extracts of Jala sinus glands; in fact, there is no visible 
difference in the amounts of proteins synthesised in lanes 5 (treated with 0.001 SGE 
of Jala extracts) and 6 (not treated with SG extracts). This agrees with the data in 
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Fig. 38. The effect of various peptides, isolated from sinus gland extracts of J. 
lalandii, on protein synthesis in ovaries from P. semisulcatus. The values represent 
the percentage of inhibition in fragments removed from 2 ovaries (inean ± SD; n=4). 
The chromatographic profile of the sinus gland peptides is shown in Fig. 37. 
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Fig. 39 A. 12.5 % SDS-PAGE (stained with ) of ovarian homogenates of Penaeus 
semisulcalus. The equivalent of30 Ilg of proteins from different homogenates were loaded onto the 
gel (lanes 1-8). A molecular weight marker was loaded in lane 9: weights correspond to myosin (212 
kDa), p-galactosidae (112 kDa), BSA (83 kDa), ovalbumin (51.8 kDa), carbonic anhydrase (35 kDa), 
soybean trypsin inhibitor (28.4 kDa), lysozyme (20 kDa) and aprotinin (7.2 kDa). Proteins were 
transferred to nitrocellulose membranes and exposed to autoradiographic film to reveal the effect of 
B. different doses of crude extracts of lala sinus glands on de novo protein synthesis: 2 SG (lane 1), I 
SG (lane 2), 0.1 SG (lane 3), 0.01 SG (lane 4), 0.001 SG (lane 5), untreated ovary (lane 6), 0.1 SG of 
Pese (lane 7) and C. pe?tides purified from lala sinus glands: lanes 1-7 correspond to ovaries treated 
with peaks 5, 6,4, 3, I and 2 (see Fig. 37); untreated ovary was loaded into lane 7. 
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Fig. 36 which was derived at from counting dpm values of the samples. In Fig. 39C, 
the effect of purified lata sinus gland peptides on de novo protein synthesis in the 
ovary can be seen. The vitellin bands, e.g. Vt 200, in lanes 5 (peak fraction 1 of Fig. 
37) and 6 (peak fraction 2 of Fig. 37) have the same strong intensity as that of non-
SG treated ovaries (lane 7, Fig. 39C). This Fig. 39 further shows that ovaries treated 
with peak fractions 6 and 4 (of Fig. 37) have the highest inhibition of protein 
synthesis. It is further apparent that total protein synthesis was inhibited and not 
specifically the egg proteins. 
3.3. Sequence elucidation of cHHIMIHIVlH peptides from 1. lalandii 
Conventionally, disulfide linkages are reduced and alkylated to linearise the molecule 
before determining its primary sequence. The extent of peptide loss during this 
procedure was examined with the use of synthetic insulin. The process of 
reduction/alkylation was successful in that the A and B chains of insulin were 
separable on HPLC but the combined peak area of the peaks corresponding to these 
chains, however, did not equal that of the non-reduced insulin and represented a loss 
of 43 % of the starting material (results not shown). Even bigger losses in peptide 
yield were experienced after reduction and alkylation of lala cHH-I (results not 
shown). It was, thus, decided not to linearise the cHHlMIHfVllf peptides from J 
lalandii by reduction and alkylation in order to elucidate their primary structures, but 
rather to use non-reduced (i. e. native) sample material. Reduction and alkylation was, 
however, carried out as a pilot experiment on 25 SGE of lala cHH-I and -II, and 
each step was monitored by mass spectrometry to determine its success. Fig. 40 
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Fig. 40. MALDI-TOF mass spectra of Jala cHH-I obtained with sinapinic acid as matrix: A. native, non-reduced peptide; B. reduction buffer 
only; C. Jala cHH-I after reduction of the disulfide bridges and, D. after alkylation of the reduced bridges. Aliquots of the peptide were removed 
at each step of the reduction/alkylation procedure, diluted with acetonitrile/TF A to lower the buffer salt content in the sample, and spotted onto 
the sample plate for MS. 
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shows that it is possible to cany out reduction of disulfide bonds on a small scale and 
still demonstrate the results by MALDI-TOF MS. In Fig. 40A the protonated mass 
peak of lala cHH-I (8381) and its doubly-charged ion (4190) is visible before 
modification of the peptide. Fig. 40C illustrates a mass shift of +6 units (8387), 
which indicates that the reduction of the disulfide bonds have been successfully 
carried out. In Fig. 40D the "family" of 6 mass peaks in the 8000+ Da range, 
corresponds to the alkylation of the 6 Cys residues of the: reduced lala cHH-I peptide 
(+58 mass units for each Cys). In both Fig. 40C and D, mass peaks relating to buffer 
components are also present (cf mass peaks in Fig. 40B). The strategy to elucidate 
the amino acid sequence of the cHHIMIHIVIH peptides present in 1. lalandii was, 
thus, to cleave only non-reduced peptides (by means of enzymes and chemicals), 
. separate and sequence the resulting peptide fragments, reduce the disulfide linkages 
of the fragments, and analyse the reduced mixtures on MALDI-TOF mass 
spectrometry . 
3.3.1. lala cHH-I 
3.3.1.1. lala cHH-I: trypsin digest. 
N-terminal sequence analysis of native cHH-I peptide (peak 4 in Fig. 24) yielded the 
first 30 amino acid residues (Fig. 41). This provided evidence that the amino 
terminus of this peptide is not blocked. Cys residues at positions 7, 23 and 26 were 
identified by sequence homology (conserved residues in decapod cHHs) and by the 
smaller increases of the PTH dehydro-alanine derivative compared with Ser in the 
Edman degradation cycle. From the sequencing data, a yield of 100 ng (± 12 pmol) 
of cHH-I peptide per SG has been estimated. Trypsin digestion of non-reduced 
purified cHH-I produced a tryptic map (Fig. 42A) whose peptide fragments were 
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AVFDQSCKGVYDRSLFSKLDRVCDDCYNLYRKHYVATGCR 
~----------------------------------------------------~ 
t----T26-H-Tll-i r-T23; T46--1 I T46 ~ 
-------CNBr------------------------------
'--D23---t 1---------D23 
41 50 60 70 
RNCYGNLVFRQCLDDLMLTDVVDEYVASVQMV-NH2 
10-- T26 ~ r--T46 ------------1 
---------------------------~II CNBr--~ 
I-D23-t 1----D 15-----1 
Fig. 41. Primary structure of cHH-I from Jasus lalandii as deduced from sequenced peptide fragments: Tx, tryptic peptides; Dx, 
endoproteinase Asp-N peptides; CNBr, cyanogen bromide-cleaved products. Note: The dark line indicates the sequenced residues while 
the faint line indicates the unsequenced residues of a particular fragment. The dotted line shows residues identified by N-terminal 
sequencing of native Jala dHI-I. Amidation was established by methylation of the C-terminal fragment (58-72) of a partial CNBr 
cleavage. 
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Fig. 42. Peptide maps of native cHH-I from J. lalandii SGs after digestion with 
A. trypsin and B. endo-Asp-N. The same column, solvents and HPLC system 
were used as in Fig. 24. A linear gradient (dotted line) from 0 % B to 99 % B was 
developed in 90 min after an isocratic step at 0 % B for 5 min. Peptides that were 
selected for sequencing analysis are numbered in the order of elution. (Tx, tryptic 
peptides; Dx, endoproteinase Asp-N peptides) 
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subjected to mass spectrometry. The 4 major peaks (TIl, T23, T26 and T46) were 1\-
teITIlinally sequenced. It became apparent that TIl was an individual peptide chain, 
whereas T26 and T46 consisted of 2 and 3 peptide chains, respectively, linked by 
disulfide bonds. Arrangement of these sequences was aided by (a) sequence 
infoITIlation obtained from Edman degradation of native laia ctrn-L (b) sequence 
similarity with Roam ctrn-A (Tensen et al., 1991) and (c) mass spectrometric 
analysis of reduced T26 and T46 fragments (Table 5~ Fig. 41). Cystine residues were 
assigned on the basis of ctrn sequence homology, mass analysis and an increase in 
PTH dehydro-alanine derivatives in Edman degradation. Table 5 shows how well the 
mass data of the reduced peptide fragments correlate with that of the sequenced 
peptide chains. Figure 43 shows, as an example, the mass analyses of tryptic 
fragments T26 and T 46 after reduction of the disulfide bonds. Surprisingly, although 
fragment T23 (residues 22-31) contained 2 Cys residues, it was sequenced as a single 
peptide chain, whereas it should have fOITIled part of the linked peptides ofT46. 
Residues at position 32 and 41 could not be established by sequencing the tryptic 
fragments. However, K32 and R41 were later identified by sequencing data obtained 
from overlapping Endo-Asp N digest fragments (see 3.3:1.2. below). Further, one of 
the peptide chains of tryptic fragment T26, N42_Rso, yielded an [M+Hf ion of 1981 
following an overnight digestion with trypsin (see Table 5). With a partial tryptic 
digest of only a few hours duration, however, a fragment corresponding to T26 on 
HPLC yielded an [M+Hf ion of 2137 (results not shown). The resulting mass 
difference of 156 Da corresponds to the mass of Arg, and it was deduced that R41 was 
cleaved offfrom R40 and ~2 during the extended period of digestion. 
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Table 5. Relative mass of pep tides obtained from peptide fragments generated by enzymatic and chemical cleavage of non-reduced cHH-I 
purified from Jasus lalalldii sinus glands. 
PEPTIDE POSITION 
TRYPSIN 
Til 
T23 
T26 
T46 
CYANOGEN BROMIDE 
Complete CNBr digest 
Partial CNBr digest 
ASP-N PROTEASE 
DIS 
D23 
9 - 13 
22 - 31 
1 - 8; 42 - 50 
1 - 8 
42 - 50 
33 - 40; 22 - 3 1; 51 - 72 
33 - 40 
22 -31 
51 - 722 (51 - 58) 
1 - 572 (1 - 14) 
58 - 7.12 (58 - 69) 
58-71 
58-72 
63 -72 
4-11;20-53 
4 - 11 
20-532 (20 - 42) 
55-594 
Mr ACCORDING TO: 
MALDI-TOF [M+Hr 
NON-REDUCED REDUCED! 
609 
1262 
1981 
4648 
6684 3 
1519 3 
1519 3 
1666 
1006 
5006 
898 
1086 
907 
1263 
2488 
900 
4117 
SEQUENCE 
608 
1261 
896 
1084 
4649 
905 
1261 
2484 
66843 
15183 
15183 
1665 
1139 
5012 
897 
4114 
IMass of reduced fragments is measured by MALDI as [M+Ht + n[Ht, where n = number of Cys. (Reduction by DTT adds H to 
each S). 2Expected positions as deduced from the entire sequence. The fragment was only partially sequenced (sequenced positions in 
brackets). 3Mass when homoserine lactone is formed. 4 Fragment co-eluted with D23, see text. 
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Fig. 43. MALDI-TOF mass spectra of Jala cHH-I tryptic fragment T26 and T46 
before reduction (sinapinic acid matrix; A, C) and after reduction of the disulfide 
bonds (cinnamic acid matrix; B, D, E). A, B = T26; C, D, E = T46. 
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From N-terminal sequencing data it also became clear that, in addition to other 
peptide chains (see Table 5 and Fig. 41), tryptic fragment T46 contained the C-
terminal peptide chain of cHH-I; this chain was, however, only partially sequenced 
up to residue 58 (Fig. 41). 
3.3.1.2.Ja/a cHH-I: endo-Asp N digest 
Non-reduced cHH-I peptide was digested with endo-Asp N to generate overlapping 
peptide fragments. The resulting peptide map is shown in Fig. 42B. The 2 major 
peaks of this digest (D 15 and D23) were selected for further analysis. Sequencing 
data showed DIS to be the carboxyl-terminal peptide fragment, and residues 63 -72 
were identified (Fig. 41 ).The mass discrepancy between the calculated DIS sequence 
and the actual fragment mass obtained by MALDI, i.e. 1139 versus I005 (Table 5), 
may be explained by a loss of 0 63 (= 115) in the N-terminal position, as well as a 
H20 molecule (= 18) from the adjacent E64 residue during MALDI-TOF analysis. 
Sequencing data of D23 showed that this fragment consisted of 2 peptide chains 
linked by disulfide bridges, and amino acid residues 4-] 1 and 20-53 were identified 
(Fig. 41). From the obtained sequence it is clear that endo-Asp N failed to cleave 
between C23 and D24, as well as between D24 and D25. A probable reason for this may 
be that the two flanking Cys residues (position 23 and 26) form disulfide bonds and 
so the enzyme is excluded from this region by steric hindrance. The presence of only 
2 peptide chains in this fragment was confirmed by mass analyses on a mixture of the 
reduced products of fragment D23 (Table 5). As with DIS, the mass of the non-
reduced D23 fragment is also less than that calculated from its sequence (Table 5). 
These odd results may stem from the interactions between the N-terminal Asp and its 
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adjacent residues during the MALDI procedure. Quite surprisingly, a third peptide 
chain, residues 55-59 without a Cys residue, was also sequenced from D23 peak 
material (Fig. 41), thus co-eluting with fragment D23. 
3.3.1.3. lala cHH-l: CNBr cleavage and methylation 
The assigned Met at position 57 enabled the execution of a cyanogen bromide 
cleavage of native cHH-I. MS analysis of the completely cleaved peptide mixture 
revealed that homoserine lactone products were present (Table 5) and N-terminal 
sequencing identified residues 58 to 69 (Fig. 41). To unambiguously determine 
whether the C-terminal residue (V72) is amidated, methylation was carried out on a 
C-terminal fragment of cHH-I and analysed by MALDI-TOF MS. This fragment for 
methylation was obtained from partial cleavage of cHH-I with CNBr which yielded 
[M+Hr ions of 1519 and 1666 (Fig. 44) that corresponded to the cleaved residues 
58-71 with a C-terminalhomoserine lactone, and to residues 58-72 of the uncleaved 
fragment, respectively, (see Table 5). The [M+Hf ion of the uncleaved C-terminal 
fragment shifted from 1666 to 1708 when the fragment was converted to its methyl 
ester (Fig. 44). This corresponded to an increase of 42 Da, thus revealing the 
incorporation of3 methyl groups (i.e. 3 x 14 Da) and, since fragment 58-72 contains 
3 free carboxyl groups, viz. D60, D63 and E64, it was concluded that (V72) must be 
amidated. 
The accuracy of the methylation method and the correct interpretation of the ensuing 
results were controlled by including several peptides of known sequences. Figure 45 
shows that, under the current conditions for methylation, all free carboxy] groups are 
esterified. 
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Fig. 44. MALDI-TOF analysis of the C-tenninal fragments of Jala cHH-I following 
partial CNBr cleavage and methylation. The [M+H]+ ions of 1519 and 1666 
correspond to the homoserine lactone product of fully cleaved residues 58-71 and the 
partially-cleaved residues 58-72, respectively. Interpretation of other mass peaks are 
indicated. The increase of 42 m.u. relates to 3x14 m.ll. and 56 m.ll. corresponds to 
4x14 m.u. 
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Fig. 45. Methylation of synthetic peptides and analyses by MALDI-TOF MS: mass spectra 
before and after methylation. A. calibration 1 standard mix (PerSeptive), B. des pGlu-Cam-
HrTH-II, C. Pea-Ast 5 (see 2.5.5. for explanation of abbreviations). In Band C the 
primary peptide structure is given as single-letter code with acidic residues and amide 
groups indicated in bold letters. 
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3.3.1A.lnvestigation into chirality of lala cHH-I 
3 3 To determine whether lala crrn:-I was composed of a D-Phe or an L-Phe , 2 
synthetic octapeptides, A VFDQSCK, which corresponds to the N-teffilinal residues 
1-8 of Jala crrn:-I, were made with the different confoffilations of the Phe3 residue. 
In order to purifY the native octapeptide from lala crrn:-I, reduction and alkylation 
was performed on tryptic fragment T26 (see Fig. 42A). Aliquots, collected for MS 
after each step in the procedure, indicated the success of the method (Fig. 46). The 
reduced and alkylated mixture of fragment T26 was then purified on HPLC (Fig. 
46C). To facilitate direct comparison between the: reduced/alkylated native 
octapeptide and the synthetic octapeptides, the latter were also subjected to reduction 
and alkylation. The retention times on HPLC and mass of these synthetic peptides 
were established after these procedures (Fig. 46A,B). Figure 46C shows a clear peak, 
corresponding to the L-Phe3 fOffil of the octapeptide, from native crrn:-I but no such 
peak relating to the D-Phe3 form of the peptide. The second, later-eluting peak in Fig. 
46C is the second peptide chain of this tryptic fragment (residues 42-50, see also 
Table 5). 
3.3.2. lala cHH-II 
3.3.2.1. Jala cHH-II: trypsin digest 
N-terminal sequencing of Jala crrn:-ll (see peak 5 of Fig. 24) resulted in the first 20 
amino acids (Fig. 47), indicating a free N-terminus. The Cys residue at position 7 
was assigned by sequence homology with other crrn:s and by the smaller increase of 
the PTH dehydro-alanine derivative compared with Ser in the Edman degradation 
cycle. The peptide yield of crrn:-ll has been estimated at 3 pmollSG. A tryptic map 
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Fig. 46, Chromatographic and mass spectrometric analyses of2 synthetic octapeptides corresponding to the 
N-terminal se~uence of Jala cHH-I, but with different conformations of the third residue, viz. A. L-Phe3 
and, B. D-Phe- after the procedure of reduction/alkylation. C. Tryptic fragment T26 of Jala cHH-I after 
reduction/alkylation. 
The samples were applied to a Nucleosil C18 column under a gradient of 15 % B for 4 min, followed by a 
linear increase to 50 % Bin 3S min. using the same HPLC and solvent system as described in 2.2. The 
asterisk (*) marks minor impurities in the synthetic peptides. 
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AVFDQSCKGVYDRSLFKKLDVVCDDCYNLYRKPYVATGCR 
r----------------------------------1 
I--TI4-II-T9 -I T27 II-Tgil-T27--i 
1--- CNBr---l 
1-- D 17---11-D 12 --1+-D 17"'\ D 17 ----
41 50 60 70 
ENCYSNLVFRQCLDDLMLVDVVDEYVSTVQMV-NH2 
-----T27 ~ T 14 · II CNBr-
,--'D11 
Fig. 47. Primary structure of Jala cHH-II as deduced from sequenced peptide fragments: Tx, tryptic peptides; Dx, endoproteinase Asp-N 
peptides; CNBr, cyanogen bromide-cleaved products. Note: The dark line indicates the sequenced residues, while the faint line indicates 
the unsequenced residues of a particular fragment The dotted line shows residues identified by N-terminal sequencing of the native, 
uncleaved cHH. Amidation was inferred from sequence homologies and mass' spectrometry. 
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of non-reduced lala cID-I-ll revealed 4 major peptide fragments (Fig. 48A) that were 
analysed by MALDI-TOF mass spectrometry and subjected to Edman degradation. 
Although no mass data was forthcoming from fragment T8, it became apparent from 
sequencing data that T8 and T9 were single peptides (Fig. 47; Table 6). Moreover, 
T8 was the atypical result of a tryptic digest and, more likely, resulted from a 
chymotrypsin contamination in the trypsin preparation. It was also evident from mass 
data and sequence information that tryptic fragments T14 and T27 consisted of2 and 
3 peptide chains, respectively, linked by disulfide bonds (Fig. 47; Table 6). 
Interpretation of the sequence information was facilitated by knowledge of the first 
20 amino acid residues, sequence similarity with lala cID-I-I and mass spectrometric 
analyses of the fragments in both the non-reduced and the reduced form (Table 6). 
Figure 49 shows mass analyses data of tryptic fragment T14 before and after 
reduction of the disulfide bonds, as an example. 
3.3.2.2. lala cHH-ll: endo-Asp N digest 
Further sequence information and confirmation resulted from overlapping fragments 
following digestion of non-reduced cID-I-ll material with endo-Asp N. Three major 
fragments were purified from this digest (Fig. 48B) for Edman degradation and mass 
analyses. It became apparent that fragments D 11 and D 12 were single peptide chains, 
whereas D 17 consisted of3 peptide chains linked by the intact disulfide bonds (Table 
6). Clearly, also, D 11 represented the C-terminus of lala cID-I-n (Fig. 47). 
3.3.2.3. lata cHH-II: CNBr cleavage 
Native, non-reduced cID-I-ll was chemically cleaved with CNBr. This cleavage with 
CNBr took advantage of the 2 Met residues in the cID-I-ll sequence, viz. M57 and M71 
Un
iv
rsi
ty 
of 
Ca
pe
 To
wn
0.05 [AJ T27 T14 94 T9 
'" 
, 
, 
.... 
8 " '" ..-
.. 
= "'" .... '::te < ~ c 
20 
0 Dll D17 
0.05 
lID 
.. 
"'" ....
< 
o 
Retention time (min) 
Fig. 48. Peptide maps of native Jala cHH-II after digestion with A. trypsin and 
B. endoproteinase Asp-N. The same column, HPLC system and solvents were 
used as in Fig. 24. A linear gradient (dotted line) from 0 % B to 99 % B was 
developed in 90 min after an isocratic step at 0 % B for 5 min. Peptides that 
were selected for sequencing analysis are numbered.in the order of elution. 
(Tx=tryptic peptide; Dx=endo-Asp N-derived peptide). 
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Table 6. Average protonated mass of pep tides obtained from peptide fragments generated by enzymatic and chemical cleavages of non-reduced 
cHH-1I purified from sinus glands ofJasus lalandii. 
PEPTIDE 
Trypsin: T8 
T9 
T14 
T27 
Endo-Asp N: 011 
D12 
017 
Cyanogen bromide: 
POSITION OF RESIDUES 
32-34 
9-13 
1-8; 41-50 
1-8 
41-50 
19-31; 35-40; 5]-72 
19-3 ] 
35-40 
5]-72 
63-72 
12-19 
4-11; 20-23; 24-53 
4-11 
20-23 
24-53 
1-57 
58-71 
OBSERVED MASS [M+Hf: 
NON-REDUCED 
No mass data 
609.68 
2140.09 
4672 
1174 
1006.8 
4939(K+ adduct) 
6636 
1571 (Na+ adduct); 
1587 (K+ adduct) 
REDUCED 
897.34 
1244.52 
1592.64 
606.96 
2516.30 
900 
436.26 
3604 
CALCULATED Mr.: 
FROM SEQUENCE 
407 
609.65 
2140.38 
898.00a 
1245.38" 
4671.38 
1591.77a 
606.71" 
25]4.93" 
1170 
1007.21 
4900.54 
899.98a 
435.51" 
3609" 
6632.56b 
1549. 71 b 
a Mass of reduced fragment is calculated as [M+Hr + n(Ht, where n=number ofCys. (Reduction by OTT adds H to S of each Cys). 
b Mass when homo serine lactone is formed. 
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Fig. 49. MALDI-TOF mass spectra of tryptic fragment T14 of Jala 
cHH-II A.before and, B. after reduction of the disulfide bonds with 
DTT. 
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(Fig. 47) and mass analyses of the resulting mixture indicated homoserine lactone 
products corresponding to chemically-modified residues 1-57 and residues 58-71 
(Table 6). For the latter residues, 2 masses were obtained which corresponded to the 
sodiated ([M+Na]) and the potassiated ([M+K]) ions. Amidation of lata cHI-l·1l 
was not experimentally established, but was deduced from the average mass obtained 
from the whole molecule and that from the sequence information. 
3.3.3. lata MIH 
3.3.3.1. lata MIH: trypsin digest 
N-terminal sequence analysis of native MIH peptide (see peak 3 of Fig. 24) isolated 
from 50 sinus glands, resulted in the first 40 amino acid residues, thus indicating a 
free N-terminus (Fig. 50). Cys residues at positions 6, 23, 26 and 39 were identified 
by smaller increases of the PTH dehydro-alan~ne derivatives compared with Ser in 
the Edman degradation cycle, as well as by sequence homology to other members of 
the cHH family of pep tides. The yield oflala MIH has been estimated at 6 pmollSG. 
A tryptic map of non-reduced lala MIH revealed 7 major peaks (Fig. 51 A) that were 
analy'sed by mass spectrometry and subjected to Edman degradation. From the 
sequence data and mass analyses, it became apparent that fragments T1, T3, T6 and 
TIl were single peptides (Fig. 50; Table 7). Fragments TI and T3exhibited identical 
mass and sequence data, despite having different retention times on HPLC (Table 7; 
Fig. 50A). Tryptic fragments TIS, TI7 and TI8 consisted of more than one peptide 
chain, but linked to other peptide chains by the intact disulfide bonds (Table 7). 
Furthermore, from the sequencing data, it appeared that these 3 fragments 
represented the same region of the MIH peptide but that TI5 consisted of 4 peptide 
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RFTFDCPGMMGQRYLYE QVE QVCDDCYNLYREEKIAVNCRENCFLNSWFT 
~----------------------------------------------------------------------~ 
~TI5, T17, TI8 --11- TI5, T17, TI8 I-TI5--1~1 ----
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-
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Fig. 50. Primary structure of a putative MIH from 
.1. lalandii as deduced from sequenced peptide 
fragments: Tx, tryptic peptides; Dx, endoproteinase 
Asp-N peptides; CNBr, cyanogen bromide-cleaved 
products. Note: the dark line indicates the 
sequenced residues of a particular fragment, while 
the faint line corresponds to the unsequenced 
residues. The dotted line represents residues 
identified by N-terminal sequencing of the native, 
uncleaved MIH. Amidation was established by 
methylation of the C-terminal fragment D9 
(residues 66-74). 
-.... 
o 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
0.1 
..,. 
-... 
-< 
o 
os 
.. 
-<,.. 
o 
Tll 
TI8 
I 
T17 
Tl TJ 15,1 
U1 T6 11\ L-.,...::......,.J"' .. -... :......---
o 
48 
SO 
Retention time (min) 
[£] 
6 
7 
5 
4 
Retention time (min) 
I 
86 
. 
100 
Fig. 51. Peptide maps of native Jala MIH after digestion with A. trypsin and B. 
endoproteinase Asp-N, and C. after cleavage with cyanogen bromide. The HPLC 
system, column and solvents are identical as described in Fig. 24. After an 
isocratic step of 0 % B for 5 min, a linear gradient from 0 to 99 % B was 
developed in 90 min. Peptides that were selected for sequencing analysis are 
numbered in order of elution. 
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Table 7. Average protonated mass of pep tides obtained from peptide fragments generated by enzymatic and chemical cleavages of non-reduced 
MIH purified from sinus glands ofJaslis lalandii. 
OBSERVED MASS [M+Hr: CALCULATED [M+Hr_~ 
PEPTIDE POSITION OF RESIDUES NON-REDUCED REDUCED FROM SEQUENCE 
Trypsin: Tl 59-64 768.97 768.80 
T3 59-64 768.93 768.80 
T6 70-73 No mass data 460.59 
TIl 65-69 736.90 736.84 
T15 2-13; 14-31; 35-40; 41-58 6540.10 6539.43 
2-13 1390.77 1390.6Y 
14-31 2317.60 2317.54" 
35-40 671.94 675.81" 
41-58 2164.66 2164.51 " 
T17 2-13; 14-31;35-58 6543.89 [Na+ adduct] 6521.41 
2-13 1391.77 1390.63" 
14-31 2321.01 2317.54" 
35-58 2825.40 2821.31 " 
T18 2-13; 14-31; 35-58 6532.03 6539.43 
2-13 1392.66 1390.63" 
14-31 2319.60 2317.54" 
35-58 Not found 2821.31" 
Endo-Asp N: 04 59-65 915.81 915.97 
D7 i-4 570.38 570.66 
09 66-74 1101.01 1101.31 
1123 (Na+ adduct) 
017 5-16; 17-58 6498.4 6494.42 
5-16 1436.30 1434.69" 
17-58 5068.57 5066.68" 
020 5-58 6476.96 6476.33 
Cyanogen bromide: CNBr4 58-74 2153.93 2154.45 
CNBr5 58-74 2139.74 2154.45 
CNBr6 58-74 2181.91 2154.45 
CNBr7 58-74 2209.96 2154.45 
"Mass of reduced fragment is calculated as [M+Hf + n(Hf, where n=number ofCys. (Reduction by OTT adds H to S of each Cys). 
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chains, whereas T I 7 and T 18 had only 3 chains (Table 5) - apparently, trypsin did 
not cleave at R 40 in the latter 2 fragments. Interpretation of the sequence information 
was facilitated by knowledge of the first 40 amino acid residues and mass 
spectrometric analyses of fragments in both, the non-reduced and the reduced form 
(Table 7). Figure 52 shows the mass analyses of tryptic fragment T 15 before and 
after reduction of the disulfide bonds. 
3.3.3.2. lala MIH: endo-Asp N digest 
Further· sequence information and confirmation resulted from the overlapping 
fragments following digestion of native Mill with endo-Asp N proteinase. Five 
major peaks were separated from this digest mixture (Fig. 5IB) for mass analyses 
and Edman degradation. The resulting data indicated that fragments D4, D7 and D9 
were single peptide chains, whereas D17 consisted of2 chains (Table 7, Fig. 50). 
Fragment D20 was sequenced as a single peptide chain from residue 5 to 55, 
presumably extending up to residue R58, judging from the known cleavage specificity 
of the proteinase, as well as the mass of this fragment (Table 7, Fig. 50). 
The interpretation of the sequencing data at hand, led to the identification ofD9 as 
the carboxyl-terminal peptide fragment of lala Mill and residues D66_K73 were 
sequenced. The calculated protonated mass for this sequence, viz. 1030 Da, did not 
match with the actual mass observed from the fragment D9, viz. 1101 Da. Thus, the 
sequence was deemed incomplete. The mass difference of 71 indicated that an Ala 
residue might have remained unsequenced. 
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Fig. 52. MALDI-TOF mass spectra of tryptic fragment TI5 of Jala 
MIH A. before and, B, C after reduction of the disulfide bonds. 
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3.3.3.3. lala MIH: eNBr cleavage and amidation 
To confinn our assignment of the short fragments at the C-tenninal region of Mill 
and to elucidate the full sequence of lala MIH, native Mill material was chemically 
cleaved with CNBr and the resulting mixture purified on HPLC. This cleavage 
particularly took advantage of the M57. Four peaks (Fig. 51 C) were selected for N-
tenninal sequencing; the molecular mass of these fragments indicated that they could 
be the predicted C-tenninal fragment starting with residue R58, although not all the 
peaks displayed the calculated mass for such a fragment (Table 7). All 4 peaks 
yielded the identical amino acid sequence and thereby revealed the identity of the last 
amino acid residue of lala MIH unequivocally as A74 (Fig. 50). This was confinned 
by the construction of a synthetic nonapeptide: DIWRSll..KA-NH2; the characteristics 
of the synthetic peptide were compared with that of fragment D9 (see 3.3.3 .2. above). 
Firstly, the native fragment D9 co-eluted with the synthetic nonapeptide when co-
injected on RP-HPLC (Fig. 53); secondly, the 2 peptides had the identical [M+Ht of 
1101 on MALDI-TOF (Fig. 54). The protonated mass of the whole Mill molecule 
([M+Ht = 9007) agrees with the value calculated for an amidated structure and this 
was further substantiated by methylation experimertts perfonned with the native C-
tenninal fragment D9 and the synthetic nonapeptide DIWRSll..KA-NH2. With both 
peptides, the [M+Ht ion of the fragment shifted from 1101 to 1115 (Fig. 54B), 
corresponding to the methyl ester fonned by the esterification of the only acidic 
residue in the fragment, viz. D66. It was, thus, concluded that lala Mill has an 
amidated C-tenninus. 
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Fig. 53. Co-elution of fragment D9 of Jala Mlli with the synthetic nonapeptide, 
DIWRSILKA·NH2, on RP-HPLC. The same column, HPLC and solvent syst1em system 
was used as described in 2.2. A gradient of35-75 % B in 30 min was applied to the 
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Fig. 54. Methylation of A. the C-terminal fragment of Jala MIH, i.e. D9, 
and B. the synthetic nonapeptide, DIWRSILKA-NH2, as monitored by 
MALDI-TOF MS. 
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3.3.4. Truncated lala cHHs 
The mass data obtained from peaks 1 and 2 (Fig. 24), did not fit into the accepted 
mass range of pep tides belonging to the clffi/Mll:I/VIH family, viz. 8000-9000+ Da, 
yet the peaks contained cHH epitopes (as illustrated in ELISA, Fig. 25) but no 
hyperglycaemic activity (Fig. 26). N-terminal sequencing of peak 1 and peak 2 
yielded sequence information of residues 1-62 (peak 1) and residues 1-60 (peak 2). 
The primary structure of peak 1 was 100 % identical to the first 62 residues of lala 
cHH-I and, that of peak 2 was 100 % identical to the first 60 residues of lala cIlli-II 
(Fig. 55). Peak 1 and peak 2 are therefore, referred to as being truncated forms of 
lala cHH-I and -II, respectively. Truncated cHH-I was chemically cleaved with 
CNBr and the mixture was purified on HPLC (Fig. 56). N-terminal sequencing of the 
resulting CNBr peak 1 yielded residues LS8_y05 (Fig. 55A). The theoretical mass 
[M+Hr of this CNBr fragment was calculated to be 952 Da; CNBr peak 1 displayed 
a protonated mass of976 Da (Fig. 56), which corresponds to 952 Da + Na+. CNBr-
derived peak 2 displayed a mass that correlates to the N-terminal fragment (Fig.56). 
The theoretical mass calculated for a truncated lata cHH-I peptide, i.e. AI- yO;s, is 
7665 Da. This fits well to the (M+Hf value of7666.41 Da obtained by MALDI-TOF 
(see Fig. 57). Theoretical calculations of the mass of a lata cHH-II peptide that is 
truncated at residue y05, matched exactly the observed mass, viz. 7613 Da (Fig. 57). 
The question of C-terminal ami dati on was addressed by carrying out methylation 
experiments on the CNBr-derived peak 1 of truncated cHH-I (Fig. 58). Before 
methylation, CNBr peak 1 yielded (M+Hf = 951 Da (Fig.58A); this shifted to 1007 
Da after methylation (Fig. 58B). This means an increase of 56 m.u., which 
corresponds to the formation of 4 methyl esters. Since thi.s fragment contains only 3 
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Fig. 55. Sequence eludication of A. truncated cHH-I 
and B. truncated cHH-II. The dotted line represents 
residues identified by N-terrninal sequencing. CNBr, 
cyanogen bromide-cleaved products. 
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Fig. 56. Peptide map of truncated Jala cHH-I after chemical cleavage with CNBr. The 
same column, HPLC system and solvents were used as in Fig. 24. A linear gradient 
from 0-99 % B was developed in 90 min after an isocratic step at 0 % B for 5 min. 
Peptide fragment 1 was selected for sequencing analysis on the basis of its mass (mass 
data are indicated as [M+H1j. 
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free carboxyl groups on residues n60, D63 and E64, it can be concluded that y65 is not 
amidated and provided a fourth free carboxyl group for esterification. 
3.3.4.1. Origin of the truncation of Jala cHHs 
To determine whether these truncated cIDi peptides were induced by the procedure 
of tissue extraction and purification, freshly-dissected sinus glands were-
homogenised in different media (see 2:5.6. for details) and, after HPLC analyses of 
the resulting extracts, the peak area of the truncated peptides were compared with 
that of the intact cIDis as a means of quantitation. The results, summarised in Table 8 
and with chromatographic examples in Fig. 59, show that certain homogenisation 
buffers can limit the ratio of the truncated cIDis and favour the "preservation" of the 
intact cIDis. Such buffers in which the intact cIDis predominate, appear to be those 
containing PMSF (an inhibitor of serine proteas~s) and thiodiglycol (an anti-oxidant) 
(Table 8). EDT A resulted in such overall low yields of peptide, that further 
quantification was not possible. The presence of trypsin-inhibitor also did not prevent 
a quantitative shift from intact cIDis to truncated cIDis (Table 8). Clearly, also, our 
prefe.r:red homogenisation buffer, i.e. 10 % acetic acid without additives, is not the 
best medium to limit the breakdown of cIDis; Jala cIDi-ll seems to be more 
vulnerable to truncation under these conditions than Jala cIDi-I (Table 8). 
3.3.5. "8400 Da" Jala peak 
Peak 4 (Fig. 37) was not typically present in HPLC separation of Jala SGs, yet it 
appeared on several chromatographic traces. The presence of this peak cannot be 
attributed to any obvious deviations from the standard protocol followed in preparing 
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Fig. 57. MALDI-TOF spectrum ofa crude extract of sinus glands fromJ lalandii (with sinapinic acid as matrix) before 
purification by RP-HPLC. The masses correspond to specific HPLC peak fractions, indicated in brackets (see Fig. 24 for 
elution profile). 
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Fig. 58. Mass spectra of the C-terminal fragment of 
truncated Jala cHH-I, ie. Fragment CNBr1: A. before 
and, B. after methylation. 
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Fig. 59. Chromatographic comparisons of peptide yields after extraction from J. lalandii sinus 
glands in different homogenisation solutions: A. PMSF in acetic acid, B. PMSF in water, C. 
thiodiglycol, D. EDTA, E. trypsin inhibitor and, F. acetic acid. 
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Table 8. Peak areas oftruncated cHH peptides and non-truncated cHHs obtained from HPLC separations of crude extracts of sinus glands from 
.I. laland;; 
Homogenising buffer Trunc. cHH-I1:Trunc. cHH-I cHH-I:Trunc. cHH-I cHH-II:Trunc. cHH-II cHH-II:cHH-I 
PMSF in acid (n=4) 2.27 ± 0.58 0.23 ± 0.08 0.37 ± 0.15 3.57 ± 1.07 
PMSF in water (n=2) 0.24 ± 0.02 0.13 ± 0.07 0.11 ± 0.02 0.24 ± 0.17 
Thiodiglycol (n=4) 1.21 ± 0.42 0.15 ± 0.05 0.41 ± 0.04 3.18±0.15 
Trypsin inhibitor (n=4) 2.47 ± 0.73 2.14 ± 0.48 4.43 ± 0.85 5.05 ± 0.9 
10 % acetic acid (n=4) 2.94 ± 0.39 1.72 ± 0.78 2.84 ± 0.97 4.97 ± 0.25 
EDTA (n=4) 
Sinus glands were prepared and extracted at 85 0 C in different buffers (see 2.5.6. for abbreviations used). The peak areas are expressed and 
compared as a ratio of2 specified peaks. Values are mean ± SD, where n = 2-4 with 5 sinus glands per sample. 
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the SGs, nor in the extraction and purification of peptide material. Although this peak 
displayed biological activity in the protein synthesis assay with prawn ovaries (see 
Fig. 38), it cannot be tenned a "vitellogenesis-inhibiting honnone" without further, 
more rigorous tests. In an ELISA with anti-Hoam dill serum, this peak 4 displayed 
an immunoreaction that equaled the intensity of immunoreactions obtained with 
crude extracts of sinus glands and the equivalent amount of purified Jala cHH-I 
(average absorbance reading ofOA was recorded 20 min after substrate application). 
N-tenninal sequencing of this peak yielded sequence infonnation up to residue 52. 
This sequence (results not shown) fits exactly to the first 52 residues of Jala cHH-I. 
Peak fraction material (120 SGE) was digested with trypsin and purified on HPLC. 
The resulting fragments were subjected to MALDI-TOF MS analyses. Fig. 60 
compares a tryptic map of Jala cHH-I (Fig. 60C) with that of the 8400 Da peak 4 
(Fig, 60A). The tryptic fragment containing the C-tenninal peptide of Jala cHH-I 
displayed a protonated mass of 4648.39 Da (Fig. 60C). On the shallow gradient 
employed for this separation, a tryptic peak originating from the 8400 Da peptide had 
approximately the same retention time but displayed a mass of 4665.77 Da (Fig. 
60A); this is thought to be the equivalent C-tenninal fragment of the 8400 Da peak 4. 
3.4. Characterisation and sequence elucidation of less-hydrophobic Iala peptides 
3.4.1. Purification by RP-HPLC 
Early-eluting material were collected as 2 ml fractions from HPLC runs in which 
cillIlMIHIVIH peptide peaks were purified from Jala SG extracts (see for example 
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Fig. 60. Tryptic maps of A. Peak 4 (of chromatogram in Fig. 37) and, C. 
Jala cOO-I. B. Separation of reduction buffer alone. The same gradient 
was used as in Fig. 42. [M+Ht values of the fragments containing the C-
terminal ends are indicated for Peak 4 (A) and cHH-I (B). 
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Fig. 24). These early-eluting fractions were later pooled and separated by employing 
different HPLC gradients and ion-pairing reagents. Figure 61 shows the result of a 
typical first separation of the pooled, less-hydrophobic fractions. Mass spectrometric 
analyses on the resulting peaks revealed that the fractions were impure (results not 
shown). The fractions were roughly grouped into 5 areas on the basis of retention 
time (Fig. 61). Similar areas from other HPLC runs were pooled and dried for further 
purification (see below). 
3.4.2. Purification, characterisation and sequence elucidation of RPCH 
Figure 62 illustrates the further purification of pep tides in area 1 of Fig. 61 by using a 
different system of HPLC solvents. The four peaks were analysed by MS (see Fig. 
62A for data). Peak fraction 1 had a mass identical to that of synthetic RPCH 
([M+Nat= 953) and co-eluted with synthetic RPCH on RP-HPLC (Fig. 62B). This 
peak fraction was also shown to have biological activity as an RPCH: injection of 1 
SGE into dark-adapted shrimps (P. pacificus) resulted in the concentrating of 
pigment in the integumental erythrophores (Fig. 63). The injection of sea water did 
not alter the state of the chromatophores (results not shown); peak fraction 1 of Fig. 
62A is considered to be the red pigment-concentrating hormone in J. lalandii and is, 
therefore called Jala RPCH. 
Since all known RPCHs are N-terminally blocked by a pyroglutamate residue (pGlu), 
Jala RPCH was first cleaved with a pyroglutamate aminopeptidase before N-terminal 
sequence analyses. Figure 64 shows the progression of the deblocking as monitored 
over time on HPLC. The deblocked peptide yielded the following amino acid 
sequence: LNFSPGW 
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Fig. 61. Re-purification on RP-HPLC of a batch of early-eluting material (300 SGE) from extracts of J lalandii sinus glands. Less-
hydrophobic fractions, originating from first HPLC separations such as that shown in Fig. 24, were pooled for re-purification, using the 
same column as in Fig. 24. A linear gradient from 25-40 % B was developed in 50 min after a 4 min isocratic step at 25 % B. Solvent 
A 0.115 % TF A in water, solvent B = 100 % acetonitrile with 0.1 %TF A, l)V detection at 214 nm and a flow rate of 1 ml/min. The 
peak fractions resulting from this separation were collected as distinct areas. Similar areas from the re-purification of other batches 
were pooled for MS analyses and further steps of purification. 
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Fig. 62. A. Separation of red pigment-concentrating hormone (RPCH) from 
other peptides of J. lalandii. Pooled fractions of Area 1 (see Fig. 61) were 
applied to a Nucleosil C18 column and subjected to a linear gradient of 30-60 
% B in 100 min, where solvent A = 0.13 % HFBA in water and solvent B = 
0.13 % HFBA in acetonitrile. The resulting peptides are labeled in the order of 
elution and aliquots were analysed by MS with cinnarnic acid as matrix. Mass 
data are indicated. B. Co-elution of peak fraction 1 (see A. above) with 
synthetic RPCH. The same column, HPLC, solvents and gradient was used as 
in A. above. 
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Fig. 63. Biological identification of RPCH from sinus glands of 1. lalandii. A, B Dark-
adapted Paleamon pacificus before injection of peak fraction 1 (see Fig. 62A for 
chromatographic profile). C, D P. pacificus 5-10 min after injection of 1 SGE of peak 
fraction 1. Band D is a close-up of the shrimp showing the distribution of pigment in 
the dispersed and concentrated states, respectively. 
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Fig. 64. Cleavage of Jala RPCH with pyroglutamate (pGlu) amino peptidase. 
Aliquots of the mixture were removed at different time intervals of the digestion and 
applied to HPLC under the following gradient: 6 min isocratic step at 25 % B, 
followed by a linear increase to 40 % B in 50 min. Solvent A= 0.115 % TF A in 
water; solvent B= 0.1 % TFA in 100 % acetonitrile. A. 45 min and, B. 135 min after 
incubation of Jala RPCH with pGlu amino peptidase. Mass data are indicated in B. 
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and a mass of [M+Ht ;;;: 820.24, as well as [M+Naf = 842.13. The difference in 
mass between the deblocked and the blocked peptide = 111 corresponds to the mass 
of a pGlu residue. To determine if Jala RPCH is amidated, methylation was 
performed. Figure 65 shows that there was no shift in the mass of the peptide, whi'ch 
indicates that Jala RPCH is C-terminally blocked. 
3.4.3. Purification ojCPRPs 
3.4.3.1. CPRP-1 and-2 
Interest area 2 consisted of a poorly-resolved doublet (see Fig. 61). Attempts were 
made to separate and resolve these "2 peaks by HPLC with 0.13 % HFBA instead of 
TF A added to the solvents. However, the 2 peaks were not separated at all and eluted 
as one, lumpy peak (Fig. 66A). This was then subjected to a last purification step 
with 0.05 % TFA in the solvents. Figure 66B shows that this was also insufficient to 
resolve the 2 fractions of the doublet The doublet was N-terminally sequenced and 
yielded 2 sequences (25 residues long) that were identical to each other, except for a 
single substitution at position 18 (Fig. 67). From sequence homology to other cHH 
precursor-related peptides, these sequences were recognised as CPRPs and the 
peptides are referred to as Jala CPRP-l and -2. Mass spectrometric data obtained 
from the CPRP doublet ([M+H]+ = 3406 and 3416, respectively) did not match the 
theoretical mass calculated for the sequenced 25 amino acid residues (3386.7 and 
3396.8, respectively). The sequences were, therefore, deemed incomplete and, to 
elucidate the C-terminus, a digestion with trypsin was carried out The resulting 
major peaks were subjected to MALDI-TOF MS, and peak T8 (Fig. 68A) was 
selected for Edman degradation. This resulted in information about residues 11-31 
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Fig. 65. Mass analysis of Jala RPCH: A. before and B. after 
methylation. 
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Fig. 66. Re-purification of peak fractions from Area 2 (see Fig. 61). A. A 
second purification step with a linear gradient from 30-60 % B in 100 min was 
applied. Solvent A = 0.13 % HFBA in water, solvent B = 0.13 % HFBA in 
acetonitrile. B. A third purification step with a linear increase from 25-40 % B 
in 50 min, following a 6 min isocratic step at 25 % B. Solvent A === 0.05 % 
TF A in water and Solvent B = 0.05 % TF A in acetonitrile. 
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1 10 20 30 
RATEGLTRMEKLFSADSPPSSTPLDAADHSLN 
S* 
~--------------------~-----------------------I 
~D5 ---i~D6-i~ D4/3*-1 t- DI-l 
--~ I-----D8 1 1------T8* 
~CNBr4 ~ 1---- CNBr9/8* ----1 
Fig. 67. Primary structure elucidation of Jala CPRP-} and CPRP-2* as deduced from sequenced 
peptide fragments: Tx tryptic peptides; Dx = endoproteinase Asp-N peptides; CNBr = cyanogen 
bromide-cleaved products. The dotted line shows residues identified by N-terminal sequencing of 
the uncleaved CPRP peptides. Note that CPRP-l and -2 differ only by 1 substi~ution at position 
18, therefore, CPRP-2-specific fragments are indicated by *. 
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Fig. 68. Peptide maps of a mixture of lata CPRP-l and -2 after digestion with A. 
trypsin and B. endo-Asp N, and cleavage with C. cyanogen bromide. The same 
column, HPLC and solvent system were used as in Fig. 24. A linear gradient from 0-
99% B was developed in 90 min after an isocratic step at 0 % B for 5 min. Peptides 
that were selected for sequencing analysis are numbered in the order of elution. 
(Tx=tryptic peptide; Dx=endo-Asp N-derived peptide; CNBr=cyanogen bromide-
derived product). 
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(Fig. 67); the calculated masses for sequences Rl_L31 was 116 m.u. less than the 
observed masses. Fraction material from the doublet was then digested with 
endoproteinase Asp-N and the mixture purified on HPLC (Fig. 68B). Six peak 
fractions were selected for N-terminal and mass spectrometric analyses (Fig. 67, 
Table 9). It became clear that fragment D 1 was the C-terminal end of the peptides 
and residues 28-32 were elucidated (Fig. 67). This was confirmed by chemical 
cleavage with CNBr, where HPLC peak fractions 8 and 9 (Fig. 68C) proved to be the 
C-terminal fragments. This cleavage took advantage ofresidueM9 (Fig. 67, Table 9). 
3.4.3.2.CPRP-3 and -4 
Interest area 5 (see Fig. 61) was subjected to RP-HPLC with HFBA as ion-pairing 
reagent. Four fractions were separated (Fig. 69). Peak fractions 1 and 2 were N-
terminally sequenced and both yielded identical residues 1-29 (Fig. 70). From 
sequence homology to other dill precursor-related peptides, these peaks were 
recognised as CPRPs and are referred to as Jala CPRP-3 and -4, since 2 other CPRPs 
have also been identified (see above). The calculated mass for the sequence of peak 2 
(named CPRP-4) did not match the mass observed for this fraction, viz. 3646. 
Peak fraction material of Jala CPRP-3 and -4 was then digested with trypsin and the 
digests were purified on RP-HPLC (Fig. 71). N-terminal sequencing of tryptic 
fragment T3 (Fig. 71 A) confirmed that CPRP-3 consisted of residues 1-29 only (Fig. 
70, Table 10). Sequence information from fragments T2 and T4 of CPRP-4 (Fig. 
71B) confirmed the N-terminal residues and provided additional information about 
the C-terminus ofCPRP-4 (Fig. 70). It appears thus, that CPRP-4 has 36 amino acid 
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Table 9. Average protonated mass of peptide fragments generated by enzymatic and 
chemical cleavages of CPRP-l and CPRP-2 purified from si:nus glands of J lalandii. Note: 
CPRP-I and CPRP-2 differ only by one substitution at position 18. 
Peptide Position of residues 
12-32 (piS) Trypsin T8 
12-32 (SiS) 
Endo-Asp N D1 28-32 
D3 16-24 (S18) 
D4 16-24 (piS) 
D5 1-9 
D6 10-15 
D8 1-15 
Cyanogen bromide 4 1-9 
10-32 (SI8) 
250 
CI) 
-+-> 
CNBr8 
CNBr9 10-32 (piS) 
Peak 2 
[M+Ht=3646 
Observed mass 
[M+Hf 
2154 
2133.13 
not determined 
890.80 
900.20 
1035.20 
. not determined 
1711.48 
1035.25 
2389.48 
2398.97 
Peak 3 
[M+Ht=7137 
Peak 4 
-o 
> E 
/ Peak 1 [M+Ht = 2949 
~ 
30 
Retention time (min) 
[M+Hr calculated 
from sequence 
2141 
2130.99 
585.S8 
890.91 
900.95 
1035.20 
694.80 
1710.99 
1035.20 
2389.53 
2399.57 
60 
Fig. 69. RP-HPLC purification of pep tides from fraction material from 
Interest area 5 (see Fig. 61). The resulting peaks are labeled in the order 
of elution and [M+Hr data are indicated in square brackets. Peak 4 
contained more than one mass (not shown) and was further purified on 
HPLC (see Fig. 72). The HPLC solvents and gradient are the same as that 
in Fig. 62A. 
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CPRP-3*/4: 
1 10 20 30 35 
RSTNGLARLERLLSSTSSSSSSAPLGLLSGADHSLN 
~------------------------------------------~ 
I T3* j 
r- T2 ----1 I T4 
Fig. 70. Primary structure elucidation of lala CPRP-3 and CPRP-4 as deduced fror:n 
sequenced tryptic peptide fragments (Tx). The dotted line shows residues identified by 
N-terminal sequencing of the unc1eaved CPRP peptides. Note: CPRP-3 appears to be a 
truncated version of CPRP-4 and consists only of amino acids 1-29; peptide fragments 
generated from CPRP-3 are marked by *. 
Table 10. Average protonated mass of peptide fragments generated by tryptic 
cleavages ofCPRP-3 and CPRP-4 purified from sinus glands of 1. lalandii. Note: 
CPRP-3 is a truncated version ofCPRP-2, the former extends only to residue 29, 
whereas the latter ends at residue 36. 
Peptide 
(ij CPRP-3: 
Trypsin 
(ii) CPRP-4: 
Trypsin 
T3 
T2 
T4 
Position of residues 
12-29 
2-8 
12-36 
Observed mass 
[M+Ht 
1692 
719.57 
2389.38 
[M+Ht calculated 
from sequence 
1693 
719 
2389.57 
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Fig. 71. HPLC purification of A. Jala CPRP-3 and B. Jala CPRP-4, after 
digestion with trypsin. Peaks that were selected for further analyses are 
numbered in the order of elution. The solvents and gradient are the same as for 
Fig. 68. 
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residues and that CPRP-3 is a C-terminally truncated form of CPRP-4, having only 
29 amino acid residues. 
An attempt was made to further purify the doublet peak fraction 4 of Fig. 69 with 
HFBA in the HPLC solvents. Figure 72 shows that a better resolution was obtained. 
These peaks produced [M+Hr data of 7186 and 7484 (Fig. 72) and were not 
investigated further. 
3.4.3.3. Attempted characterisation of the CPRPs, 
The purified lala CPRPs were tested in ELISAs for immunoreactivity with anti-
Hoam cHH serum. The cHH serum did not recognise any of the CPRPs (results not 
shown). The CPRPs were also injected into light-adapted P. pacificus to investigate a 
possible role in pigment dispersal. None of the CPRPs had a convincing PDH effect 
(Fig. 73). 
3.4.4. Purification of other HPLC areas of interest 
Interest area 3 (see Fig. 61) was further purified on HPLC with HFBA solvents. 
These peaks were collected; all yielded [M+Hr data of approximately 7000 Da 
(results not shown). These peak fractions were not investigated further. 
Similarly, interest area 4 gave rise to 2 peaks after HPLC with HFBA solvents; both 
of these peaks yielded [M+H]+ data of approximately 7400+ Da (results not shown). 
These fractions were also not studied further. 
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O~~y~-------------------
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Retention time (min) 
Peak 2 
[M+Ht= 7484 
50 
Fig. 72. Attempted HPLC separation of the doublet (peak fraction 4) in Fig. 
69. Identical gradient and solvents were used as in Fig. 62A. MALDI-TOF 
data are indicated. 
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Fig. 73 . Biological assay for pigment-dispersing honnone, showing the head of 
a light-adapted P. pacificus A. before, and B. after injection of synthetic ~­
PDH. Jala CPRP 1-4 were also assayed in shrimps, but failed to elicit a PDH 
effect. 
174 
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3.5. Preliminary investigation of cHlUMIHlVIH peptides from sinus glands of 
Palillllrus gilcllristii 
Figure 74A shows a typical HPLC chromatogram of an extract of 50 sinus glands 
from the spiny lobster P. gilchristii. Aliquots of peak material were subjected to mass 
analyses and ELISA. Immunoreactions with anti-Roam elill serum were visible in 
material from 4 peaks only, the most intense reaction coincided with peak 16 (see 
Fig. 74B). Anti-Capa MIH serum was also used in the ELISA and only weakly 
recognised peak 14,which is the major peak of the separation profile (Fig. 74). 
Surprisingly, the more-hydrophobic peaks 18 and 21 were not recognised as cHH-
family peptides by anti-Roam cHH and anti-Capa MIH sera. Mass spectrometry 
provided [M+Hf data peaks 7,8 and 14 only, as 7578, 7686 and 8524 Da, 
respectively (results not shown). As the major peak, peak fraction 14 was selected for 
N-terminal sequencing; a partial sequence of 30 residues was elucidated which 
indicated an unblocked N-terminus. The partial sequence (not shown) is 100 % 
identical to first 30 residues of Jala cHH-I. 
3.6. Molecular biological aspects 
3.6.1. RNA extraction 
Total RNA was extracted from 30 X-organs of 1. lalandii specimens. This amounted 
to a total of 14 )lg RNA, as quantified spectrophotometrically. The good, non-
degraded quality of the RNA is visible in Fig. 75. The RNA, redissolved in DEPC-
treated water, was stored at -70 DC when not in use. 
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Fig. 74. A. A typical RP-HPLC fractionation profile of an extract of 50 sinus gland5 
from the spiny lobster Palinuros gilchristii. Peak fractions are labeled in the order of 
elution. Identical separation conditions, column and solvents were used as for the 
separation of peptides from sinus glands of J. lalandii (see legend to Fig. 24). HPLC 
peak fractions were collected and tested in ELISAs for imm~noreactivity with B. anti-
Hoam elill: values above 0.1 are illustrated, and anti-Capa M1H sera (results not 
shown; only peak fraction 14 reacted weakly with the M1H serum: absorbance of 
0.067). 
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18S-
1 2 3 4 5 6 
Fig. 75. Electrophoresis of 1.14 flg total RNA, extracted from X-
organs of J lalandii (lane 6), separated on an ethidium bromide 
agarose gel. An RNA marker was loaded in lane 1, while lanes 2-5 
contain RNA from various insect tissues. 
2 3 
Fig. 76. Ethidium bromide 1.1 % agarose gel containing double 
strand cDNA of J lalandii (lane 3), derived from X-organ RNA. 
Lane 1 contains the molecular weight marker )J HindU I + EcoRI, 
while lane 2 contains cDNA of an insect. 
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3.6.2. Construction of eDNA library 
The library was constructed following the protocol and reagents supplied with the 
SMARTTM kit from CLONTECH. 
a strand cDNA was 
total RNA from lata XOs was used to 
amplified by PCR to produce double 
stranded (ds) cDNA The success of the amplification is visualised in Fig. 76. Two to 
three Ilg of the amplified ds cDNA was digested with proteinase K to inhibit any 
further enzyme activities, and thereafter, was with Sft L This Sfi I-digested 
ds cDNA was fractionated by virtue of on SPIN columns. 
fractions containing cDNA were clearly detected in fractions 11 under UV in an 
gel (Fig. 77). Thus, fractions 6-12 were pooled, the ds cDNA was precipitated, 
dried and redissolved in water. The quantity of cDNA after 
fractionation was estimated by the plate 78 that the 
recovered lala cDNA corresponds, intensity, to 50 of Lambda DNA per 0.5 ilL 
Fifty ng of the recovered ds cDNA was then mixed with 500 ng of 
vector in a ligation reaction. The ligated eDNA (400 ng) was jJ"'-m.u.j"..., .... into a Iv 
phage. 
Lysates of the unamplified lata cDNA library were diluted 1:5 and 1 :20 with Ix 
lambda dilution buffer, to coli and titred after an overnight incubation 
period. 1:5 dilution produced near-confluent plaque growth, 
dilution produced well-separated plaques which amounted to 5 
forming units (pfu )/mL 
un."c",'l" the 1:20 
x 106 plaque 
The cDNA library was amplified, yielding a titre of 6.5 x 109 pfu/ml with 92 % 
recombinant plaques. 
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Fig. 77. Gel electrophoresis of3 ~l ofcDNA fractions (derived from 
RNA of J lalandii X-organs) after size fractionation. Lane 1 contains a 
molecular weight marker (N HindlII + EcoRI) and lanes 2-10 contain 
cDNA fractions 7-15, respectively. 
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Fig. 78. Ethidium bromide plate assay to estimate the quantity of J lalandii 
cDNA (derived from RNA of X-organs). Different concentrations of A DNA 
were spotted onto the plate (the same volume as Jala cDNA, viz. 0.5 ~l) and the 
relative intensity of the latter was compared to the DNA standard. The 
approximate yield of Jala cDNA after size fractionation (i.e. recovery of full-
length transcripts) correspond to 1 00 ngl~l. 
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3.6.3. peR cloning of the coding region of lata cHH cDNA 
Several peR reactions were carried out with degenerate primers encoding lata cHH-
I. These experiments were all unsuccessful, despite designing several degenerate 
primers and modifying the peR cycling protocol in various ways. It was then decided 
to design non-degenerate primers by using the codon usage for Drosophila 
melanogaster and by carefully selecting the part of the amino acid sequence to which 
the primers should correspond to. In peR reactions with these non-degenerate 
primers that encoded the termini of lala cHH-I, a clear DNA band of about 240 bp in 
size was detected in samples that contained lala cDNA as template, regardless of 
whether the cDNA was amplified from RNA that had been extracted from male or 
female specimens (Fig. 79). This peR product band was not detected in control 
samples in which ds lala cDNA template was omitted (lane 6, Fig. 79). It also 
appears that the absence of Q solution did not have an obvious effect on the peR 
reaction (compare lanes 2 and 3 with lanes 4 and 5 of Fig. 79). After extraction of the 
DNA bands from the gel, the recovered 200+ bp fragment was estimated at a quantity 
of 50 ng/IlI, based on the relative intensity of the band compared with standard 
amounts of DNA fragments from Lambda DNA digested with Hind III (Fig. 80). 
3.6.3.1. TOPO@ cloning of 200+ bp PCRproduct and its DNA sequence 
The 200+ bp peR product was successfully cloned into the TOPO® vector and 
transformed into E. coli cells (One shot® cells) . White plaques with ampicillin-
resistance conferred by the TOPO® vector, were picked and amplified overnight in 
LB medium with ampicillin. The plasmid DNA was isolated by mini-prep. 
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79. DNA gel electrophoresis of a 216 bp product (arrow) from J IElUl¥lEl 
eDNA of (lanes 2 and 4) and males 
fragments were generated by PCR using non-degenerate 
Jala cHH-I primers and aliquots ds Jala cDNA template. molecular 
weight marker is pUC Mix Marker 8 (lane 1). with "' ..... "IJ .. ~" 
loaded 2 and 3 were carried out in the absence of Q solution, whereas 
in 4 and 5 were performed with Q solution. Lane 6 contains 
reaction mixture in which the cDNA template had been omitted. 
I 2 3 4 
80. The 216 bp PCR products (see 71) of 
Jala eDNA from females were pooled, electrophoresed, the cDNA fragment was 
from and quantified on an ethidium bromide 1 % (lane 
2). The same procedure was out the peR fragment derived from male 
cDNA (lane 3). 1 and 4 contain molecular weight markers (AlHindIII and 
AlHindIII + EcoRI, respectively). The fragment corresponded to aPJ)roxInrlat'el 
cDNN~tl with DNA standards. Only from ",-,U1<",", 
lobster (lane was cloned. 
181 
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On sequencing of clones, the following sequence information was obtained, some of 
which corresponded to the TOPO® vector itself, others corresponded to the non-
degenerate primers and others to a novel sequence (Scheme 1 illustrates how these 
different sequences could originate from the clone): 
Vector: 
TTTTNNGCCCGCTCAGATTAACCCTCCTAANGGGACTAGTCCTGCAGGTTTAAAC 
GAATTCGCCCTT 
Primer: GCCGTGTTCGATCAGAGCTGCAAGGGCGT 
Novel sequence: 
GTACGACCGCTCGCTCTTCAGCAAGCTGGACCGGGTCTGCGACGACTGCT 
ACAACCTCTACAGGAAGCACTACGTGGCCACCGGCTGCAGGAGAAACTG 
CTACGGCAACCTGGTCTTCCGCCAGTGTCTGGACGACCTGATGCTGGTGG 
ACGTGGTGGAC 
Primer: GAGTACGTGGCCTCCGTGCAGATGGTG 
Vector: 
AAGGGCGAATTCGCGGCCGCTAAATTCAATCGCCCTATAGTGAGTCGTATTACA 
ATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCA 
ACTTAATCGGCTTGCAGCACATCCCCCTTTCGCAGCTGGCGTAATAGCGAAGAG 
GCCCGACCGATCGCCTTCCAACAGTTGCGCAGCCTATACGTACGGAAGTTTAAG 
GGTTACACCTATAAAAGAGAAGCCCGTATCGCTGTTGNGGATGACNGAGGGTAT 
TATTGANCNCCGGCACGATGGGATCCCTGGCATGACGTTGTGNAANAAGCNTCC 
GGAACTTACCGGGGGCTATGGGAAAAG 
When the novel DNA sequence was aligned and compared using BLAST software, 
its deduced peptide sequence showed 100 % identity to the partial Jala cHH-I 
sequence, spanning amino acid residues yll_C52. Thus, eDNA encoding a part of one 
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of the hyperglycaemic hormones was cloned; this partial eDNA also contains a 
region that is common to Jala MIH, viz. V22CDDCYJ'IlL YR31. 
This 200+ bp eDNA is therefore a potentially useful fragment as a probe with which 
to screen the Jala eDNA library for the genes encoding members of the 
cHHlMIHNIH peptide family. 
Cloning strategy tor Jala cHH 
Sequencing primer 
... RTPCR 
C4-Non-:degen 
pnmer 
YPeR 
~-=";;;;'*=r ====-: .. peR product 
... Ligation in pTOPO 
B.mdii-ita I!! l I 1Il---UL! . g;=#-_~, .. 
" ) 
~. 
;! first strand eDNA 
Scheme 1. A diagrammatic representation of the cloning strategy employed for a 
cHH from J. lalandii. The sequencing results of the amplified PCR product relates to 
the known sequences of the TOPO vector (indicated by black ellipsoid). the 2 non-
degenerated primers (indicated by blue bars) and the nove] sequence which 
corresponds to Jala cHH-I (indicated by green lines). 
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4. DISCUSSION 
Peptide hormones appear to be the master regulators of many physiological processes 
in both invertebrates and vertebrates. Neuropeptides, i.e. peptides that are synthesised 
by neurons, also fall under this category. The best-known neuroendocrine complex is 
the vertebrate hypophyseal-hypothalamus system. The equivalent of this system in 
invertebrates is the brain-corpora cardiacaJcorpora allata system in insects and the X-
organ-sinus gland complex in crustaceans. 
Many decades ago, neuroendocrine functions were identified by classical physiological 
experiments of tissue extirpation and implantation. In this way, it was ascertained that 
a number of processes in decapod crustaceans were under the control of factors that 
were produced in the eyestalks. By the same means, observations were recorded on 
the sudden hypertrophy of certain organs following eyestalk ablations With improved 
microscopy and histological techniques, neuroendocrine and neurohaemal organs 
could be identified, described and named. 
It was during this early period of investigation into neuroendocrine tissue that the X-
organ and its associated neurohaemal organ, the sinus gland, were described 
(Hanstrom, 1939; Bliss and Welsh, 1952; Passano, 1953). Specific extirpation of these 
tissues resulted in the same outcomes as with eyestalk ablation and the involvement of 
the XO-SG complex in processes of moulting, growth, sexual maturation, regulation 
of metabolism, colour adaptation and osmoregulation was confirmed. 
In the current study, the XO-SG system in a palinuran decapod species has been 
investigated by means of immunocytochemistry at the light microscopical level and 
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. several neurohormones have been isolated from the smus glands and have been 
chemically and functionally characterised. 
4.1. Immunocytochemical aspects 
The localisation of peptides belonging to the cffiiIMIHIVIH neuropeptide family in 
the XO-SG complexes of 3 different decapod crustacean species was achieved in the 
present study with the use of heterologous antisera. In most of the 
immunocytochemical studies on cffiiIMIHIVIH peptides, homologous antisera were 
used because it was thought that there would not be cross-reactivity between different 
crustacean species and infraorders due to substantial peptide differences. The idea of 
species- or systematic group-specific neurohormones was established on the basis of 
bioassays on interspecific hyperglycaemic activity in which a number of crustacean 
species were cross-injected with crude eyestalk or sinus gland extracts, or with 
purified cHHs (Leuven et ai. 1982; Keller et ai. 1985). The conclusion drawn from 
these studies was that cHH is specific at the infraorder level, e.g. the hormone isolated 
from a brachyuran would only have a hyperglycaemic effect in other members of that 
group, and will have no effect on astacideans and vice versa. This biological 
specificity was further borne out by immunological cross-experiments using 
immunodiffusion techniques with anti-Astacus leptodactyius cHH serum and anti-
Carcinus maenas cHH serum in which there was also no interspecific cross-reactivity 
among the infraorders (Leuven et al. 1982). With the use of a more sensitive 
immunodetecting method, however, viz. tissue immunocytochemistry, Gorgels-KaUen 
et al. (1982) showed cross-reactivity of anti-A. leptodactyius cHH serum with other 
astacideans (Orconectes limosus, Nephrops norvegicus, Homarus americanus), as 
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well as with a palinuran (Palinurus vulgaris) and a caridean specIes (Pa/aemon 
serratus). Thus, the immunocytochemical study indicated an immunologically 
detectable relationship between the cHHs of different crustacean infraorders. This is 
not so surprising in view of the close sequence homology of cHHs across the 
systematic groups as recently determined by biochemical methods. For example, the 
sequence homology is 81 % between 0. limosus and H americanus cHHs and 61 % 
between O. limosus and C maenas cHHs (Keller 1992). 
In the present study I report on comparative tissue immunocytochemical and ELISA 
results that confirm the conclusions drawn by Gorgels-Kallen et al. (1982) and extend 
the immunological relationship of different cHHs to include the brachyuran infraorder. 
This was achieved by the use of anti-cHH serum from two different astacideans (H 
americanus and Procambarus bouvieri) and from a brachyuran (Cancer pagurus) (the 
primary structures of cHH from these species are shown in Fig. 81). The cHH antisera 
showed clear cross-reactivity on palinuran eyestalk tissue (Jasus lalandii and 
Panulirus homarus), as well as on brachyuran tissue (C maenas). The specific 
immunostaining of the sinus gland and X-organ perikarya with anti-Capa cHH serum 
was completely abolished when the antiserum was preadsorbed with HPLC-purified 
Capa cHH. The specificity of the anti-Hoam cHH and anti-Prbo cHH sera could not 
be tested in such preadsorption experiments because of the unavailability of purified 
Hoam and Prbo cHH peptides. However, since the staining pattern is comparable to 
that obtained with anti-Capa cHH, it can be accepted that the immunoreactive results 
are true positive. 
In this immunocytochemical study, I have also extended the comparative investigation 
to include anti-Capa l\1lH serum and anti-Hoam VIH serum. Thus far, VIH has only 
been isolated and sequenced from H americanus (Soyez et al. 1991), P. bouvieri 
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.lala cHH-I 1 AVFDQSCKGV YDRSLFSKLD RVCDDCYNLY RKHYVATGCR RNCYGNLVFR QCLDDLMLVD VVDEYVASVQ MV-NH 2 
.lala cHH- I II AVFDQSCKGV YDRSLFKKLD VVCDDCYNLY RKPYVATGCR ENCYSNLVFR QCLDDLMLVD VVDEYVSTVQ MV-NH 2 
.lala cHH-II 2 AVFDQSCKGV YDRSLFQKLD LVCDDCYNLY .RKPYVATGCR ENCYGN 
.lala cHH-I 2 AVFDQSCKGV YDRSLFGKLD RVCDDCYNLY RKPYVATGCR QNCYGN 
Hoarn cHH-A3 pEVFDQACKGV YDRNLFKKLD RVCEDCYNLY RKPFVATTCR ENCYSNWVFR QCLDDLLLSD VIDEYVSNVQ MV-NH2 
Hoarn cHH-B3 pEVFDQACKGV YDRNLFKKLN RVCEDCYNLY RKPFVIVTCR ENCYSNRVFR QCLDDLLMID VIDEYVSNVQ MV-NH2 
Prbo cHH**4 pEVFDQACKGI YDRAIFKKLD RVCEDCYNLY RKPYVATTCR QNCYANSVFR QCLDDLLLID VVDEYISGVQ TV-NH2 
Carna cHHII 8 * pE1YDTSCKGV YDRALFNDLE HVCDDCYNLY RTSYVASACR SNCYSNLVFR QCMDDLLMMD EFDQYARKVQ MV-NH, 
- -------- --------- -- - ,. 
Capa Chhii 6 * pE1Y~TSCKGV YDRGLFSD~E HVCDDCYNLY ~NSYVASACR SNCYS~VFR QCMEELLMM~ EF~KYARAVQ MV-NHL 
Peja cHH-VI 7 LVFDPSCAGV YDRVLLGKLN ~L~DDCYNVF ~EPNVATECR SNCFYNLAFV QCLEY~LPPS LHEEYQANVQ MV-NH2 
Peja cHH-1 I 17 
Maro cHH 8 
Perno cHH 9 
Meen cHHBIOH 
Pesc cHHll 
SLFDPACTGI YDRQ~LRKLG RLCDDCYNVF ~EPKVATGCR SNCYHNLIFL DCLEYLIPSH LQE~HMAAMg TV-NH 2 
A1LDQSCKG1 FDRELFKKLD RVCDDCYNLY RKPYVA1DCR RGCYQ~~VFR 1QD~Q~M~ DLDEYANAVQ TV-NH2 
SLSFRSCTGA YDRELLVRLD RVCEDCYNVY RDVGVAAECR SNCFHNEVFL Y~VQYMFRPR QRNQ!RAALg RL-NH? 
SLFDPSCTGV KDRELLGRLN RVCDDCYNVF RE~KVATECR SHCFLNPAFI QCLEY1IFEV LHEEYQANVQ LV-NH2 
ANFDPSCTGV YDRELLGRLS RLCDDCYNVF REPKVATECR SNCFYNPVFV QCLEYLIPAD LHEEYQAHVG TV-NH2 
- -- --- - - --- --- -- -- - -- - ---
Fig. 81. Comparison of the amino acid sequences of cHHs from four different infraorders, viz. Palinuridae: IJasus lalandii (current study) and 2 the partial cHH 
sequence reported from J. lalandii (Yasuda, 1997); Astacidae: 3Homarus americanus (Tensen e/ al., 1991) and 4Procambarus bouvieri (Aguilar el al., 1995); 
Brachyura: 5Carcinus maenas (Kegel et aI., 1989) and 6Cancer pagurus (Chung et al., 1998), and Penaeidae: 7 Penaeus japonicus (Yang et aI., 1995, 1997), 
8Machrobrachium rosenberg;; (Sithigomgul et aI., 1 999a,b), 9Penaeus monodon (Udomkit et al., 2000), IOMetepenaeus ens;s (Gu el al., 2000; # deduced from 
nucleotide sequence) and II Penaeus schmitti (Huberman et al., 2000). Similarities betwecn thc sequcnces of the palinurid and astacidcan species arc indicated by 
boldface letters. Similarities between all the infraorders arc underlined. * cHH-1 differs from -II by having a frec N-tcrminus; **Ihc cHH sequence of i'rocamhnrus 
bouvier; is identical to that of P. c/arkii, and cHH from Orconectes limosus differs from this by only one residue (L 62). The truncated .Inla cHH sequences of the 
current study is identical to the first 65 residues of Jala cHH-1 and -II presented above. 
..-
00 
-.J 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
188 
(Aguilar et al., 1992) and the isopod Armadillidium vulgare (Greve et aI., 1999) 
whereas MIH sequences are known from crab, prawn and crayfish species (see Fig. 
82). 
To date, MIH antisera have only been used in immunocytochemistry on brachyuran 
tissue (anti-C. maenas MIH serum reacted positively with eyestalk tissue sections 
from five different crab species~ Dircksen et al. 1988) and prawn (an antiserum raised 
against a synthetic peptide which represented the C-terminal sequence of Peja MIH 
specifically differentiated between Peja MIH and cHH peptides and reacted positively 
with the XO-SG complex of Penaeus japonicus; Shi et al., 1998). In the present study 
I show reactivity of anti-Capa MIH serum on brachyuran as well as palinuran eyestalk 
tissue. Anti-Capa MIH serum was recognised by antigens in the axon terminals of the 
sinus gland and by the granular contents of the X-organ perikarya. The weaker 
intensity of the immunoreaction on palinuran tissue, relative to the strong reaction in 
the crab tissue, might be explained by the degree of sequence similarity between the 
different MIHs. With regards to C. maenas MIH, Mill from other crabs, such as 
Callinectes sapidus and C. pagurus, are 79.5 % and 84.5 % identical, respectively 
(see Chung et al. 1996), whereas the astacidean Procamharus clarkii MIH is only 48 
% identical (Nagasawa et al. 1996). Comparisons between the sequence ofMIH from 
1. lalandii and C. pagurus show indeed only 41 % sequence identity (Fig. 82). 
Background staining associated with neural tissue of the optic ganglia was also 
observed with the use of anti-Capa MIH, despite attempts to block endogenous 
peroxidase activity. The specificity of anti-Capa rvIIH serum was, however, 
unequivocally shown by preabsorption with pure Capa l'v'IIH peptide. The application 
of the MIH + anti-MIH preabsorbed complex completely abolished the specific 
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Jala: RFTFD-CPGMMGQRYLYEQVEQVCDDCYNLYREEKIAVNCRENCFLNSWFTVCLQATMREHETPRFDIWRSILKA-NH2 100 
Prell: RYVFEECPGVMGNRAVHGKVTRVCEDCYNVFRDTDVLAGCRKGCFSSEMFKLCLLAMERVEEFPDFKRWIGILNA-NH2 43 
Casa2 *: RVINDDCPNLIGNRDLYKKVEWICDDCANIYRSTGMASLCRKDCFFNEDFLWCVRATERSSDLAQLKQWVTILGAGRI 41 
Cama 3 : RVINDECPNLIGNRDLYKKVEWICEDCSNIFRKTGMASLCRRNCFFNEDFLWCVHATERSEELRDLEEWVGILGAGRD 41 
Capa 4 : RVINDDCPNLIGNRDLYKKVEWICEDCSNIFRNTGMATLCRKNCFFNEDFLWCVYATERTEEMSQLRQWVGILGAGRE 41 
Chfe5 *: RVINDDCPNLMGNRDLYKKVEWICDDCANIYRITGMASLCRKDCFFNFDFLWCVRATFRSFDMTQLKQWVRILGAGRI 42 
Camag6 *: RVINDDCPNLIGNRDLYKRVEWICEDCSNIFRNTGMATLCRKNCFFNEDFLWCVYATERTEEMSQLRQWVGILGAGRE 41 
Peja 7 : S FIDNTCRGVMGNRDYNKKVVRVCEDCTNI FRLPGLDGMCRNRCFYNEWFL I CLKA-NRED EIEKFRVWISILNAGQ 38 
Meen 8 *: SYIENTCRGVMGNRD IYKKVVRVCEDCTNI FRLPGLDGMCRDRCFNNEWFLVCLKAANRDDE LDKFKVWISILNPGL 41 
Prbo9 : pEVFDQACKG-IYDRAIFKKLELVCDDCYNLYRKPKVATTCRENCYANSVFRQCLDDLLLINVVDEYISGVQIV-NH2 37 
Peva10 *: DTFDHSCKG-IYDRELFRKLDRVCEDCYNVFREPKVATECKSNCFVNKRFNVCV-ADLRHDVSRFLKMANSALS 36 
Fig. 82. Alignment of the peptide structure of a putative MJH fromJ. lalandii (Jala) with those purified or deduced from nucleotide sequences (*) from other 
decapod crustacean infraorders. Astacidae: 1 Procambarus clarkii (Nagasawa et al., 1996), and 9p. bouvieri (Aguilar et ai., 1996); Penaeidae: 7Penaeusjaponicus 
(Yang et al., 1996), 8Metapenaeus ensis (Gu and Chan, 1998) and lOp. vannamei (Sun, 1994); and Brachyura: 2Callinectes sapidus (Lee et a!., 1995),3Carcinus 
maenas (Webster, 1991), 4Cancer pagurus (Chung et al., 1996), 5Charybdisferiatus (Chan et aI., 1998) and 6Cancer magister (Umphrey et aI., 1998). Identical 
a..1llino acid residues, with reference to the brachyuran MIHs, are shown in bold. The (-) indicates the gapes) introduced into the amino acid sequence to align the 
Cys residues and to allow for maximal identity. Amidation is shown by: -~. Overall identity of the amino acid sequence (%) is compared with Jala MIH and 
indicated to the right of the primary structures. 
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imnnIDostaining in the SG-XO system, whereas the non-specific, background staining 
remained unaffected. 
In this immunocytochemical study, positive immunostaining of the SG-XO system 
with anti-Hoam VIH was obtained on both palinuran and brachyuran tissue, albeit 
weaker reactions than were observed with anti-cHH sera This confirms an earlier 
ELISA report that VIH does not seem to be species- or systematic group-specific 
based on cross-reactivity of anti-Hoam VIH on brachyuran, caridean and isopod sinus 
gland extracts, but contradicts the finding that anti-Hoam VIH serum does not 
recognise sinus gland material of palinurans (Meusy et al. 1987). Apart from the 
negative immunocytochemical result of anti-Hoam VIH with palinuran tissue from 
Jasus paulensis, negative results were also reported with sinus glands from the 
astacideans A. leptodactylus and 0. limosus (Meusy et al. 1987). In contradiction to 
this, cross-reactivity of anti-Hoam VIH has been illustrated for the crayfish N 
norvegicus (Giulianini et aI., 1998). Due to the unavailability of pure Hoam VIH 
peptide, I could not use preabsorbed antibody-antigen complexes to demonstrate the 
specificity of the anti-VIH reaction. However, I investigated this issue in ELISA 
experiments in which putative cHH peptides from J. lalandii and MIH peptides from 
C. maenas were identified from HPLC-generated peaks from crude extracts of sinus 
glands and used for absorption of anti-Hoam VIH. This absorbed antiserum was then 
applied to the putative cHH and MIH peptides in another ELISA The putative cHH 
and MIH peptides were also treated with unadsorbed anti-Hoam VIH to determine 
the degree of cross-reactivity between the antiserum and these peptides. Observations 
from previous ELISA experiments have indicated that similar antigenic determinants 
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reside in elm and Vlli peptides of H. americanus, which leads to cross-reactivity of 
anti-Hoam VIH with Hoam cHH peptide (Meusy and Soyez 1991). This may 
therefore account for the observed positive immunoreaction between anti-VIH 
antiserum and the identified cHH fractions in the current study. The cross-reactivity of 
anti-Hoam VIH with C. maenas'MIH, although never tested before, may also not be 
surprising, since it is known that 'MIH and Vlli share greater sequence identity with 
each other (51% - 53 %) than with any cHH (19 %) (Chung et a,l. 1996). Preabsorbed 
complexes of anti-Hoam Vlli with either pure C. pagurus cHH or pure C. pagurus 
MIH peptide did not eliminate specific staining when applied to 1. lalandii tissue 
sections in the present study. Specific immunostaining was also not eliminated in the 
ELISA investigation when preabsorbed anti-Hoam VIH and 1. lalandii cHH peptide, 
or anti-Hoam Vlli and C. maenas 'MIH were applied, thus indicating that Vlli-like 
antigens are being positively identified after the suppression of cross-reactivity with 
cHH and 'MIH antigens. However, anti-Vlli serum did not react with a unique peptide 
in ELISA investigations on peptides separated by HPLC from crude extracts of sinus 
glands from 1. lalandii and it may be speculated that the Vlli pep6de( s) has(have) not 
been resolved with the given HPLC gradient but may be co-eluting with the other 
peaks. MALDI-TOF analyses of the HPLC peaks, however, revealed only 1 mass per 
peak, which argues for the purity of the separated peaks and cross-reactivity of anti-
Vlli serum with cHH and 'MIH epitopes. 
A further result, emanating from the use of serial sections in the present study, 
revealed co-localisation of cHH, 'MIH and VIH antigens in the X-organ perikarya. 
Partial co-localisation of cHH and Vlli antigens have also been documented in 
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immunocytochemical studies with H americanus (Kallen and Meusy 1989), and has 
been confirmed at the mRNA level by in situ hybridisation (De Kleijn et al. 1992); in 
both studies, homologous antisera and cRNA probes were used. Co-localisation of 
cHH and vrn: peptides and their mRNAs has also been reported for Homarus 
gammarus using antisera and cRNA probes against H american us (Rotllant et ai., 
1993). In another study where heterologous antisera (anti-a. limos us cHH and anti-
Hoam VIR) were used on N norvegicus tissue sections, co-localisation of the two 
hormones was not apparent (Giulianini et aI., 1998). Thus, there is no clear trend 
emerging about the dual synthesis of cHH and vrn: in the same perikarya and the 
expected co-release of the two hormones. Similar1y with co-localisation of Mll:I and 
cHH immunoreactivity: in both immunocytochemical and in situ hybridisation studies 
with specific C. maenas antisera and cRNA probes, respective1y, co-localisation of 
cHH and Iv1IH in C. maenas was not observed (Dircksen et ai. 1988; Klein et ai. 
1993a). Yet, co-localisation of:MJH and cHH has been reported inP. japonicus with 
specific antisera raised against Peva cHH and :MJH (Shih et ai., 1998), The fact that 
the preabsorption experiments with Capa antisera and respective peptides eliminated 
all positive immunoreactions in tissue immunocytochemistry in the current study, 
points to the possibility that the observed results must be specific for the particular 
antisera A logical conclusion, therefore, follows that cHH and Mll:I peptides are 
indeed co-localised in some neurons. Co-localisation of cHHIMIHIVIH peptides in 
the present study was also investigated by double staining with a cocktail of two 
primary antisera and detection of immunoreactivity by immunofluorescence. This 
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method could not be fully optimised, largely because of the age (post-expiry) of the 
flourescent-labeled secondary antisera. Despite this, however, evidence of co-
localisation of cRR with MIH and VIH immunoreactivity in 1. lalandii was obtained. 
More information regarding this co-synthesis/secretion of Jala hormones may be 
obtained from embarking on in situ hybridisation studies with specific cRNA probes; 
such studies must still be undertaken. In view of the sequence homologies, crab MIH 
is similar to lobster VIH, and since lobster eRR and VIH 'are co-localised, it does not 
seem improbable to find that crab cRR and MIH also have partial co-localisation. At 
present, there is no explanation for the observed discrepancy between the results of 
the present study and that of earlier workers, with n~spect to irnmunostaining of C 
maenas tissues, except to point out that different antisera (anti-C pagurus MIH 
serum in the present study and anti-C. maenas MIH serum in earlier studies) and 
different methods of study have been carried out (indirect peroxidase technique in the 
present study and the peroxidase-antiperoxidase technique was used by Dircksen et al. 
1988). Although C pagurus MIH is recognised by 1\00 receptors on C maenas Y-
organs, and both of these MIHs exhibit similar biological activity (Webster 1993), 
radioimmunoassays of C pagurus MIH using C maenas MIH antiserum showed 
limited cross-reactivity (see Chung et al. 1996), therefore, suggesting differences in 
their antigenic determinants. In the current ELISA study on HPLC-ge:nerated ' 
fractions from crude extracts of J. lalandii sinus glands, anti-C pagurus MIH serum 
clearly recognised one peak only, whereas anti-C pagurus cHH serum recognised this 
same putative MIH fraction in addition to the two cHH peaks. Thus, one would 
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speculate that the 1. lalandii MIH peptide may structurally be more similar to the crab 
elm: than to the lobster cHH peptide. There is, however, not a significant difference ih 
the sequence identity between Jala MIH and Hoam cHH (27 %), and that between 
Jala MIH and Capa cHH (28 %), and it must be assumed that anti-Capa cHH serum 
is not as specific as anti-Hoam cHH and anti-Prbo cHH serum. It can further be 
postulated that anti-Capa cHH serum may be recognising the residues V22_R31, which 
is a highly conserved region in the Jala :MIH, Jala cHH and Capa cHH peptides (cf 
Fig. 81 and 83). 
The current immunocytochemical study has shown that members of the 
cHH/MllIlVIH peptide family in the palinurans 1. lalandii and P. homarus are 
sufficiently homologous to peptides from the astacideans H. americanus and P. 
bouvieri and to the brachyuran C. pagurus to· achieve cross-reactivity with 
heterologous antisera. This cross-reactivity resulted, largely, in very specific 
immunoreactions that could be abolished by preadsorbing the antiserum with its 
specific peptide. In the case of 1. lalandii and C. maenas, the immunoreactions were 
attributed to distinct HPLC peaks, following the separation of peptide fractions in 
extracts of sinus glands. These antisera could then be used as useful tools with which 
to identifY cHH/MllIlVIH peptides after HPLC separations. 
Further information from this study relates to morphology of the eyestalk of decapod 
crustaceans, especially the XO-SG complex. Whereas the optic ganglia and X-organ 
of the crab and spiny lobster species are no different than what have previously been 
described for other crustaceans (see Cooke and Sullivan, 19982), the position of the 
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sinus gland relative to the lIDderlying optic ganglia varies. In the current study, there is 
confirmation of the location of the sinus gland in C. maenas (at the medulla intema; 
cf Jaros and Keller, 1979), and information is supplied on the position of the sinus 
gland in J. ZaJandii and P. homarus (between the medulla intema and the medulla 
terminalis). This relatively distal position of the sinus gland in the spiny lobster agrees 
with a previous report on Panulirus interruptus (Mancillas et al., 1981) and has also 
been reported for the prawn P. japonicus (Shih et ai., 1998). In other crustaceans the 
sinus gland is situated at the transition between the medulla extema and the medulla 
interna (e.g. A. leptodactylus: Van Deijnen et ai., 1985) or at the medulla intema (e.g. 
N norvegicus: Giullianini et al., 1998). 
Results from the present comparative immunocytochemical study indicate co-
localisation of diHlMIHlVIH neuoropeptides in the X-organ, which suggests dual 
synthesis and processing of the peptides in the pelikarya and simultaneous release 
from the axon terminals. Since the inhibitory hormones (VIH and MIH) are assumed 
present in high titres in the circulation for most of the year to be effective in 
suppressing growth and reproductive development, and since cErn is also required on 
a daily basis, it is perhaps not so strange to have frequent co-release of these 
necessary hormones into the haemolymph. Further studies at the molecular biological 
level are needed to confirm the co-localisation and to monitor the rate of mRNA 
synthesis (transcription of the genes) over different periods of the day, moulting and 
reproductive cycles. 
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4.2. Functional characterisation of cHHIMIHIVlH peptides from sinus glands of 
1. laland;; 
Crude extracts of sinus glands, prepared in hot acetic acid to minimise the action of 
degradative proteases, were applied to RP-HPLC. A gradient was designed to 
separate and resolve the hydrophobic material from such extracts and the resulting 
pattern of fractionation was observed by monitoring the absorbance of peptide bonds 
of the eluting material at a wavelength of 214 nm. In this manner, reproducible 
separations were achieved and the peak material was subjected to immunoassays, 
mass spectrometry and biological assays to characterise and identify cID-IfMIHIVIH 
peptides of 1. lalandii. 
4.2.1. Assessment of hyperglycaemic activity 
In the current study, in vivo homologous assays were carried out with juvenile spiny 
lobsters (i.e. sexually immature animals to minimise the possible influence of 
reproductive cycles on glycaemia; Dean and Vernberg, 1965a) under controlled 
temperature conditions of the aquarium room (12-14 °C), since temperature is also 
known to affect glycaemia in decapod crustaceans (Dean and Vernberg, 1965b). In a 
number of crustacean species, the secretory rhythm of elm over a 24 hour period has 
shown that glucose levels peaked during the night and then stabilised during late-
morning hours (Dean and Vernberg, 1965b; Reddy et al., 1981; Kallen, 1985). 
Therefore, to ensure a lowered and stable level of glucose in the haemolymph, assays 
in the current study were always carried out after 10hOO. In pilot experiments, juvenile 
J lalandii specimens of roughly .the same size and weight classes were starved for a 
few days prior to the injection of 1 SGE of crude homologous extracts or sea water. 
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Two hours post-injection, a significant increase (p<O.OS) in glucose concentration was 
measured in the haemolymph of sinus gland-injected lobsters compared with sea 
water-injected animals. Two hours were thus selected as the time frame over which to 
measure a change in glycaemia following injection of a test substance. These pilot 
experiments further showed that there was quite a wide variation in initial glucose 
values of the juveniles, despite having selected similar sized animals and the fact that 
all the juveniles were maintained under similar aquarium conditions, including the 
feeding regime. Such variations have been reported before and attempts to counteract 
this have included eyestalk ablations and prolonged periods of starvation (see for 
example Aguilar et al., 1995; Sithigorngul et al., 1999a). To prevent unnecessary 
trauma to the juvenile lobsters and not to interfere with their overall hOImonal 
balance, it was decided not to ablate their eyestalks and, instead, to group and select 
animals for injection based on their initial glucose levels. In this way, the standard 
deviations inside the group were lowered and the significance of the change in 
glycaemia could be unequivocally established. This non-random selection of the test 
animals did not bias the outcome of the experiments, since the current study has 
shown that all the juveniles showed a similar level of response after the injection of 
crude extracts of sinus glands, regardless of whether they had low or high initial 
glucose concentrations. Furthermore, the initial glucose levels also did not aflect the 
response of the lobsters to sea water injections. The:se assay conditions wen:, thus, 
applied to discover which of the peaks, separated on HPLC from crude extracts of J 
lalandij sinus glands, showed hyperglycaemic activity. From the immunologicall 
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characterisation of the five peaks typically separated in the current study, four had 
shown a positive immunoreaction with anti-Hoam cHH serum (peaks 1, 2, 4 and 5 of 
Fig. 24), whereas all 5 peaks had reacted positively with anti-Capa cHH serum. 
Biological activity was only associated with peaks 4 and 5, eliciting a significant 
increase in glucose levels of 170 and 81 %, respectively. These bioactive peptides are 
thus code-named Jala cHH-I and Jata cHH-II in the order of elution, as well as 
abundance (cHH-I being the major peak). 
4.2.2. Determination ojMIH activity 
4.2.2.1. Characterisation oj cir.culating ecdysteroids in J. talandii 
The moult cycle of crustaceans is under the control of two hormones: a peptide 
hormone that has an inhibitory effect (MIH) and a steroid hormone that has a 
stimulatory effect (moulting hormone = ecdysteroid). The accepted, simplified, 
paradigm for moult control in crustaceans is that high titres of:MIH suppress the 
synthesis of ecdysteroids and only when this repressive action of:MIH is lifted, can 
sufficient ecdysteroids be produced to reach a critical level in the haemolymph, which 
then initiates ecdysis (see Webster, 1998). Ecdysteroids are produced and secreted in 
various chemical forms from a pair of thoracic glands known as the Y-organ.For 
example, ecdysone (E) and 25-deoxyecdysone (25dE) are secreted from C. maenas 
Y-organs (Lachaise et at., 1989), ecdysone and 3-dehydroecdysone (3DE) are 
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secreted in Cancer antennarius (Spaziani et al., 1989), Procambarus clarkii (Sonobe 
et al., 1991), Orconectes limosus (Bocking et al., 1993) and Penaeus vannamei (Blais 
et ai., 1994). Research has shown that these ecdysteroids are further modified by 
peripheral tissues in the proximity of the Y-organs (see Lachaise et at., 1993): E and 
25dE are hydroxylated to give rise to 20-hydroxyecdysone (20E, which is the active 
form of the ecdysteroids) and ponasterone A, respectively; 3DE is reduced by 3P-
reductase into ecdysone and then converted into 20E (Bocking et al., 1995). Thus, it 
is possible to deduce which form of ecdysteroids is produced by the Y-organ.::; from 
the ecdysteroids present in the haemolymph. In the present study, extracts of 
haemolymph samples from J. lalandii were subjected to normal phase (NP) HPLC; 
the retention times of the resulting peak fractions were compared to the retention 
times of known ecdysteroid compounds chromatographed under the same conditions, 
and the fractions were tested for immunoreactivity in an EIA with AS 4919 (an 
antibody that recognises a variety of different ecdysteroid forms; Porcheron et al., 
1976). In the current study, peak fractions that had the same retention times as E and 
20E on NP-HPLC were immunoreactive, which suggests that these are the major 
forms of ecdysteroids occurring in the haemolymph of J. ialandii and further, that 
either E or 3DE or both, i.e. E and 3DE, are produ(;ed by the Y-organs of this spiny 
lobster species. Based on these conclusions, an EIA was designed to titre the 
ecdysteroids produced in vitro by J. lalandii Y-organs in the presence of various 
substances. Two other less-polar compounds also eluted as minor peaks on NP-HPLC 
fromJ. lalandii haemolymph in the current study. These peaks could not be identified 
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by their retention times but were immunoreactive with AS 4919 antisera. It could be 
argued that, depending on the extent o(cross-reactivity of these unknown peaks with 
AS 4919, the final conclusions concerning the ecdysteroids of Jala V-organs could 
greatly differ. I have, however, presumed that these unknown peaks are well 
recognised by AS 4919 and hence, conclude that 20E is the major circulating 
ecdysteroid in 1. lalandii. The moulting hormone, 20E, was incidentally first isolated 
in crustaceans from carcasses of the spiny lobster Jasus iaiandei (Hampshire and 
Horn, 1966). and was later also extracted from insects, a crayfish and a pine tree 
(Galbraith et ai., 1967). Prior to this, ecdysone was first purified from insects by 
Butenandt and Karlson in 1954 (see Smith and Sedlmeier, 1990). 
4.2.2.2. Y-organ incubations and EIAs 
The biological activity of a putative moult-inhibiting hormone has mostly been 
deduced from the indirect evidence of ecdysteroid production from in vitro 
incubations of Y -organs - a reliable method that was first introduced by Soumoff and 
o.'Connor (1982). Coupled with sensitive methods of immunodetection, such as 
radio- or enzyme-immunoassays, this biological assay has provided a means to 
quantitatively assess the effect of compounds on the output of ecdysteroids from the 
moulting glands. Instrumental to the success of such a biological assay are two 
considerations: (i) dissection of the V-organ, i.e. knowledge of the location and clear 
identification of the moulting gland; (ii) accurate quantification of the ecdysteroids 
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produced in vitro, i.e. selecting the appropriate antibody to best recognise the 
ecdysteroid and thereby to provide accurate interpretations of the ecdysteroid titre. 
In the current study, successful explantation of the Y-organ was confirmed by 
immunoreactivity of the secreted products with antisera raised against ecdysteroids, as 
well as by demonstrating that the productivity of the gland can be altered by the 
presence of crude extracts of sinus glands, a source of the moult-inhibiting peptide. A 
survey of the more recent literature on the gross anatomy and location of the Y-
organs highlights the inaccurate descriptions of older reports and subsequent 
misidentifications, especially confusions between the Y -organ and the mandibular 
organ (see Spaziani, 1990; Aiken, 1980; Lachaise et ai., 1993). The lack of adequate 
illustrations regarding the anatomical position ofY-organs have further compounded 
this problem One of the few undisputed reports is the description of the brachyuran 
Y -organs as clearly discemable, discrete glands, whi(;h is accompanied by drawings of 
the location of these glands (see Lachaise et aI., 1993). Another good report gives the 
description of the position of the Y-organ relative to the mandibular organ in 
Orconectes limosus, and this is also supplied with a lucid sketch for orientation 
(Burghause, 1975). The only attempt to locate th~~ Y-organs of a spiny lobster is 
documented in a very descriptive report by Paterson (1968). However, the emphasis 
on gross anatomical features, such as muscles and thl~ir points of insertion, without an 
adequate diagram to clearly mark the position of the Y-organ, has not made this 
report very useful. Therefore, in the current study on J. lalandii, careful attention was 
given to the location of the Y-organs and the best approach to remove the organs for 
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in vitro incubations. It appears that the Y-organs of J lalandii are larger and not as 
diffuse in structure as reported for clawed lobsters and crayfish (see for example, 
Lachaise et aI., 1993). Morphologically, the structure that I have removed and 
identified as the Y-organ of J lalandii in the present study, matches that of Paterson 
(1968), except that the crescent-shaped Y-organ is yellowish, not whitish in 
appearance in vivo. To confirm my conclusions, several tissues in the cephalothorax 
have also been incubated and analysed for the production of ecdysteroids, but only the 
identified Y -organ tissues have given positive results in the EIA. It was with absolute 
certainty therefore, that these organs have been removed for in vitro biological assays. 
The second consideration of the assay, viz. that of antibody selection to confidently 
recognise the produced ecdysteroids, was also carefully addressed in the current 
study. Characterisation of the circulating ecdysteroids had pointed to the likelihood of 
E, 3DE or both compounds being produced by the Y-organs of J. lalandii. To 
optimally bind these ecdysteroids in an EIA for their exact quantification, the RUD-2 
antibody was used; this polyc1onal antiserum was shown to have a high specificity 
towards both E and 3DE (Von Gliscynski et al., 1995). 
The Y -organ assays of the current study have clearly demonstrated the presence of a 
factor in the sinus glands of J lalandii, which inhibits ecdysteroid synthesis by 
homologous Y -organs. The maximum inhibition of 50-60 % of the control Y -organs 
achieved by 1 SG, has also been reported by investigations on other species (e.g. 
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Webster, 1986; Sefiani et a!., 1996; Terauchi et aI., 1996). This inhibition, however, 
appears to be dependant on the moulting stage of the Y-organ donor: crude extracts 
of sinus glands in the present study were unable to inhibit the synthesis of ecdysteroids 
in Y-organs that were obtained from post-ecdysis animals, i.e. postmoult, whereas 
significant inhibition was achieved in Y-organs from intermoult and premoult spiny 
lobsters (54 and 60 %, respectively). Variation in the response of Y-organs from 
prawns at different premoult stages to homologous sinus gland extracts have already 
been reported, where ecdysteroid synthesis in late premoult animals was inhibited by 
less than 10 % and mid-premoult animals were inhibited by 72 % (Sefiani et aI., 
1996). A similar phenomenon was observed in the crab, C. maenas (Webster and 
Chung, 1999). 
In the current study, the ecdysteroid titre in the haemolymph of.!. lalanelii was 
measured over different times of the moult cycles, viz. intermoult, premoult and 
postmoult. The results show a fluctation pattern that is very similar to that recorded in 
P. vannamei (Blais et al., 1994), O. limosus (Willig and Keller, 1973) and Callinectes 
sapidus (Lee et al., 1998) with the maximum concentration of ecdysteroids occurring 
during the premoult phase of the cycle and a decline in the titre evident already before 
ecdysis (late premoult). This change in circulating ecdysteroids in C. sapidus 
correlated to the levels of M1H mRNA in the eyestalk, thus affinning the model of 
moult control in crustaceans: Mill mRNA levels dropped during premoult and then 
increased in the postmoult stage, remaining high during intermoult (Lee et ai., 1998). 
Just after ecdysis (postmoult), the Y-organs of.!. lalandii produce very low amounts 
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of ecdysteroids when incubated in vitro and this is also reflected in the circulating 
ecdysteroid titre of the present study, The decrease in circulating ecdysteroid titres 
during the critical stages immediately before and after ecdysis is not brought about 
just by the influence of MIH, since this fluctuation in ecdysteroid titres are also 
observed in eyestalk-ablated lobsters in the present study and by others (Hopkins, 
1983), Recent experiments have demonstrated that ecdysteroid production by the Y-
organs of a. limosus is under negative feedback control by circulating ecdysteroids 
(Dell et al., 1999), This might explain the observed drop in titre before ecdysis, 
whereas the observed low circulating titre of ecdysteroids immediately after ecdysis (a 
period from 3 days to about 3 weeks post-ecdysis was under observation in this study) 
is directly connected with the low production rates in the Y -organs, The contributing 
factors for this low production of ecdysteroids are not known at this stage; it does not 
seem to be MIH, since the postmoult Y -organs in the current study were not 
negatively influenced by sinus gland extracts, A possible reason why postmoult Y-
organs are not responsive to crude extracts of sinus glands in the present study may be 
that these Y -organs are not yet expressing receptors for MIH, This was not 
investigated and remains speculation at this stage but which seems to be refuted by an 
earlier study on crabs, Specific receptors for MIH (and cHH) on the V-organs of 
intermoult brachyuran crabs have been demonstrated and MIH peptides from 2 other 
brachyuran crab species could bind effectively to the C maenas MIH receptor, which 
suggests that there is a high degree of conservation in the binding domains of the 
brachyuran MIH peptides (Webster, 1993), It was, surprisingly, reported that neither 
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the density nor the affinity of the MIH and cHH receptors on the Y -organ changed 
significantly during the moult cycle of the crab, which may suggest that the 
incompetence of the Y-organ to respond to MIHlcHH during late premoult and early 
postmoult could be due to uncoupling of the signal transduction pathways (Webster 
and Chung, 1999). 
In the current study, moult stage was estimated from the circulating ecdysteroid titres, 
coupled with observations of the condition of the exoskeleton. Previous studies have 
determined moult stages from various externaL macroscopic changes in the 
exoskeleton, microscopic examinations of setal development on various appendages 
and measurement of the size of gastroliths (see Willig and Keller, 1973; Lyle and 
MacDonald, 1983; Chan et ai., 1988). Classically, the moult cycle of crustaceans is 
divided into four phases: (i) metecdysis (postmoult) "'" the period immediately 
following ecdysis; (ii) anecdysis (intermoult) = a period of tissue growth and 
accumulation of food reserves; (iii) proecdysis (premoult) = a period of active changes 
(morphological and physiological); (iv) ecdysis (moulting) ::.::: the actual act of shedding 
off the old exoskeleton (Drach, 1939). These phases were further subdivided by 
investigators, on the basis of observation of morphological changes during the moult 
cycle. Normal variations in this pattern arising from species differences, as well as the 
varied terminology used in the different studies, hav~~ left a rather confusing protocol 
for determining moult stage of crustaceans. It was for this reason that ecdysteroid 
titres in the haemolymph of J lalandii were correlated with moult stage. As shown in 
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the current study, the classic stages could be accurately and relatively easily be 
discerned on this basis but attempts were not made to further divide the moult stages. 
Intermoult spiny lobsters were preferred as Y -organ donors in the current study 
because of the clear inhibition effected by sinus glands on these organs. A typical 
saturation curve was achieved when crude sinus gland extracts of J. lalandii were 
applied in different doses to the Y -organs from intermoult animals. One SGE, the 
highest dose tested, effected a 54 % inhibition, whereas the lowest dose of 0.001 SGE 
did not have any effect on ecdysteroid synthesis. The lowest dose to have an inhibitory 
effect was 0.002 SGE with 6 % inhibition, whereas the first dose to elicit an inhibitory 
response that was significantly different to that caused by 1 SGE, was 0.025 SGE 
(25.4 % inhibition). 
To identify the moult-inhibiting factor(s) from the sinus glands of J. lalandii in the 
current study, 1 SGE of HPLC-separated fractions were added to in vitro Y -organ 
incubations. Peak 3 (of chromatogram in Fig. 24) showed the most pronounced 
!nhibitory effect (52 %), peak 4 also inhibited ecdysteroid synthesis, whereas peak 1 
had a negligible effect. Peak 4 had also exhibited a significant hyperglycaemic effect 
and showed strong dill immunoreactivity in the current study and was characterised 
as a cRH. Peak 3, on the other hand, had no effect in the hyperglycaemic bioassay and 
was the only peak that showed Mlli immunoreactivity, although it was also 
recognised by one of the three different anti-cHH sera. Further, peak 3 displayed the 
mass characteristics of a typical Mlli peptide, whereas peak 4 had a mass in the range 
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of the cOO peptides. On this basis, peak 3 was identified as Jala MIH, the moult-
inhibiting honnone of the spiny lobster. Crustacean hyperglycaemic hormone from 
other crustacean species have also exhibited moult-inhibiting activity, e.g. C. maenas 
(Webster and Keller, 1986), H americanus (Chang et aI., 1990), P. vannamei 
(Sefiani et al., 1996), C. pagurus (Chung et ai., 1996), P. japonicus (Yang et aI., 
1996) and P. clarkii (Yasuda et al., 1994). It was demonstrated in C. maenas that 
two different membrane-bound receptors occurred on the Y-organ: one type 
specifically bound MIH and the other bound cOO only (Webster, 1993). These results 
seem to implicate the direct involvement of cOO in the moulting cycle. 
4.2.3. In vitro ovarian cultures 
In crustaceans, vitellogenesis is under the control of an inhibitory peptide hormone, 
vitellogenesis- or gonad-inhibiting hormone (Vlli/GlH), which is synthesised and 
released from the XO-SG complex. Vitellogenesis is a phase of the reproductive cycle 
that is dominated by yolk protein production and accumulation of these proteins into 
the oocytes. The accumulated lipoprotein, vitellin (Vt), is derived from a circulating 
precursor molecule, vitellogooin (Vg). By definition Vg is the extraovarian form ofVt 
(Fainzilber et al., 1992); it has been demonstrated that both V g and Vt of the prawn 
Penaeus semisu/catus consists of 3 polypeptide subunits (200, 120 and 80 kDa) but 
have a different lipid composition: by comparison with Vg, Vt carried more 
triacylglycerols and hardly any diacylglycerols (Lubzens et al., 1997). While the 
" 
hepatopancreas, haemocytes adipose tissue are potential 
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sources of V g in other crustaceans (Kerr, 1969; Meusy and Payen, 1988), the ovary 
itself is a major site of VgNt synthesis in prawns (Fainzilber et al., 1989~ 
Quackenbush, 1989; Browdy et a!., 1990; Shafir et ai., 1992). Whereas it is accepted 
that VIH mediates an effect by inhibiting VgNt production, it is still not clear whether 
VIR acts only on the ovary or also on the extra-ovarian sources of V g (see Thurn and 
Hall, 1999). 
Over the years, a number of methods have been employed to identifY the putative 
VIHs; to date, only 3 VIHs have been characterised and sequenced. The first VIH 
peptide was isolated from a lobster and functionally characterised in a heterologous in 
vivo assay where injections of the VIH peptide into shrimps significantly retarded the 
growth of their oocytes relative to control animals (Soyez et ai., 1987). In many of 
the larger decapod crustacean species, such as lobsters, spiny lobsters and crayfish, in 
vivo assays cannot be of a homologous nature because these species usually have 
prolonged reproductive cycles, with egg laying occurring only once per annum 
Prawns and shrimps, with their much shorter reproductive cycles, are therefore used 
in heterologous assays. The second VIR peptide to be sequenced was isolated from a 
crayfish and identified by an in vitro heterologous assay where the incorporation of 
radio labeled leucine into yolk proteins of a prawn was measured after treatment with 
the VIH peptide; it must be noted, however, that VIH activity was only achieved with 
an unphysiologically high dose of 10 SGE (Aguilar et a!., 1992). Both of these assays 
indicated that the VIR peptide was not acting in a species- or group-specific manner 
as has been reported for the cHH peptide (see Leuven et al., 1982). Recently, a VIH 
was sequenced from a terrestrial isopod and biologically characterised in 2 
homologous assays: (i) in vitro incubations of female a~pose tissue with or without 
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VIH and the determination of vitellogenin quantities by immunoprecipitation, and (ii) 
an in vivo assay based on the delay of the onset of vitellogenesis: in these assays 
female woodlice were maintained under environmental conditions that would naturally 
stimulate vitellogenesis; some of these females were then periodically injected with the 
VIH peptide while others received a Ringer solution and the time of egg-laying was 
monitored (Greve et ai., 1999). This assay took full advantage of the relatively short 
reproductive cycle of the woodlice. 
In the current study an attempt was made to identifY vitellogenesis-inhibiting pE~ptides 
from the sinus gland of J. lalandii by utilising a heterologous in vitro assay in which 
the incorporation of radiolabeled amino acids into proteins of prawn ovaries was 
assessed. It has been shown that along the length of the prawn ovary, ovarian 
development is not uniform and that different regions of the ovary may exhibit 
different levels of protein synthesis (Thurn and Hall, 1999). Therefore, to remove any 
bias from the study, ovary tissue pieces were randomly placed into the tissue culture 
wells and each substance (crude extract or purified peptide) was tested in duplicate. 
Vt was synthesised de novo in the ovary pieces (as judged by the electrophoretic 
mobility of proteins, which was analysed using gel electrophoresis under denatured 
conditions, followed by autoradiography) and this synthesis was inhibited in a dose-
related manner by the addition of crude extracts of sinus glands from J. lalandii. 
Although this showed that sinus gland peptides from a spiny lobster could elicit a 
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biological effect on penaeid prawn ovaries at a physiological dose, the inter-species 
difference wa~ evident in the different doses of heterologous (J iaiandii: 2 SGE) 
versus homologous (P. semisulcatus: 0.1 SGE) extracts required to achieve the same 
percentage of inhibition. The lowest dose of J laiandii sinus gland extracts tested in 
these assays, viz. 0.001 SGE, did not inhibit de novo protein synthesis in the prawn 
ovaries and the lowest dose to produce a significantly different effect from the 
maximum dose of 2 SGE, was 0.1 SGE. These experiments further showed that the 
crude extracts of sinus glands, regardless of its origin (i.e. homologous or 
heterologous), inhibited total protein synthesis and not specifically just Vt. This 
general inhibition of ovarian protein synthesis was also reported from other studies 
(Khayat et ai., 1998; Thurn and Hall, 1999). 
Not all the cHH-like peptide fractions separated from sinus gland extracts of J 
laiandii could inhibit de novo protein synthesis in the prawn ovaries. Applied at a dose 
of 1 SGE, peak fractions 1 and 2, corresponding to truncated Jala cHH-I and -II (see 
chromatogram in Fig. 37), did not have any effect in the assay, whereas the peak 
fractions corresponding to Jaia cHH-I, Jala cHH-II and Jala MIH resulted in 
inhibition of protein synthesis. Jala cHH-II caused the highest inhibition (49 %), 
which was significantly different to the effect of peak 4 (34 %) and Jala cHH-I (20 
%). The inhibitory effect of cHH-II approximates the maximum inhibition observed 
with 1 SGE of crude extracts of Jala sinus glands, whereas Jala MIH inhibited 
protein synthesis in the prawn ovaries by about only 15 %. It seems therefore, that 
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Vlli activity, as defined in the present study to inhibit vitellogeninlvitellin synthesis in 
the ovaries, is not associated with a unique peptide of J. lalandii and that Jala cffi-I-II 
(the minor isoform of hyperglycaemic hormone) has gn~ater Vlli activity than cllli-I 
(the major isoform). Furthermore, the unidentified/uncharacterised peak 4 also shows 
significant Vlli activity in this heterologous bioassay, whereas MIH has only a small 
effect of less than 20 % inhibition. Peptides belonging to the cffi-I family from' P. 
japonicus were also shown to affect protein, as well as inRNA synthesis in in vitro 
incubated ovaries from P. semisulcatus (Khayat et al., 1998). The results from the 
current study are in agreement with this previous study, viz. that the cffi-I peptides 
substantially inhibited protein synthesis in the ovary while the MIH peptide had only a 
slight effect. In the current study, none of the selected peptides elicited a stimulatory 
response on ovarian protein synthesis, which signifies that a gonad stimulating 
hormone (GSH) was not included among the studied peptides. The absence of at GSH 
was similarly shown among the cHHIMIHIVIH peptides of P. japonicus (Khayat et 
aI., 1998), whereas a GSH in the sinus glands of P. bouvieri was reported to enhance 
protein synthesis in P. vannamei by 300 % (Huberman et al., 1995). 
4.3. Sequence elucidation of cHHIMIHIVIH peptides from 1. lalandii 
Peptides belonging to the cHHIMIHIVIH peptide family from J. lalandii were 
identified in an ELISA with antisera raised against cHH, MIH and VIR peptides from 
other decapod crustacean species. Mass spectrometry on aliquots of these 
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immunoreactive peaks revealed that the single HPLC purification step had yielded 
pure or uncontaminated peaks, since only one mass was obtained per fraction. 
Further, mass analyses revealed that most of the immunoreactive peptides were in the 
8-9 kDa mass range, while 2 others were around 7.6 kDa. All the immunoreactive 
peaks were tested in biological assays (see above) and were selected for primary 
sequence elucidation. This was successfully achieved with non-reduced peptide 
material~ linearisation by means of breaking the disulfide bonds was only carried out 
on a micro-scale with selected peptide fragments and analysed by mass spectrometry 
to confirm the assignment of the sequences. In this way, less starting material could be 
used to elucidate the full sequence of a peptide compared with studies that followed 
the conventional strategy of reducing the disulfide bonds prior to sequencing. This 
novel approach that I employed with success in the current study, relied heavily on 
accurate mass spectrometric determinations and reliable software for calculating and 
predicting peptide mass following various manipulations, such as enzymatic digestion 
and chemical cleavages. With the aid of a MALDI-TOF instrument and a GPMAW 
~oftware package (see Materials and Methods), I was able to implement my strategy 
to assist in the elucidation of the primary sequence of 5 cffi-l-Iike peptides from 1. 
lalandii. 
4.3.1. Crustacean hyperglycaemic hormones 
From a typical separation of 1. lalandii sinus glands in the current study, four peaks 
were recognised by anti-cffi-I sera, and only two of these displayed biological activity 
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in a hyperglycaemic assay. 
4.3.1.1. Jala cHH-I 
The most abundant peptide from J lalandii sinus glands (100 nglsinus gland = 12 
pmol), peak 4 (of chromatogram in Fig. 24), had displayed strong hyperglycaemic 
activity, as well as MIH and some VIR activity in biological assays of the current 
study. By omitting the step of reducing the disulfide bonds known to be conserved in 
these peptide members, the complete sequence was obtained from material purified 
from only 387 SGs, whereas previous studies needed between 600 and 6000 SGs 
(Yang et aI., 1995; Huberman and Aguilar, 1988; Chang et a!., 1990; Huberman et 
aI., 1993). Mass spectrometry played an important role in assigning the sequences and 
was particularly efficient because accurate mass spectra could quickly be obtained 
with sub-picomole quantities. Figure 81 gives the complete cHH-I sequence from the 
spiny lobster J lalandii and compares it with the major cHH structures from the 
lobster H american us, the crayfish P. bouvieri, P. clarkii (Yasuda et aI., 1994) and 
O. limosus (Kegel et a!., 1991), as well as the crab C maenas and C pagurus, the 
prawn P. japonicus, Macrobrachium rosenbergii, Penaeus monodon, Metapenaeus 
ensis and Penaeus schmitti. Also included in this comparison is the partial sequence of 
cHH-I isolated fromJ lalandii (Yasuda, 1997), which was published while my own 
work was in progress. The complete Jala cHH-I structure is, on average, 76 %, 74 %, 
65 % and 60 % identical to lobster, crayfish, crab and prawn species listed in Fig. 8l. 
Interestingly, in one aspect Jala cHH resembles more the cHH of prawns and isopods, 
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despite its overall lower homology to this group: it contains a free N-terminus, 
whereas other cHHs have an N-terminus blocked by pyroglutamate. The widely-
accepted theory about an N-terminally blocked peptide concerns the increased 
stability and biological activity of blocked versus unblocked peptides. However, this 
hypothesis was recently challenged by the finding that the minor cHH isoform of C. 
maenas has a free N-terminus and displays identical biological activity and rates' of 
release and degradation compared with the N-terminally blocked major eHH isoform 
of the crab (Chung and Webster, 1996). 
A comparison of the complete Jala cHH-I structure presented here and that of the 
previously determined partial Jala cHH-I structure (residues 1-46; Yasuda, 1997) 
shows distinct differences (residue mass given in brackets below): 
S17 (87) versus a17 (57), H33 (137) versus p33 (97), R41 (156) versus Q41 (128). The 
sum of the mass differences between these pairs of residues is 98 Oa; this may account 
for the 100 Da mass difference recorded for Jala cHH-I in each case (8380 in the 
present study and 8280 reported by Yasuda, 1997). Since the mass of the partially 
sequenced Jala cHH-I can be substantiated by the 3 amino acid substitutions above, it 
does not seem likely that sequencing errors have occurred. On the other hand, the 
unequivocal evidence in the present study shows that the complete J lalandii 
sequence is correct: (a) S17 was clearly identified in at least two attempts of Edman 
degradation of native cHH-I peptide, (b) H33 was confirmed by sequencing 
overlapping tryptic and endo-Asp N-generated peptide fragments; it is also known 
that trypsin will not cleave when Lys is followed by Pro (Croft, 1980; Tensen et al., 
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1991), and (c) R41 was first deduced from a mass difference of 156 between a partial-
and a fully digested cHH-I sample, and was then confirmed by sequencing data from 
an endo-Asp N digest fragment, as well as from the sequencing information of the· 
truncated cHH-I peptide (peak 1 in Fig. 24) which yielded residues 1-62 in Edman 
degradation (see 4.3.1.2. below). I therefore conclude that the partial cHH sequence 
(Yasuda, 1997) may not have been generated from SGs isolated from 1. lalandii 
specimens but from another spiny lobster species whose cHH may be as much as 93 % 
. homologous to that of 1. lalandii. Since 1. lalandii is an endogenous species of the 
west coast of South Africa, it seems likely that some other species may have been 
used in the studies by Yasuda. It can be speculated to be a Japanese spiny lobster but 
proper identification of the species would help to get insights into the phylogenetic 
relationship between the genera of spiny lobsters. It would be very interesting, indeed, 
to have this particular species properly identified. In the current study, 2 other spiny 
lobster species which occur locally along the South Af:rican coasts have been included 
in preliminary investigations. Tissue immunocytochemistry with eyestalk sections from 
Panulirus homarus indicates that, like in the case of 1. lalandii, there is sufficient 
homology between cHHlMllWIH peptides of this spiny lobster and those from a 
brachyuran crab, and 2 astacideans. From ELISAs on crude extracts of sinus glands, 
however, it became clear that the extracts from J. lalandii gave more intense reactions 
with the different antisera than did extracts from P. homarus. This would suggest that 
the 1. lalandii peptides have a greater sequence identity with the known peptides than 
do the peptides from P. homarus. The current study did not provide any comparative 
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peptide sequence information from P. homarus to corroborate the results of the 
immunocytochemical study, but extracts of sinus glands from a third spiny lobster 
species, Palinurus gilchristii, were prepared and fractionated in the same manner as 
for J. lalandii. Mass analyses and immunological investigations by ELISA of the 
resulting hydrophobic peak fractions were carried out. In this way, a putative cHH 
was identified and subjected to Edman degradation. The partial sequence of the 
putative Pagi cHH peptide (residues 1-30) is 100 % identical to Jala cHH-I. This was 
a rather surprising result because the chromatographic behaviour and the mass data of 
Pagi cHH differed to that of Jala cHH-I: the putative Pagi cHH displayed greater 
hydrophobicity (eluting about 4 min later than Jala cHH-I on RP-HPLC) and is also 
143 mass units heavier. It is my belief, therefore, that the primary structure of Pagi 
cHH will show some differences to Jala cHH-I in the remaining part of the peptide, 
Homologous biological assays for hyperglycaemia could not be carried out because 
there is no laboratory access to live specimens of P. gilchristii, but the relative 
abundance of this peptide, judging from peak areas on the HPLC chromatogram (Fig. 
74), is a strong indication that this peak is indeed a cHH. In cHH isolated from 
crayfish species, such considerable sequence identity has been reported, for example: 
P. bouvieri and P. clarkii have identical sequences, while 0. limosus differs from 
them by only one amino acid substitution (Kegel et al., 1991; Huberman et af., 1993; 
Yasuda et al., 1994). This reflects the evolutionary relationship between the crayfish 
species; similarly, the identical peptide sequences of J. lalandii and P. gilchristii also 
reflects their close ancestry in the infraorder Palinuridae. In this context it is necessary 
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again to reflect on the data of Yasuda (1997); certainly by sequence identity, the 
species. he studied appears to be a palinurid lobster but cannot be J. lalandii or P. 
gilchristii. His data, and information from the current study reveals that 3 out of the 
49 palinurid species listed by Phillips et aI., (1980) have cHH peptide sequences that 
are more than 90 % identical. Studies have been undertaken on the relationships of the 
genera within the Palinuridae, and the evolution of these spiny lobsters (see George 
and Main, 1967) which propose that the genus Jasus evolved independently from the 
genera Palinurus and Panulirus, and that Jasus had evolved first, while Panulirus 
evolved more recently. It would be interesting to study the phylogenetic relationships 
of the Palinuridae genera at the level of neuropeptides, specifically cHH and 
preprocHH to see if it supports the proposed relationships. Practically, such a study 
would be feasible because: (i) a total of 27 species of the genera Jasus, Palinurus and 
Panulirus are commercially-fished in the world's oceans (see Phillips et al., 1980) and 
an adequate supply of sinus gland material could therefore be available; (ii) cHH is the 
most abundant neuropeptide in the sinus gland and (iii) can be recognised 
immunochernically by antisera raised against cHH from astacideans. 
In a number of decapod crustacean species, cHH isoforms with the same peptide 
sequence and molecular mass have been reported. These isoforms elute from HPLC as 
doublet peaks and they differ only by the configuration of the third amino acid residue, 
i.e. either L- or D-Phe3 (P. bouvieri, Aguilar et al., 1995; O. limosus, De Kleijn et al., 
1994a;H. americanus, Soyezetal., 1994;P. clarkii, Yasuda et aI., 1994 and Yasuda, 
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1997). To investigate the possibility of such confonnational polymorphism in J 
lalandii, the N-tenninus of Jala cHH-I was studied to assess whether the third amino 
acid was L-Phe3 or D-Phe3 . This was done in an indirect manner: (i) two synthetic 
peptides were made that corresponded to the first 8 amino acid residues of Jala cHH-
I but one with L-Phe3 and the other with D-Phe3 . These synthetic peptides had the 
same mass but distinctly different retention times on RP-HPLC. (ii) The native N-
terminal octapeptide of Jala cHH-I had been sequenced earlier in the current study as 
one of two. peptide chains from the tryptic fragment T26 and could then be isolated 
from this fragment by reducing and alkylating the disulfide bonds between Cys 7 and 
Cys43. (iii) The retention times on HPLC of the isolated native octapeptide was 
compared with that of the synthetic L- and D-Phe3 octapeptides. The results indicate 
that the octapeptide fragment from Jala cHH-I is a homogenous peak consisting of 
peptide material with L-Phe3 only. 
4.3.1.2. Jala cHH-// 
,Peak 5 (see Fig. 24) was identified as a second and minor isofonn of cHH (molecular 
mass = 8357 Da) in J. lalandii, which also displayed significant VIH activity. With a 
yield of only 3 pmol of cHH-II per sinus gland and greater hydrophobicity of this 
peptide, considerably more material had to be purified to obtain the full primary 
structure than what was needed for cHH-I. It is clear from sequence comparisons of 
the two Jala cHH peptides that the nature of the cHH heterogeneity in the spiny 
lobster is clearly genetic in origin and not due to post-translational modifications. This 
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difference in cHH isoforms, as well as the free N-terminus of cHHs in the spiny 
lobster has also been observed in prawns (Sefiani et a/., 1996; Yang et al., 1997; Gu 
et al., 2000) and differs from the situation in true crabs~ true lobsters and crayfish 
(Soyez et al., 1994; Yasuda et aI., 1994; Aguilar et al., 1995; Chung and Webster, 
1996; Chung et aI., 1998). 
The 7 amino acid substitutions in the primary sequence of lala cHH-II (Fig. 81), 
perfectly accounts for the observed mass difference of 23 Da between lala cHH-II 
and lala cHH-I, and the two peptides are thus 90 % identical to each other. In the 
only other study on cHH pep tides from a palinurid species, two isoforms were 
reportedly also isolated from J. lalandii and partially sequenced (residues 1-46; 
Yasuda, 1997; Fig. 81) during the time when my own work was in progress. There 
are, however, discrepancies between sequencing data emanating from the afore-
mentioned study and the current study (see also 4.3.1.1. above). Yasuda (1997) has 
reported the cHH peptides to have a mass of 8280 and 8258 Da, respectively for 
~HH-I and -II: thus, 100 Da less for each peptide compared with the data for lala 
cHH-I and -II of the current study. The 100 Da mass difference betweenlala cHH-II 
of the current study and the partial cHH-II of Yasuda (1997) can, however, not be 
explained by the observed 3 amino acid substitutions (residue mass given in brackets): 
Kl7(128) versus Q17 (128); V21 (99) versus L21(113); S45(87) versus G45(57). 
Since the sum of the mass differences between these pairs of residues is only 16 Da, 
we predict that further substitutions will be discovered in the complete sequence of 
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the cID-I -II peptide reported by Yasuda (1997). In fact, the mass difference of 22 Da 
between the partial cID-I-I and -II peptides (Yasuda, 1997) can also not be explained 
by the amino acid substitutions and substantiates my prediction of further sequence 
changes. With the complete elucidation of Jala cID-I-II in the present study, it appears 
that the partially sequenced cID-I peptides (Yasuda, 1997) were not isolated from 
Jasus lalandii but from another, perhaps closely-related species. The accuracy of the 
assignment of the amino acid sequence bf Jala cID-I-I and -II is confirmed by the 
sequencing data of the truncated cID-Is (see 4.3.1.3. below), where the uninterrupted 
N-terminal sequencing of the native peptides up to residues 62 and 60, eliminated the 
opportunity for misinterpretation of the primary structural data. 
A comparison of the complete Jala cID-I-II structure with cID-I structures of other 
decapod crustaceans, shows 76-82 %, 63-67 %, and 42-71 % sequence identity with 
cID-Is from true lobster and crayfish, true crab and prawn species, respectively (Fig. 
81). Clearly, cID-I is a very conserved molecule, with many stretches of conserved 
residues throughout most of the molecule; this could account for the observed cross-
reactivity in the immunocytochemical component of the current study. 
4.3.1.2. Truncated Jala cHH pep/ides 
In addition to the two biologically active cID-Is, two other peptides (peaks 1 and 2 in 
Fig. 24) were isolated from the sinus glands of J lalandii in the present study. 
Although these peptides were recognised by the anti-H. americanus cHH serum, their 
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lack of hyperglycaemic activity, mass of 7000+ Da and their less-hydrophobic 
behavior in RP-HPLC indicated that they could not be true cHHs as defined earlier 
(see Introduction). Sequencing data shed some light on this puzzle: the two peaks had 
exactly the same amino acid sequence as the lala cHH-I and lala cHH-II peptides, 
except that they were truncated at residue y;5 and were, therefore, referred to as 
truncated cHH-If-II. This sequence identity with the lala cHHs explained why the 
anti-cHH serum could recognise epitopes on the truncated molecules, whereas the 
truncation itself may be the reason for the lack of biological activity of the truncated 
cHHs. It is not presently possible to identify the exact region of the cHH molecule 
that is responsible for functional activity, since there are no synthetic or genetically-
modified variants of cHH available as yet. However, since the truncated cHHs in the 
present study could not induce hyperglycemia under the same assay conditions as the 
non-truncated cHHs, one could speculate that the amino acid residues from position 
66-72 may be important in this regard. The potential role of the C-terrninus of eHH in 
interacting with the cHH receptor has been alluded to before (Huberman et aI., 1993); 
this theory, based on the relative degrees of homology of cHH (especially between 
residues 61 and 68) from species belonging to different infraorders, seems to be 
supported by results of interspecies bioassays for hyperglycaemia. In such bioassays, 
crude extracts of eyestalks or purified peptides isolated from one brachyuran species 
could induce hyperglycaemia in another brachyuran species but failed to elicit such a 
hyperglycaemic effect in an astacidean species, and vice versa (Kleinholz and Keller, 
1973; Keller et al., 1985). Thus, the biological specificity of cHH was demonstrated at 
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the infraorder level. This rule, however, cannot always be strictly applied: extracts of 
eyestalks from a palinuran spiny lobster, Palinurus vulgaris, significantly raised the 
glucose concentration in the astacidean crayfish, Astacus leptodactyius (Leuven et al., 
1982). Indeed, when we examine the C-terminal region (residues 61-72) of the cHH 
molecules in Fig. 81, there is a high degree of sequence identity between the palinuran 
and astacidean species, viz. 66M83 %, compared with 42-50 % identity between the 
astacurans and brachyurans. This could explain the observations made by Leuven et ai 
(1982) from their bioassays. Biological differences of cHH isoforms are also evident 
within the same species. For example, doseMresponse relationships of the five cHH 
peptides of P. japonicus showed that, although they were equally potent in 
homologous bioassays, Peja cHH-VI had a considerably higher efficacy, thus 
producing a higher increase in glucose levels than did Peja cHH-III (Yang et ai., 
1997). Since these two peptides of the prawn share an overall identity of68 % but are 
only 50 % identical in the C-terminal region of residues 61-72, one can assume that 
this region may well affect the efficacy of the cHH molecule. 
Also, when one considers the change of charge in the cHH molecule in this region 
(residues 61-72; Fig. 81), either by suppression or introduction of charged residues, 
one finds that there is no change between the spiny lobster and the crayfish/true 
lobster. On the other hand, the introduction of a positive charge is the net result of 
amino acid substitutions between brachyurans and astacideans/palinurans, brachyurans 
and penaeids, and between astacideans/palinurans and penaeids. Thus, the variation in 
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explain some· of the observed functional differences through lack of receptor 
recognition or inability of the cHHs to bind to the receptor due to strategic structural 
differences (amino acid substitutions) in that region. This can, however, only be 
unequivocally shown when suitably modified, synthetic cHFI peptides are available for 
cross-injection experiments across the different infraorders. Some progress towards 
the synthesis of cHHIMIH/VIH peptides have been reported: the ion-transporting 
peptide of the locust Schistocerca gregaria has been completely chemically 
synthesized, with the correct disulfide linkages and C-terminal amidation (King et al., 
1999); using recombinant DNA technology, prawn MIl-I was successfully expressed in 
Eschericia coli to produce a large quantity of biologically active hormone (Ohira et 
al., 1999), recombinant low molecular weight protein (LMWP) from the spider, 
Latrodectus mactans tredecimguttatus has also been engineered and expressed in E. 
coli (Gasparini et al., 1994) and prawn cHH was rece~ntly expressed in bacterial cells 
and recovered with biological activity (Gu et al., 2000). Nevertheless, the importance 
of the C-terminus of cHHs for biological functioning is also implied by the negative 
results of the truncated cHHs in various biological assays in the current study. For 
example, the lack of MIH activity of truncated lala cHH-I on V-organs, and the 
failure of both truncated lala cHHs to inhibit protein synthesis in the ovary. 
Finally, since both cHH peptides are truncated at a Tyr residue in 1. lalandii, 
chymotryptic activity is implicated in this mode of truncation. The present study has 
shown that the addition of PM SF, which inhibits serine proteases, such as 
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chymotrypsin, and an anti-oxidant, such as thiodiglycol, could lower the incidence 
(ratio) of truncation. It is our opinion that the Jala cHHs are susceptible to protease 
activity, and that this degradation can be minimised during extraction procedures by 
the addition of protease inhibitors. 
4.3.1.3. JalaMIH 
In this study, I report on the characterisation and complete sequence elucidation of a 
neuropeptide with Mill activity, which was isolated from the sinus gland of the 
palinurid lobster, Jasus lalandii. This peptide (peak 3 in Fig. 24) was identified as a 
moult-inhibiting hormone by means of (i) a homologous in vitro biological assay, (ii) 
immunoreactivity with anti-Mill serum, and (iii) mass and sequence homology to 
previously identified Mills. It is, therefore, referred to as Jala Mill in the current 
study. The peptide has 74 amino acid residues, a free N-terminus, is amidated at the 
C-terminus and did not demonstrate any hyperglycaemic activity in an in vivo 
homologous bioassay, although the previously-identified hyperglycaemic hormone 
Jala cHH-I (peak 4 in Fig. 24) was shown to have an inhibitory effect on ecdysteroid 
synthesis in this study. Such a functional complexity of cHH is not unknown and has 
been described for several species (Van Herp, 1998; Webster, 1998). 
A single HPLC purification step yielded sufficiently pure material of Jala Mill which 
is a relatively less-hydrophobic peptide than the 2 cHHs found in this species (see Fig. 
24). Jala Mill was uniquely recognised and bound in an ELISA by an antiserum 
raised against the Mill peptide of C. pagurus. The complete primary sequence of Jala 
Mill was obtained from a combination of automated sequencing and MALDI-TOF 
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mass analyses of peptide fragments generated by enzymatic digests and cleavages of 
the native, non-reduced peptide material. Several anomalies are apparent when we 
consider the HPLC and sequence data of a number of these fragments. Some of the 
anomalies can be explained by incomplete enzymatic digestions due to inaccessible 
cleavage sites and possibly, steric hindrances brought about by the conformation of 
the molecule around the 3 disulfide bridges (consider the tryptic fragments TIS, T 17 
and T18, as well as the endo-Asp fragments D17 and D20 in Fig 51A, B and the data 
in Table 7). In the case of tryptic fragments Tl and T3, the molecular mass and amino 
acid sequences are identical to each other, yet they exhibited different retention times 
on HPLC. This may be explained by Ito being differently protonated in the 2 
fragments. The 4 distinct peak fractions observed in RP-HPLC after cleavage with 
CNBr (peaks 4-7, Fig. SIC) yielded identical amino acid sequences which 
corresponded to the C-terrninus of the MIH peptide. Their differential elution can be 
explained by a persistent mass difference of 28 units in the case of peak fractions 4, 6 
and 7 which can be accredited to the addition of a £Drmyl group (27.995 Da) and 
Ipultiples thereof due to the use of 70 % formic acid in the cleavage mixture; the 
difference of 14 mass units from peak fraction 5 is inexplicable. 
Amidation of lala MIH was definitively established by methylation and subsequent 
MALDI-TOF analyses of the native fragment D9, which yielded a mass shift 
characteristic of an amidated peptide, as was shown by the identical behaviour of the 
synthetic amidated counterpart ofD9. The average molecular mass measured for the 
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entire lala MIH peptide, i.e. 9006 Da, fits well with the mass calculated from the 
amino acid sequence of the amidated MIH peptide. 
Figure 82 shows the alignment of the amino acid sequences of the putative lala MIH 
neuropeptide with those from other crustacean species either obtained by means of 
peptide sequencing or deduced from the nucleotide sequences. It must be noted that" in 
the latter case, the peptide itself was never isolated and its biological activity was, 
hence, also not established for several species; function was merely inferred from 
sequence identity with other peptides of known MIH activity. Further, gaps in the 
amino acid sequence of some of the peptides have been introduced in Fig. 82 to align 
all the Cys residues and to allow for a maximal degree of identity. It is clear that all 
the putative MIH peptides thus far isolated from the brachyuran crabs conform to a 
distinct type, viz. 78 residues long, free N- and C~terminus,6 Cys residues in 
conserved positions and sequence identity in excess of 70 %. From the other 
infraorders, viz. Penaeidae (represented by 3 species) and Astacidea (represented by 2 
species) there is no structural conformity of the MIH peptides. In the former group, 
all 3 putative MIH peptides apparently have free N - and C-terrnini, but range in length 
from 72-77 residues with sequence identity of between 30 and 79 %. Whereas the Cys 
residues from P. vannamei MIH are not in the positions typical for the brachyuran 
MIHs, but rather in the positions typical of the clffi peptides, those from the other 2 
penaeid species conform to the brachyuran type. Concerning the 2 astacidean MIH 
peptides, both are C-terminally blocked, whereas only 1 is N-terminally blocked. The 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
227 
latter, isolated from P. bouvieri, is a 72 residue peptide with 90 % sequence identity 
to the hyperglycaemic peptide found in that species but which is only active in the 
MllI bioassay (Aguilar et al., 1996) while the former was isolated from P. clarkii and 
is more typical of the brachyuran MllIs with 44 % sequence identity to C. maenas 
MllI. The present study supplies the first report on the structure of a putative l\1IH in 
Palinuridae. The 74 residue amidated peptide shares 36-43 % sequence identity with 
other putative MllIs and is most similar to P. clarkii MllI (Fig. 82) and has 32-34 % 
. identity with the 2 cHH peptides isolated from J. lalandii (Fig. 83). Unique to lala 
MllI is the location of the first Cys residue at position 6 in the sequence. In both, the 
cHH and MIH peptides from other crustacean species, the first Cys residue occurs at 
position 7 and a shift in the Cys residues between the 2 types of pepddes occurs with 
the second Cys residue (C23 in the case of cHHs versus C24 in the case ofMIHs). This 
apparent atypical alignment of the Cys residue in lala MIH may be attributed to a 
deletion on the gene encoding this peptide, but this cannot be verified yet. The 
structural data, however, presented here of a MIH from a palinurid species, supplies 
further information that the highest interspecific similarity of the molecule is found in 
discreet regions: (i) closely clustered around the Cys residues and (ii) in the C-terminal 
7-10 amino acid residues (a hexapeptide with the sequence WXXILXA) which may 
point to the importance of these regions in maintaining the conformation of the entire 
molecule and may suggest that the C-terminal region is not involved in any species-
specific activity of the MIH peptide. There is tentative evidence that the C-terminaI 
region of the cHH molecule, contrary to MIH, may be important not only for 
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MIH : RFTFDCPGMMGQRYLYE.QVEQVC:ODCYNLYREEKIAVNCRENCFLNSWFTVCLQATMREHET PRFDIWRS I LKA-NH2 
cHH-I: AVFDQSCKGVYDRSLFSKL~RVCDDCYNLYRKHYVATGCRRNCYGNLVFRQCLDDLMLVDVVDEYVASVQMV-NH2 
cHH-II: AVFDQSCKGVYDRSLFKKLDVVCDDCYNLYRKPYVATGCRENCYSNLVFRQCLDDLMLVDVVDEYVSTVQMV-NH2 
Fig. 83. Comparison of the amino acid sequence of Jala MIH and that of the 
hyperglycaemic peptides found in.f. lalandii: .Jala cHH-I and Jala cHH-II. Identical 
residues are indicated in bold. 
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functional activity per se but also for functional differences between different 
infraorders, as discussed in 4.3.1.2. The current study has shown that C-terminally 
truncated cHHs (peaks 1 and 2 in Fig. 24) from J. lalandii do not elicit 
hyperglycaemia in homologous bioassays in vivo nor do they affect protein synthesis 
in a heterologous in vitro assay, and that truncated Jala cHH-I also does not inhibit 
ecdysteroid synthesis in vitro, which reaffirms the importance of the C-terminal part 
of cHH for functional activity. The question of how the cHH molecule can elicit 
multiple functions, and which exact regions of the cHH and Mlli molecules are 
important for biological activity remain, as yet, unanswered. 
4.3.1.4. The atypical 8400 Da peak 
The fractionation of acetic acid extracts from J. lalandii sinus glands on RP-HPLC 
provided a typical separation profile of five clear peaks in the hydrophobic elution 
zone (see Fig. 24for example). However, atypical separations, resulting in 6 or more 
peaks in this region, were suddenly and inexplicably obtained (see Fig. 37). The only 
possible natural contributing factor may be the season during which these glands were 
collected: ordinarily, sinus glands were prepared en masse during the austral summer 
months of December to March. The sinus gland extracts that resulted in the a.typical 
separations were collected and prepared during the austral autumn and winter period 
(April to August). During this time the South African spiny lobsters moult and the 
females enter the reproductive stage (Heydom, 1969). It is possible, therefore, that 
the changed physiological status of the animals may also be reflected in the profile of 
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their neuropeptide content in the sinus gland. This would then mean that the 8400 Da 
peak is naturally occurring only at certain times in the life-cycle of the spiny lobster. 
On the other hand, the different elution pattern may have resulted from degradation 
processes induced and perpetuated by certain unnoticed laboratory conditions over 
that time, e.g. old homogenisation buffers, oxidation of peptides, protease activities 
due to incorrect handling of the glands. It must be said, however, that dissection, 
extraction and HPLC conditions were kept as uniform as possible over time. 
Peak 4 (Fig. 37) eluted just before MIH and was characterised to have a protonated 
molecular mass of 8400 Da, thus, 19 mass units heavier than lala cIlli-I and 607 
mass units lighter than lala MIH. Does this peak represent breakdown material of the 
MIH peptide or the cIllis? If the latter, then how does one reconcile the observed 
increase in mass with degradation? This would only be a feasible option if oxidation of 
the Met7l residue of lata cIlli-I has taken place; such a modification would increase 
the mass by 16 mass units and further, render the peptide less hydrophobic. N-terrninal 
sequencing of the native 8400 Da peak revealed that the 52 amino acid residues of the 
p.artially sequenced peptide, are identical to that of lala cIlli-I, a clear indication that 
this peak is not directly linked to lala MIH. A small portion of the 8400 Da peak 
material was subjected to digestion with trypsin and the resulting HPLC 
chromatogram was compared with that of lata cIlli-I to see if there were any unique 
fragments. This was coupled with mass spectrometry on the fragments. The results 
show that a hydrophobic tryptic fragment of peak 4, of co-incident retention time with 
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the C-terminal fragment of lala cIffi-I, displayed a mass of approximately 18 mass 
units more than the corresponding fragment of cIffi-I. This could be interpreted as 
evidence for the theory about Met-oxidation of lata cHH-I, since Mee l is contained 
in these C-terminal fragments. 
Functionally, the 8400' Da peak was tested in an in vitro assay to assess its ability to 
inhibit protein synthesis in prawn ovaries: the peak displayed substantial inhibitory 
activity, as did the full-length cHHs but not the truncated cHHs. This indicates that if 
this is indeed a modified lata cIffi-I, then the modification does not interfere with 
some of its biological activities. Unfortunately, there was not sufficient material to test 
in a hyperglycaemic assay, or to complete the sequence elucidation. It is my 
expectation, from the above evidence, that this spurious peak represents the Met-
oxidised form of lala cIffi-I and is merely an artefact arising from handling of the 
sinus gland material. However, one should keep an open mind and not merely dismiss 
the idea that this peak 4 might represent a novel, seasonally-expressed peptide without 
first conducting further investigations into the nature, the functional potential and the 
fidl sequence of this 8400 Da peak. 
4.4. Sequence elucidation and characterisation of non-cHHIMIHIVlH peptides 
Crude extracts of sinus glands prepared from 1. lalanclii were subjected to RP-HPLC 
in order to separate the cHHlMIHlVIH peptide family peaks in the current study. In 
the process, the less-hydrophobic peptide material was not well separated but were 
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collected, pooled and dried for further separation. The gradient conditions were 
changed to achieve this subsequent purification. From mass spectrometric analyses, it 
became clear that this purification step was not sufficient and more separation steps 
were carried out with different ion-pairing reagents to resolve peaks with different 
ionic characteristics. Peaks within defined regions of the separation chromatograms, 
and certain pure, individual peak material were tested in chromatophoric biological 
assays. 
4.4.1. Red pigment-concentrating hormone (RPCH) 
After the first re-purification of the less-hydrophobic sinus gland material, the 
chromatogram could be divided into 5 regions of interest (see Fig. 61). Material from 
all of these regions was redissolved in sea water and 1 SGE was injected into dark-
adapted shrimps (Palaemon pacificus).Only peak material from the first region of 
interest on the chromatogram had a blanching, i.e. pigment-concentrating, effect on 
the shrimps. MALDI-TOF analyses revealed that this region contained more than one 
peptide, which was confirmed by a subsequent HPLC step. Peak fraction 1 from this 
purification (Fig. 62A) was identified as RPCH by mass analyses, biological activity 
and co-chromatography with synthetic RPCH. The primary sequence of this peak was 
obtained following digestion with a pyroglutamate (pGlu) aminopeptidase. The 
presence of the suspected pGlu residue at the N-terminus was confirmed by mass 
spectrometry on the peptide before and after treatment with the amino peptidase. The 
amino acid sequence of lala RPCH is not a novel structure and is 100 % identical to 
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variety of decapod crustacean infraorders to date (caridean, penaeid, astacidean, 
palinuran and brachyuran) shows that RPCH is a highly conserved peptide in 
crustaceans and is only present in one form (see Table 1). This differs remarkably 
from the structurally homologous AKH peptides in insects, which can occur as an 
octa-, nona-, or decapeptide; most insect species have more than one isoform of 
AKH, arising as distinct gene products and not resulting from post-translational 
modification (see Gade, 1997), although the latter has been shown as well (Gade et 
al., 1992) 
Despite attempts In the current study, there was no success in isolating a 
neurohormone with pigment-dispersing activity from the sinus glands of J. lalandii. 
This antagonist to RPCH readily causes a darkening of light-adapted shrimps by 
stimulating dispersion of the pigments in epidermal chromatophores. In addition, PDH 
causes the translocation of pigment in extraretinular cells of the crustacean compound 
eye to provide a protective screen under light conditions (Rao and Riehm, 1993). In 
the current study, crude extracts of sinus glands and purified peptide peak fractions 
from J lalandii sinus glands were assayed for PDH activity in light-adapted shrimps. 
Only injections of synthetic PDH resulted in pigment dispersal of the epidermal 
chromatophores in the present study. Furthermore, mass analyses of lala sinus glands 
and purified peptides from these extracts did not reveal the presence of a typical PDH 
entity (mass approximately 1900 Da) at all. It was, thus, concluded that the hot acid 
extraction procedure of the present study is not conducive to maintaining the chemical 
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integrity of a PDB. Evidence that the PDB molecules are susceptible to oxidation and 
proteolytic enzymes has been documented (see Josefsson, 1983). But is there a 
biological relevance for PDB in the spiny lobsters? The characteristic colours of 
lobsters are due to carotenoids, mainly astaxanthin, that occur in the pigmented layer 
just beneath the epicuticle of the exoskeleton (see Phillips et at., 1980), and unlike 
other non-translucent crustaceans, such as crabs and crayfish, lobsters do not display 
pronounced colour changes. The fiddler crab, Uca pugiiator, is frequently selected as 
a PDB assay animal because of its ability to respond to the background colour by 
lightening or darkening the melanophores, erythrophores and leucophores (see 
Sandeen, 1950; Rao and Riehm, 1989). In my opinion, PDB does not obviously affect 
integumentary pigment changes in spiny lobsters, but is surely involved in the 
screening effect of the pigment layers in the eyes. The compound eyes of crustaceans 
are categorised by their position: (i) the appostion type is typical of animals who 
usually live under high light intensity; the retinular cells extend from the basement 
membrane to the crystalline core of the ommatidium; (ii) the superposition type is 
typical of nocturnal or deep sea animals who are exposed only to low light intensities; 
in this eye type there is a clear zone between the crystalline cone and the rhabdome of 
the ommatidium (Phillips et ai., 1980). Lobsters have the superposition type of eyes. 
Pigment movements within retinular cells are stimulated mainly by the direct action of 
light, whereas the extra-retinular ommatidial pigment cells are under the control of 
RPCB and PDB (Rao and Riehm, 1988). Under prolonged exposure to high light 
intensity (e.g. 2.5 hr in sunshine for Nephrops norvegicus), the visual pigment of the 
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eye is bleached, the structure of the rhabdomes is destroyed and blindness results 
(Loew, 1976). It is, however, not certain if other lobsters are very susceptible to light-
induced blindness since many of the commercially important palinurid species and 
Homarus species commonly occur in much shallower water than N norvegicus and 
are, therefore, more exposed to relatively high light intensities. 
4.4.2. Crustacean hyperglycaemic hormone-precursor-related peptides (CPRPs) 
The CPRP, previously called peptide C (VVeidemann et al., 1989), was demonstrated 
to be part of the preprohormone structure of cHH in several crustacean species (see 
Van Herp, 1998; Ohira et al., 1997a, b). Comparisons of the preprohormones of cHH, 
.M1H and VIH further illustrated that only the cHH pre:cursor had a precursor-related 
peptide. This difference at the precursor level and the degree of peptide sequence 
identity (53 % between VIH and .M1H, and only 19 % identity between cHH and 
VIHfMIH) has led to the postulation of a cHH subfamily versus a VIHfMIH subfamily 
(see. Van Herp, ·1998). The CPRPs characteristically have multi-serine amino acid 
residues (Fig. 84) and their biological functions have not been determined yet. In the 
present study, peptide material which corresponded to four HPLC peaks from the 
less-hydrophobic material of J. lalandii sinus glands were sequenced and found to 
resemble the CPRPs (see Fig. 84). The lata CPRPs 1-4 have been named in the order 
of elution. lata CPRP-I and -2 eluted as a doublet from the second region of interest; 
the doublet could not be completely separated under the different chromatographic 
conditions employed. Mass analyses confirmed the sequencing data that these two 
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Carnal: RSTQGYGRMDRILAALKTSPMEPSAALAVQHGTTHPLE 
Capa 2 : RSAQGMGKMERLLASYRGALEPSTPLGDLSGSLGHPVE 
Caca 3 : RSADGFGRMESLLTSLRGSAESPAALGEASAA--HPLE 
HoamA4: RSVEGASRMEKLLSSSN-SPSST PLGFLSQD--HSVN 
HoarnB4: RSVEGVSRMEKLLSS I --SPSST-PLGFLSQD--HSVN 
Orli 5 : RSVEGSSRMDRLLSS--GSSSSE-PLSFLSQD--QSVS 
PejaIU6 :RSFDA-------------SPSAT----- SGN--HSLN 
Perno7 : RS----------------SPEAS-PVT--SL---HTSD 
MeenA8 : - --------- - -------SPVEAAS PWVE---- - HRLVRR 
MeenB8 : ----------------- SPVEAASSPRVD----HRLVRR 
Jalal: RATEGLTRMEKLFSAD--SPPSSTPL---DAAD-HSLN 
Jala2: RATEGLTRMEKLFSADS-SP-SSTPL---DAAD-HSLN 
Jala3: . RSTNGLARLERLLSSTSSSSSSA-PLGLLS 
Jala4: RSTNGLARLERLLSSTSSSSSSA-PLGLLSGA-DHSLN 
Fig. 84. Alignment of crustacean hyperglycaemic hormone-precursor-related peptides from 
various decapod crustaceans: Ie. maenas (Weidemann et al., 1989), 2e. pagurus (Chung et al, 
1998), 3Cardisoma carnifax (Newcomb, 1987), 4H. americanus (De Kleijn et al, 1995), 
50rconectes limo~ms (De Kleijn et al., 1994a), 6Penaeusjaponiclls (Ohira et al., 1997a), 7Penaeus 
monodon (Udomkit et al" 2000), 8Metepenaeus ensis (Gu et al, 2000), Jasus lalandii (present 
study). Gaps (-) have been introduced into the shorter sequences for ;maximal identity; identical 
residues are indicated in bold. 
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peptides, 32 amino acids in length, are identical, except for an amino acid substitution 
at position 18 (plS versus S18). Jala CPRP-3 and --4, on the other hand, are more 
hydrophobic (eluted from the fifth region of interest on the chromatogram in rig. 61) 
and could be completely purified on HPLC. Sequence elucidation showed that Jala 
CPRP-3 (29 amino acids long) is identical to Jala CPRP-4 (36 amino acids long), but 
the former represents a C-terminally truncated form of the latter. The presence of four 
CPRP-like structures in J. lalandii is puzzling at the moment, since only two cHH 
peptides have been elucidated to date. It is possible that Jala CPRP-l and ,-2 is a 
display of genetic microheterogeneity in the populations of J. lalandii found along the 
west coast of South Africa; the presence of only one variant, i.e. either S18 or p lS, in 
populations of spiny lobsters from different sampling areas can best be demonstrated 
by the fractionation of a pair of sinus glands from individual spiny lobsters with the aid 
of micro-HPLC, coupled with MALDI-TOF analyses. Alternatively, this issue can 
also be clarified by cDNA cloning of Jala CHH to determine its preprohormone 
structures. Similarly, it may be argued that Jala C:PRP-4 is a full-length precursor-
related peptide and that Jala CPRP-3 is a mere artefact of peptide degradation and 
that, therefore, only two CPRPs are found in J. lalandii sinus glands: either Jala 
CPRP-I and -4, or Jala CPRP-2 and -4. At this stage no definite answers can be 
provided, although a previous study on C. maenas also reports on the finding of three 
CPRPs when only two cHHs have been elucidated (Chung and Webster, 1998). There 
is always still the possibility that a hitherto undetected cHH-like peptide occurs in the 
sinus gland, perhaps a very hydrophobic peptide that does not elute on the gradients 
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used in the current study and which can account for the "extraneous" precursor-
related peptides. CPRPs have also been isolated from other crustacean species, such 
as 0. !imasus, H. americanus and C. maenas (Tensen et al., 1991b) and C. pagunls 
(Chung et al., 1998). Alignment of the different CPRPs in Fig. 84 reveals certain 
regions of identical amino acids and also shows that the CPRPs may vary in length, 
even within one species. Strikingly different in Jala CPRP-l and -2, is the RIA2 
residues compared with the conserved R1S2 of other CPRPs. Other exceptions are the 
CPRP structures of Metapenaeus ensis, where the first 2 residues are SP (Fig. 84). 
The CPRP of C. pagurus was recently studied with immunocytochemical and 
radioimmunoassay techniques and revealed the following: CPRP co-localises with 
cHH in the eyestalks and pericardial organs; CPRP was stochiometrically released 
with cHH, and the main target tissue for CPRP appeared to be the hypodermis 
(Wilcockson et al., 1998). In the current study it was shown that the CPRPs are not 
recognised by anti-cHH sera (confirmation that cHH and CPRP do not have common 
epitopes). I have also established that the CPRPs do not play a role in integumental 
pigment migration, i.e. they could not elicit RPCH or PDH activity in biological 
assays. 
4.5. Molecular biology aspects 
Molecular biology techniques have been successfully applied by several investigators 
to the field of crustacean neuroendocrinology (see De Kleijn and Van Herp, 1995; 
Van Herp, 1998). To initiate study on the spiny lobster neuropeptides at this level, a 
cDNA library was constructed from RNA of J lalandii X-organs in the current study, 
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using commercially available kits. The amplified Jala eDNA library showed a high 
titre with more than 90 % recombination and an average insert size of about 1.5 kbp. 
This preliminary study has, thus, provided an available library which will latm be 
screened with various Jala cDNA probes in order to obtain information about the 
number and primary sequences of preprocHHs, as well as other eyestalk neuropeptide 
precursors. In future studies, too, cRNA probes will be made for Jala cHHs and MIH 
which will be useful to study the expression of these neuropeptide mRNAs under 
specified environmental or developmental conditions, as well as to achieve clarity 
about co-expression of Jala cHH and MIH in the same cells. Towards this end, PCR 
reactions were carried out in the present study with two synthetic oligonucleotides, 
deduced from the amino acid sequence of Jala cHH-I and corresponding to the N-
and C-terminus of the peptide, and cDNA from Jala X-organs as template. The 
sequence data obtained from the resulting PCR product indicates 100 % sequence 
identity with the partial sequence of Jala cHH-I, viz. residues yll_CS2. This partial 
cDNA also encodes a region that is common to both Jala cHHs and to Jala MIH and 
is, thus, a potentially useful candidate to serve as a probe for screening the Jala eDNA 
library for genes encoding both of these hormones. A similar strategy has recently 
been applied, with success, to isolate a cDNA encoding a cHH-like peptide from the 
silkworm Bombyx mort (Endo et al., 2000). 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
2.+0 
4.6. Concluding comments 
A number of n,europeptide hormones have been isolated, functionally characterized 
and sequenced for the first time from the eyestalk of the spiny lobster Jasus lalandii. 
This species is a valued commodity in South Africa because it not only generates 
much-needed foreign revenue for this developing country, but it also provides 
employment and upliftment to mainly impoverished coastal communities. To date, the 
South African rock lobster industry has complied with the increasing overseas demand 
by increasing the fishing yields, extending the lobster collection season and reducing 
the legal size limit of lobsters. These changes in fisheries management policies place 
enormous pressure on the sustainability of the natural resource, especially when tons 
of lobsters are also periodically killed by deoxygenated coastal waters (as had 
occurred in 1999 during severe black-tide conditions). It is at a time like this when 
purely ecological research reaches its limit - not that such studies should be under-
rated, but one should also acknowledge the worth of knowing which physiological 
and biochemical parameters impact most on the biology of these large, but also 
vulnerable crustaceans. 
The present study has laid the foundation for future non-ecological research on J. 
lalandii by providing structural information of important bioregulators. Some 
information can already be implemented practically by the existing lobster industry, for 
example, the accurate assessment of moulting stage will eliminate mortalities (and the 
resulting decrease in revenue) when only the hardiest animals, i. e. those in intermoult, 
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are selected for live export. With the methodology and infonnation at hand from the 
current study, specific antisera can be raised and cRNA probes can be made to study 
these neuropeptide regulators during development and during an array of 
environmental conditions, which will produce useful basic infonnation for budding 
aquaculturists of J. lalandii. Gene manipulation and re:combinant DNA technology 
with regards to J. lalandii neuropeptide honnones, are also not far-off possibilities 
anymore. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
242 
REFERENCES 
Abdu, D., Takac, P., Laufer, H. and Sagi, A (1998) Effect of methyl famesoate on late 
larval development and metamorphosis in the pravmMachrobrachium rosenbergii 
(Decapoda, Palaemonidae): ajuvenoid-like effect? Bio!. Bull. 195: 112-119. 
Abramov.itz, AA, Hisaw, F.L. and Papandrea, D.N. (1944) The occurrence ofa 
diabetogenic factor in the eyestalks of crustaceans. Bioi. Bull. 86: 1-5. 
Adiyodi, K.G. and Adiyodi, R.G. (1970) Endocrine control of reproduction in decapod 
Crustacea. BioI. Rev. 45: 121-165. 
Aguilar, M.B., Quackenbush, L.S., Hunt, D.T., Shabano'witz, 1. and Huberman, A 
(1992) Identification, purification and initial characterization of the vitellogenesis-
inhibiting hormone from the Mexican crayfish Procambarus bouvieri. Compo Biochem. 
Physio/ B 102:491-498. 
Aguilar, M.B., Soyez, D., Falchetto, R., Arnott, D., Shabanowitz, J., Hunt, D.F. and 
Huberman, A. (1995) Amino acid sequence of the minor isomorph of the crustacean 
hyperglycemic hormone (CHH-II) of the Mexican crayfish Procambarus bouvieri 
(Ortmann): Presence ofa D-amino acid. Peptides 16: 1375-1383 . 
. Aguilar, M.B, Falchetto, R., Shabanowitz, J., Hunt, D.F. and Huberman, A (1996) 
Complete primary structure of the molt-inhibiting hormone (MIH) of the Mexican crayfish 
Procambarus bouvieri (Ortmann). Peptides 17:367-74. 
Aiken, D.E. (1980) Moulting and growth. In: Cobb, 1.S. and Phillips, B.F. (Eds.) The 
Biology and Management of Lobsters. Vol. I. PhYSiology and Behaviour. Academic 
Press, New York. pp. 90-163. 
Barkai, A., Davis, c.L. and Tugwell, S. (1996) Prey selection by the South African cape 
rock lobster Jasus lalandii: ecological and physiological approaches. Bull. Mar. Sci. 58: 
1-8. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Berlind, A. (1977). Cellular d)namics in invertebrate neurosecretory systems. Int. Rev. 
Cytol.49:171-251. 
243 
Blais, C. Sefiani, M. Toullec, J-Yand Soyez, D. (1994) In vitro production of 
ecdysteroids by V-organs of Penaeus vannamei (Crustacea, Decapoda). Correlation with 
hemolymph titers. Invert. Reprod. Dev. 26:3-12. 
Bliss, D.E. and Welsh, lH. (1952) The neurosecretory system ofbrachyuran Crustacea. 
BioI. Bull. Woods Hole Mass. 103:157-169. 
Bocking, D., Dauphin-Villemant, C., SedImeier, D. Blais, C. and Lafont, R. (1993) 
Ecdysteroid biosynthesis in molting glands of the crayfish Orconectes limosus: evidence 
for the synthesis of 3-dehydroecdysone by in vitro synthesis and conversion studies. Insect 
Biochem. Molec. BioI. 23:57-63. 
Bocking, D., Dauphin-Villemant, C. and Lafont, R. (1995) Metabolism of3-
dehydroecdysone in the crayfish Orconectes limosus (Crustacea: Decapoda). Eur. J. 
Entomol. 92:63-74. 
Booth, J.D. and Phillips, B.F. (1994) Early life history of spiny lobster. Crustaceana 66: 
271-294. 
Bowman, T.E. and Abele, L.G. (1982) 1. Classification of the recent Crustacea. In: Bliss, 
. D.E. (Ed.) The Biology of Crustacea. Academic Press, New York. Vol. 1, pp. 1-27. 
Brandt, W.F., Alk, H., Chauhan, M., and Von Holt, C. (1984) A simple modification 
converts the spinning cup sequencer into a vapor phase sequencer. FEBS Lett. 174,228-
232. 
Browdy, c.L., Fainzilber, M., Tom, M., Loya, Y. and Lubzens, E. (1990) Vitellin 
synthesis in relation to oogenesis in in vitro incubated ovaries of Penaeus semisulcatus 
(Crustacea, Decapoda, Penaeidae). J. Exp. Zool. 225:205-215. 
Burghause, F. (1975) Das V-organ von Orconectes limosus (Malacostraca, Astacura). Z. 
Morph. Tiere 80:41-57. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
244 
Chan, S-M., Rankin, S.M. and Keeley, L.L. (1988) Characterization of the molt stages in 
Penaeus vannamei: setogenesis and haemolymph levels of total protein, ecdysteroids, and 
glucose. BioI. Bull. 175:185-192. 
Chan, S-M., Chen, X-G. and Gu, P-L. (1998) PCR cloning and eX"Pression of the molt-
inhibiting hormone gene for the crab (Charybdis/eriatus). Gene 224:23-33. 
Chang, E.S. (1995) Physiological and biochemical changes during the molt cycle in 
decapod crustaceans: an overview. J. Exp. Mar. BioI. Ecol. 193: 1-14. 
Chang, E.S. and Bruce, MJ. (1980) Ecdysteroid titers of juvenile lobsters follov.'.ing molt 
induction. J. Exp. Zool. 214: 157-160. 
Chang, E.S., Bruce, MJ. and Newcomb, R.W. (1987) Purification and amino acid 
composition of a peptide with molt inhibiting activity from the lobster, Homarus 
americanus. Gen. Compo Endocrinol. 65:56-64. 
Chang, E.S, Prestwich, G.D. and Bruce, M.J. (1990) Amino acid sequence ofa peptide 
with both molt-inhibiting and hyperglycemic activities in the lobster, Homarus 
americanus. Biochem. Biophys. Res. Commun. 171:818-826. 
Chang, E.S., Chang, S.A., Benz, B. and Kravitz, E.A. (1999) Crustacean hyperglycemic 
hormone in the lobster nervous system: localization and release from cells in the 
subesophageal ganglion and thoracic second roots. J. Compo Neurology 414:50-56. 
Charmantier-Daures, M., Charmantier, G., Janssen, KP.C., Aiken, D.E. and Van Herp, 
F. (1994) Involvement of eyestalk factors in the neuroendocrine control of osmoregulation 
in adult American lobster, Homarus americanus. Gen. Camp. Endocrinol. 94:281-293. 
Chung, 1.S. and Webster, S.G. (1996) Does the N-terminal pyroglutarnate residue have 
any physiological significance for crab hyperglycemic neuropeptides? Eur. J. Biochem. 
240:358-364. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
245 
Chung, 1.S, Wilkinson, M.e. and Webster, S.O. (1996) Detennination of the amino acid 
sequence of the moult-inhibiting hormone from the edible crab, Cancer pagurus. 
Neuropeptides 30:95-101. 
Chung, 1.S. and Webster, S.O. (1998) Unexpected microheterogeneity of crustacean 
hyperglycemic hormone precursor-related peptides (CPRPs) in the green shore crab, 
Carcinus maenas. Conference Proceedings of Iflh Conference of European Comparative 
Endocrinologists p. 14. 
Chung, J.S., Wilkinson, M.e. and Webster, S.O. (1998) Amino acid sequences of both 
isoforms of crustacean hyperglycemic hormone (CHH) and corresponding precursor-
related peptide in Cancer pagurus. Regul. Peptides 77: 17··24. 
Chung, J.S., Dircksen, H. and Webster, S.O. (1999) A remarkable, precisely timed release 
of hyperglycemic hormone from endocrine cells in the gut is associated with ecdysis in the 
crab Carcinus maenas. Proc. Nat. Acad. Sci. 95:13103-13107. 
Cockcroft, A.C. and Payne, A.I.L. (1997) Cautious fisheries management in South Africa: 
the fisheries for rock lobster. ICES 3: 1-14. 
Cooke, I.M. and Sullivan, R.E. (1982) 6. Hormones and neurosecretion. In: Bliss, D.E. 
(Ed.) The Biology o/Crustacea. Academic Press, New York. Vol. 3, pp. 205-290. 
Croft, L.R. (1980) Handbook 0/ Protein Sequence Analysis. Second Edition. Wiley and 
Sons, Norwich. 
Dean, lM. and Vernberg, F.J. (1 965a) Variations in the blood glucose level of Crustacea. 
Compo Biochem. Physiol. 14:29-34. 
Dean, J.M. and Vernberg, F.J. (1 965b) Effect of temperature acclimation on some aspects 
of carbohydrate metabolism in decapod Crustacea. Bioi. Bull. 129:87-94. 
De Kleijn, D.P.V., Coenen, T., Laverdure, A.M., Tensen, c.P. and Van Herp, F. (1992) 
Localization ofmRNAs encoding the crustacean hyperglycemic hormone (CHH) and 
gonad inhibiting hormone (01H) in the X-organ sinus gland complex of the lobster 
Homarus americanus. Neuroscience 51: 121-128. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
246 
De Kleijn, D.P.V., Linck, R, Klein, lM, Weidemann, W.M., Keller, R and Van Herp, F. 
(1993) Structure and localization ofmRNA encoding a pigment dispersing hormone 
(PDH) in the eyestalk of the crayfish Orconectes limosus. FEBS Lett. 321:251-255. 
De Kleijn, P.V., Janssen, KP., Martens, GJ.M., and Van Herp, F. (1994a) Cloning and 
expression of two crustacean hyperglycemic hormone mRNAs in the eyestalk of the 
crayfish Orconectes limosus. Eur. J Biochem. 224:623-629. 
De Kleijn, D.P.V., Sleutels, FJ.G.T., Martens, GJ.M. and Van Herp, F. (l994b) Cloning 
and expression ofmRNA encoding prepro-gonad-inhibiting hormone (GIH) in the lobster, 
Homarus americanus. FEBS Lett. 353:255-258. 
De Kleijn, D.P.V., De Leeuw, E.P.H., Van Den Berg, M.C., Martens, GJ.M. and Van 
Herp, F. (1995). Cloning and expression of two mRNAs encoding structurally different 
crustacean hyperglycemic hormone precursors in the lobster Homarns americanus. 
Biochem.Biophys. Acta 1260:62-66. 
De Kleijn, D.P.V. and Van Herp, F. (1995). Molecular biology of neurohormone 
precursors in the eyestalk of Crustacea. Comp. Biochem. Physiol. B. 112:573-579. 
Dell, S., Sedlmeier, D., Backing, D. and Dauphin-Villemant, C. (1999) Ecdysteroid 
biosynthesis in crayiish V-organs: feedback regulation by circulating ecdysteroids. Arch. 
Insect Biochem. Physiol. 41:148-155. 
Desmoucelles-Carette, c., Sellos, D. and Van Wormhoudt, A. (1996) Molecular cloning 
of the precursors of pigment dispersing hormones in crustaceans. Biochem. Biophys. Res. 
Commun. 221:739-743. 
Dircksen, H., Webster, S. and Keller, R (1988) Immunocytochemical demonstration of 
the neurosecretory systems containing putative moult-inhibiting hormone and 
hyperglycaemic hormone in the eyestalk ofbrachyuran crustaceans. Cell Tissue Res. 251: 
3-12. 
Dircksen, D. and Heyn, U. (1998) Crustacean hyperglycemic hormone-like peptides in 
crab and locust peripheral intrinsic neurosecretory cells. In: Vaudry, H., Tonon, M-C., 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Roubos, E.W. and de Loof, A (Eds.) Trends in comparative endocrinology and 
neurobiology. New York Academy of Sciences, pp. 392·394. 
Drach, P. (193.9) Mue et cycle d'intennue chez les Crustaces Decapodes. Annales de 
I 'Institut Oceanographique 19: 103·392. 
247 
Endo, H., Nagasawa, H. and Watanabe, T. (2000) Isolation of a cDNA encoding a CID-I-
family peptide from the silkwonn Bombyx mori. Insect Biochem. Mole. Bioi. 30: 355-
361. 
Fainzilber, M., Browdy, C.L., Tom, M., Lubzenz, E. and Applebaum, S. (1989) Protein 
synthesis in vitro in cultures of the subepidermal adipose tissue and the ovary of Penaeus 
semisulcatus de Haan (Crustacea, Decapoda, Penaeidae). Tissue and Cell 21:911-916. 
Fainzilber, M., Tom, M., Shafir, S., Applebaum, S.W. and Lubzens, E. (1992) Is there 
extraovarian synthesis ofvitellogenin in penaeid shrimp? Bioi. Bull. 183:233-241. 
Fernlund, P. (1976). Structure of a light-adaptinghonnone from the shrimp Pandalus 
borealis. Biochem. Biophys. Acta. 439:17-25. 
Femlund, P. and Josefsson, L. (1972). Crustacean color change honnone: amino acid 
sequence and chemical synthesis. Science 177:173-175. 
Gabe, M. (1966) Neurosecretion. International Series of Monographs in Pure and 
Applied Biology. Vol. 28. Pergammon Press, Oxford. 
Gade, G. (1996) The revolution in insect neuropeptides illustrated by the adipokinetic 
honnone/red pigment-concentrating honnone family of pep tides. Z. Naturforsch. SIc: 
607-617. 
Gade, G. (1997). The explosion of structural infonnation on insect neuropeptides. In: 
Herz, W., Kirby, G.W., Moore, R.G., Steglich, W. and Tamm, Ch. (Eds.) Progress in the 
Chemistry of Organic Natural Products. Springer, Wien, New York. 71: 1-128. 
Un
iv
r i
ty 
of 
Ca
pe
 To
wn
248 
Gade, G., Kellner, R., Rinehart, K.L. and Proefke, M.L. (1992) A tryptophan-substituted 
member of the AKHIRPCH family isolated from a stick insect corpus cardiacum. 
Biochem. Biophys. Res. Commun. 189: 1303-1309. 
Galbraith, M.N., Hom, D.H.S., Hocks, P., Schultz, G. and Hoffmeister, H. (1967) The 
identity of the 20-hydroxy-ecdysones from various sources. Chem. Commun. 1967:471-
472. 
Gasparini, S., Kiyatkin, N., Drevet, P., Boulain, J-c., Tacnet, F., Ripoche, P., Forest, E:, 
Grishin, E. and Menez, A (1994) The low molecular weight protein which co-purifies 
with a-latrotoxin is structurally related to crustacean hyperglycemic hormone. J. Bioi. 
Chem. 269: 19803-19809. 
Gaus, G., Kleinholz, L.H., Kegel, G. and Keller, R. (1990) Isolation and characterization 
of red-pigment-concentrating hormone (RPCH) from six crustacean species. J. Compo 
Physiol. B 160:373-379. 
George, R.W. and Main, AR. (1967) The evolution of spiny lobsters (Palinuridae): a 
study of evolution in the marine environment. Evolution 21 :803-820. 
Goosen, P.C. and Cockcroft, AC. (1995) Mean annual growth increments for male West 
coast rock lobster Jasus lalandii, 1969-1993. S. Afr. J. Mar. Sci. 16:377-386. 
Gorgels-Kallen, J.L., Van Herp, F. and Leuven, R.S.E.W. (1982) A comparative 
immunocytochemical investigation of the crustacean hyperglycemic hormone (CHH) in the 
eyestalks of some decapod Crustacea. J. Morphol. 174: 161-168. 
Greve, P., Sorokine, 0., Berges, T., Lacombe, c., Van Dorsselaer, A and Martin G. 
(1999) Isolation and amino acid sequence of a peptide with vitellogenesis inhibiting 
activity from the terrestrial isopod Armadillidium vulgare (Crustacea). Gen. Compo 
Endocrinol. 115:406-414. 
Griffiths, c.L. and Seiderer, J.L. (1980) Rock lobsters and mussels -limitations and 
preferences in a predator-prey relationship. J. Exp. Mar. Bioi. Ecol. 44:95-109. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
249 
Gu, P-L. and Chan, S-M. (1998) Cloning of a cDNA encoding a putative molt-inhibiting 
hormone from the eyestalk of the sand shrimp, Metapenaeus ensis. Mol. Mar. Bioi. 
Biotech. 7:214-220. 
Gu, P-L. and Chan, S.M. (1999) Cloning ofa shrimp eyestalk neuropeptide gene encoding 
for the putative gonad-inhibiting hormone. Amer. Zool. 39:26A. 
Gu, P-L., Yu, K.L. and Chan, S-M. (2000) Molecular characterization of an additional 
shrimp hyperglycemic hormone: cDNA cloning, gene organization, eJl.l'ression and 
biological assay of recombinant proteins. FEBS Lett. 472:122-128. 
Guilianini, P.G., Smullen, R.P., Bentley, M.G. and Ferrero, E.A. (1998) Cytological and 
immunocytochemical study of the sinus gland in the Norway lobster Nephrops norvegicus 
(L.).1nvert. Reprod. Dev. 33:57-68. 
Hampshire, F. and Hom, D.H.S. (1966) Structure of crustecdysone, a crustacean 
moulting hormone. Chem. Commun. 1966:37-38. 
Hansttom, B. (1939) Hormones in Invertebrates. University Oxford Press, London. 
Heydom, A.E.F. (1969) The rock lobster of the South African west coast Jasus lalandii 
(H. Milne-Edwards). 2. Population studies, behaviour, reproduction, moulting, grO\vth and 
migration. Investl. Rep. Div. Sea Fish. S. Afr. 71:1-52. 
Homola, E. and Chang, E.S. (1997) Methyl famesoate: crustacean juvenile hormone in 
search of functions. Compo Biochem. Physiol. B 117:347-356. 
Hopkins, P.M. (1983) Patterns of serum ecdysteroids during induced and uninduced 
proecdysis in the fiddler crab, Uca pugilator. Gen. Compo Endocrinol. 52:350-356. 
Huberman, A. and Aguilar, M.B. (1988) Single-step purification of two hyperglycaernic 
neurohormones from the sinus glands of Procambarus bouvieri. Comparative peptide: 
mapping by means of high-performance liquid chromatography. J. Chromatogr. 443:337-
342. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
250 
Hubennan, A, Aguilar, M.B., Bre\v, K., Shabanowitz, 1. and Hunt, D.F. (1993) Primary 
structure of the major isomorph of the crustacean hyperglycemic honnone (CHH-I) from 
the sinus gland of the Mexican crayfish Procambarus bouvieri (Ortmann): Interspecies 
comparison. Peptides 14:7-16. 
Hubennan, A, Aguilar, M.B. and Quackenbush, L.S. (1995) A neuropeptide family from 
the sinus gland of the Mexican crayfish, Procambarus bouvieri (Ortmann). Aquaculture 
135: 149-160. 
Hubennan, A Aguilar, M.B., Navarro-Quiroga, 1., Ramos, L., Fernandez, 1., White, 
F.M. and Hunt, D.F. (2000) A hyperglycemic peptide honnone from the Carribean shrimp 
Penaeus (litopenaeus) schmitti. Peptides 21:331-338. 
Jaros, P.P. and Keller, R. (1979) Immunocytochemical identification of hyperglycemic 
honnone-producing cells in the eyestalk of Carcinus maenas. Cell Tiss. Res. 204:379-
385. 
Josefsson, L. (1983). Invertebrate neuropeptide honnones. Int. J Peptide Protein Res. 
21:459-470. 
Kallen,1. (1985) The hyperglycemic honnone producing system in the eyestalk of the 
crayfish Astacus leptodactylus. Catholic University ofNijmegen, The Netherlands, 
Thesis. 
Kallen, J. and Meusy, J-1. (1989) Do the neurohonnones VIH (vitellogenesis inhibiting 
honnone) and CHH (crustacean hyperglycemic honnone) of crustaceans have a common 
precursor? Immunolocalization ofVIH and CHH in the X-organ sinus gland complex of 
the lobster, Homarus americanus.lnvert. Reprod. Dev. 16: 43-52. 
Kegel, G. Reichwein, B., Weese, S., Gaus, G., Peter-Katalinic, 1. and Keller, R. (1989) 
Amino acid sequence of the crustacean hyperglycemic honnone (CHH) from the shore 
crab, Carcinus maenas. FEBS Lett. 255:10-14. 
Kegel, G., Reichwein, B., Tensen, c., Keller, R. (1991) Amino acid sequence of 
crustacean hyperglycemic honnone (CHH) from the crayfish, Orconectes limosus: 
Emergence of a novel neuropeptide family. Peptides 12:909-913. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Keller, R (1977) Comparative electrophoretic studies of crustacean neurosecretory 
hyperglycemic and melanophore-stimulating hormones from isolated sinus glands. J 
Camp. Physiol. 122: 359-373. 
Keller, R (1992) Crustacean neuropeptides: structures, functions and comparative 
aspects. Experientia 48: 439-448. 
251 
Keller, R and Wunderer, G. (1978) Purification and amino acid composition of the 
neurosecretory hyperglycaemic hormone from the sinus gland of the shore crab Carcinus 
maenas. Gen. Camp. Endocrinol. 34:328-335. 
Keller, R, Jaros, P. and Kegel, G. (1985) Crustacean hyperglycemic neuropeptides. 
A mer. Zool. 25:207-221. 
Kerr, M.S. (1969) The hemolymph proteins of the blue crab, Callinectes sapidus. II. A 
lipoprotein serologically identical to oocyte vitellin. Dev. Bioi. 20: 1-17. 
Khayat, M., Lubzens, E., Tietz, A. and Funkenstein, B. (1994) Are vitellin and 
vitellogenin coded by one gene in the marine shrimp, Penaeus semisulcatus? J. Mol. 
Endocrinol. 12:251-254. 
Khayat, M., Yang, W-l, Aida, K., Nagasawa, H., Tietz, A., Funkenstein, B. and 
Lubzens, E. (1998) Hyperglycaemic hormones inhibit protein and rnRNA synthesis in in 
vitro-incubated ovarian fragments of the marine shrimp Penaeus semisulcatus. Gen. 
Camp. Endocrinol. 110:307-318. 
King, D.S., Meredith, J. Wang, YJ. and Phillips, lE. (1999) Biological actions of 
synthetic locust ion-transport peptide (ITP). Insect Biochem. Malec. Bio!. 29: 11-18. 
Kittaka, l and Booth, J.D. (1980) Prospectus for aquaculture. In: Spiny lobster 
management. pp. 365-373. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Klein, 1.M., De Kleijn, D.P.Y., Keller, R. and Weidemann, W.M. (1992) Molecular 
cloning of crustacean pigment dispersing hormone precursor. Biochem. Biophys. Res. 
Commun. 189:1509-1514. 
252 
Klein, 1.M., De Kleijn, D.P.V., Hiinerneyer, G., Keller, R. and Weidemann, W. (1993a) 
Demonstration of the cellular expression of genes encoding molt-inhibiting hormone and 
crustacean hyperglycemic hormone in the eyestalk of the shore crab Carcinus maenas. 
Cell Tissue Res. 274: 515-519. 
Klein, 1.M., Mangerich, S., De Kleijn, D.P., Keller, R. and Weidemann, W.M. (1993b) 
Molecular cloning of a crustacean putative molt-inhibiting hormone (MIH) precursor. 
FEBS Lett. 334:139-142. 
Klein, 1.M., Mohrherr, C.1., Sleutels, F., Riehm, J.P. and Rao, K.R. (1994) Molecular 
cloning of two pigment dispersing hormone (PDH) precursors in the blue crab, 
Callinectes sapidus, reveals a novel member of the PDH neuropeptide family. Biochem. 
Biophys. Res. Commun. 205:410-416. 
Klein, J.M., Mohrherr, CJ., Sleutels, F., Jaenecke, N., Riehm, lP. and Rao, K.R. (1995). 
A highly conserved red pigment-concentrating hormone precursor in the blue crab 
Callinectes sapidus. Biochem. Biophys. Res. Commun. 212:151-158. 
Kleinholz, L.H. and Keller, R. (1973) Comparative studies in crustacean neurosecretory 
hyperglycemic hormones. I. The initial survey. Gen. Camp. Endocrinol. 21: 554-564. 
Kleinholz, L.H. and Keller, R. (1979) Endocrine regulation in crustacea. In: Barrington, 
EJ.W. (Ed.) Hormones and Evolution. Academic Press, New York, 1: 160-213. 
Kleinholz, L.H., Rao, K.R., Riehm, J.P., Tarr, G.E., Johnson, L. and Norton, S. (1986) 
Isolation and sequence analysis of pigment dispersing hormone from eyestalks of the crab 
Cancer magister. BioI. Bull. 170: 135-143. 
Lachaise, F., Carpentier, G., Sornrne, G., Colardeau, 1. and Beydon, P. (1989). 
Ecdysteroid synthesis by crab Y -organs. J Exp. Zool. 252:283-292. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Lachaise, F., Le Roux, A, Hubert, M. and Lafont, R (1993) The molting gland of 
crustaceans: localization, activity, and endocrine control (a review). J. ernst. Bioi. 
13: 198-234. 
Lacombe, C., Greve, P. and Martin, G. (1999) Overview on the sub-grouping of the 
crustacean hyperglycemic honnone family. Neuropeptides 33:71-80. 
Laufer, H. Borst, D., Baker, F.C., Carrasco, c., Sinkus, M., Reuter, C.C., Tsai, L.W. 
and Schooley, D.A (1987) Identification of a juvenile honnone-like compound in a 
crustacean. Science235:202-205. 
253 
Laufer, H., Ahl, J.S.B. and Sagi, A (1993) The role of juvenile honnones in crustacean 
reproduction. Amer. Zool. 33:365-374. 
Laufer, H., Liu, L. and Van Herp, F. (1994) A neuropeptide family that inhibits the 
mandibular organ of Crustacea and may regulate reproduction. In: Borkovec, A B. and 
Loeb, MJ. (Eds.) Insect Neurochemistry and Neurophysiology. CRC Press, Boca Raton, 
FL. Pp. 203-206. 
Laverdure, AM., Breuzet, M., Soyez, D. and Becker, 1. (1992) Detection of the mR1\1A 
encoding vitellogenesis inhibiting honnone in neurosecretory cells of the X -organ in 
Homarus american us. Gen. Compo Endocrinol. 87:443-450. 
Lee, KJ, Elton, T.S, Bej, AK., Watts, S.A and Watson, R.D. (1995) Molecular cloning 
of a cDNA encoding putative molt-inhibiting honnone from the blue crab, Callinectes 
sapidus. Biochem. Biophys. Res. Commun. 209:1126-1131. 
Lee, KJ., Watson, RD. and Roer, R.D. (1998) Molt-inhibiting honnone mRNA levels 
and ecdysteroid titer during a molt cycle of the blue crab, Callinectes sapidus. Biochem. 
Biophys. Res. Commun. 249:624-627. 
Leuven, RS.E.W., Jaros, P.P., Van Herp, F. and Keller, R (1982) Species or group 
specificity in biological and immunological studies of crustacean hyperglycemic hormone. 
Gen. Comp. Endocrinol. 46: 288-296. 
Un
ive
rsi
ty 
of 
Ca
e T
ow
n
254 
Linck, B., Klein, J.M., Mangerich, S., Keller, R. and Weidemann, W, M. (1993), 
Molecular cloning of crustacean red pigment concentrating hormone precursor. Biochem. 
Biophys. Res. Commun. 195:807-813. 
Liu, L. and Laufer, H. (1996) Isolation and characterization of sinus gland neuropeptides 
with both mandibular organ inhibiting and hyperglycaemic effect from the spider crab 
Libinia emarginata, Arch. Insect Biochem. Physiol. 32:375-385. 
Liu, L., Laufer, H., Gogarten, PJ. and Wang, H. (l997a) cDNA cloning of a mandibular 
organ inhibiting hormone from the spider crab Libinia emarginata. Invert. Neurosci. 
3:199-204, 
Liu, L., Laufer, H., Wang, Y. and Hayes, T. (I 997b) A neurohormone regulating both 
methyl farnesoate synthesis and glucose metabolism in a crustacean, Biochem. Biophys. 
Res. Commun. 237:694-701. 
Loew, E.R (1976) Light and photoreceptor degeneration in the Norway lobster, Nephrops 
norvegicus (L.). Proc. R. Soc. Lond. Ser. B. 193:31-44. 
Lubzens, E., Ravid, T. Khayat, M., Daube, N. and Tietz, A (1997) Isolation and 
characterization of the high-density lipoproteins from the hemolymph and ovary of the 
penaeid shrimp Penaeus semisulcatus (de Haan): apoproteins and lipids. J Exp. Zoo!. 
278:339-348. 
Lyle, W.G. and MacDonald, C.D, (1983) Molt stage determination in the Hawaiian spiny 
lobster Panulirus marginatus, J Crust. Bioi. 3:208-216. 
Mancillas, J .R., McGinty, J ,F., Selverston, AI., Karten, H. and Bloom, F .E. (1981) 
lrnmunocytochemicalloca1ization of enkephalin and substance P in retina and eyestalk 
neurones oflobster. Nature 293:576-578, 
Martin, G., Sorokine, 0, and Van Dorsselaer, A (1993) Isolation and molecular 
characterization of a hyperglycemic neuropeptide from the sinus gland of the terrestrial 
isopod Armadillidium vulgare (Crustacea). Eur. J Biochem. 211:601-607, 
Un
ive
r i
ty 
of 
Ca
pe
 To
wn
McCullum, M.L., Rao, K.R., Riehm, 1.P., Mohrherr, C.J. and Morga, W.T. (1991) 
Primary structure and relative potency of an analog of ~·PDH (pigment dispersing 
hormone) from the crayfish, Procambarus clarkii. Pigment Cell. Res. 4:201-208. 
Meredith, 1., Ring, M., Macinis, A., Marshall, l, Cheng, N.N., Theilmann, D. Brock, 
H.W. and Phillips, lE. (1996) Locust ion transport peptide: (ITP): primary structure, 
cDNA and e}.'Pression in a baculovirus system. J. Exp. BioI. 199: 1053-1061. 
Meusy, J-1., Martin, G., Soyez, D., Van Deijnen, 1.E. and Gallo, J·M. (1987) 
Immunochemica1 and immunocytochemical studies of the crustacean vitellogenesis-
inhibiting hormone (VIH). Gen. Compo Endocrinol. 67: 333·341. 
255 
Meusy, J.1. and Payen, G.G. (1988) Female reproduction itn malacostraca crustacea. Zool. 
Sci. 5:217·265. 
Meusy, J.J. and Soyez, D. (1991) Immunological relationships between neuropeptides 
from the sinus gland of the lobster Homarus americanus, \\ith special references to the 
vitellogenesis inhibiting hormone and crustacean hyperglycaemic hormone. Gen. Compo 
Endocrinol. 81: 410-418. 
Mohrherr, C.1., Rao, K.R. and Riehm, J.P. (1991) Characterization of a pigment-
dispersing factor from the American cockroach. Soc. Neurosci. Abstr. 17:276. 
Mohrherr, C.J., Maruska, K., Raabe, M., Riehm, J.P. and Rao, K.R. (1994) Primary 
structure of a pigment-dispersing factor from the stick insect, Carausius morosus. Soc. 
Neurosci. Abstr. 20:914. 
Mordue, W. and Stone, 1.V (1976) Comparison of the biological activities of an insect 
and a crustacean neurohormone that are structurally similar. Nature 264:287-289. 
Morris, 1.F., Nordmann, J.1. and Dyball, R.E.1. (1978) Structure-function correlation in 
mammalian neurosecretion. Int. Rev. Expt!. Patho!. 18: 1·95. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
256 
Nagasa\va, H., Yang, W.J., Shimizu, H., Aida, K., Tsutsumi, H., Terauchi, A and Sonobe. 
H. (1996) Isolation and amino acid sequence of a molt-inhibiting hormone from the American 
crayfish, Procambarus clarkii. Biosei. Biotechnol. Bioehem. 60:554-556. 
Newcomb, R.W. (1987) Amino acid sequence ofneuropeptides in the sinus gland of the land 
crab Cardisoma carnifex: a novel neuropeptide proteolysis site. J. Neurochem. 49:574-583. 
Ohira, T., Watanabe,T, Nagasawa, H. and Aida, K. (1997a) Cloning and sequence analysis 
of a cDNA encoding a crustacean hyperglycemic hormone from the Kuruma pra\\'n Penaeus 
japonicus. Mol. Mar. BioI. Biotechnol. 6:59-63. 
Ohira, T, Watanabe, T, Nagasawa, H. and Aida, K. (l997b) Molecular cloning of a molt-
inhibiting hormone cDNA from the Kuruma pravm Penaeus japonicus. Zoo!. Sci. 14:785-
789. 
Ohira, T, Nishimura, T., Sonobe, H., Okuno, A, Watanabe, T., Nagasawa, H., Kawazoe, I. 
And Aida, K. (1999) Expression of a recombinant molt-inhibiting hormone of the Kuruma 
pra\\-n Penaeus japonicus in Eschericia coli. Biosci. Biotechnol. Biochem. 63: 1576-1581. 
O'Shea, M. and Rayne, R.C. (1992). Adipokinetic hormones: cell and molecular biology. 
Experentia 48:430-438. 
Passano, L.M. (1953) Neurosecretory control of molting in crabs by the X-organ sinus gland 
complex. Physiol. Compo Gecol. 3:155-189. 
Paterson, N.F. (1968) The anatomy of the Cape Rock lobster, Jasus lalandii (H. Milne-
Edwards). Annals of the South African Museum 51: 1-232. 
Phillips, RF., Cobb, 1.S. and George, R.W. (1980) I. General Biology. In: Cobb, 1.S. and 
Phillips, RF. (Eds.) The Biology and Management of Lobsters. Vol. 1. Academic Press, New 
York. pp. 2-82. 
Phillips, J.E., Meredith, 1., Audsley, N., Ring, M., Macinis, A, Brock, H., Thielmann, D. and 
Littleford, D. (1998) Locust ion transport peptide (ITP): function, structure, cDNA and 
expression. In: Coast, G.M. and Webster, S.G. (Eds.) Recent Advances in Arthropod 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
Endocrinology. Cambridge, MA: Cambridge University Press; Society for Experimental 
Biology Seminar Series 65. pp. 210-226. 
Phillips, I.M., Rao, K.R., Riehm,lP. and Morgan, W.T. (1988) Isolation and 
characterization of a pigment-dispersing honnone from the shrimp Penaeus aztecus. Soc. 
Neurosci. Abstr. 14:534. 
Pollock, D.E. (1986) Review of the fishery for and biology of the care rock lobster Jasus 
lalandii -with notes on larval recruitment. Can. J Fish. Aquat. Sci. 43:2107-2117. 
257 
Porcheron, P., Foucrier, 1., Gros, C., Pradelles, P., Cassier, P. and Dray, F. (1976) 
Radioimmunoassay of arthropods moulting honnone: ~-ecdysone antibodies production and 
125I-iodinated tracer preparation. FEBS Lett. 61:159-162. 
Porcheron, P., Moriniere, M., Grassi, 1. and Pradelles, P. (1989) Development of an enzyme 
immunoassay for ecdysteroids using acetylcholinesterase as label. Insect Biochem. 19: 117-
122. 
Quackenbush, L.S. (1989) Yolk protein production in the marine shrimp Penaeus vannamei. 
J. Crust. Biol. 9:509-516. 
Quackenbush, L.S. (1999) Yolk synthesis in the marine shrimp Penaeus vannamei. Amer. 
Zool. 39:87A. 
Raina, A.K. and Gade, G. (1988) Insect peptide nomenclature. Insect Biochem. 18:785-789. 
Rao, K.R. and Riehm, J.P. (1988). Pigment-dispersing honnones: A novel family of 
neuropeptides from arthropods. Peptides 9:153-159. 
Rao, K.R. and Riehm, I.P. (1989) The pigment-dispersing honnone family: chemistry, 
structure-activity relations, and distribution. BiOI. Bull. 177:225-229. 
Rao, K.R. and Riehm, J.P. (1993) Pigment-dispersing honnones. In: The Melanotropic 
Peptides. Ann. NY Acad. Sci. 680:78-88. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
258 
Rao, K.R., Riehm, J.P, Zahnow, C.A., Kleinholz, L.H. Tarr, G.E., Johnson, L., Norton, S., 
Landau, M., Sennnes, OJ., Sattelberg, R.M., Jorenby, W.H. and Hintz, M.F. (1985). 
Characterization of a pigment-dispersing hormone in eyestalks of the fiddler crab Uca 
pugilator. Proc. Natl. Acad. Sci. USA. 82:5319-5322. 
Rao, K.R., Mohrherr, C.I, Riehm, IP., Zahnow, C.A., Norton, S., Johnson, L. and Tarr, 
G.E. (1987). Primary structure of an analog of crustacean pigment-dispersing hormone from 
the lubber grasshopper Romalea microptera. J. BioI. Chem. 262:2672-2675. 
Rao, K.R., Kleinholz, L.H. and Rhiem, J.P. (1989) Characterization of three forms of 
pigment-dispersing hormone from the shrimp Panda Ius jordani. Soc. Neurosci. Abstr. 
15:26. 
Reddy, C.S.D., Ragbupathi, M., Puroshothanz, V.R. and Naidu, B.P. (1981) Daily rhythms 
in levels of blood glucose and hepatopancreas glycogen in the fresh water field crab 
Oziotelphusa senex senex (Fabricius). Ind. J. Exp. Bioi. 19:403-404. 
Rodbard, D.W., Bridson, W. and Rayford, P. (1969) Rapid calculation ofradioinnnunoassay 
results. J. Lab. Clin. Med. 74:770-776. 
Rotllant, G. De Kleijn, D., Charmantier-Daures, M. Charmantier, G. and Van Herp, F. 
(1993) Localization of crustacean hyperglycemic hormone (CHH) and gonad-inhibiting 
hormone in the eyestalk of Homarus gammarus larvae by innnunocytochemistry and in situ 
hybridization. Cell Tiss. Res. 271:507-512. 
Sandeen, M.I. (1950) Chromatophorins in the central nervous system of Uca pugilator, with 
special reference to their origins and actions. Physiol. Zool. 23:337-352. 
Scharrer, B. (1990) The neuropeptide saga. Amer. Zool. 30: 887-895. 
Scharrer, E. and Scharrer, B. (1945) Neurosecretion. Physiol. Rev. 12:171-181. 
Sedlmeier, D. (1985) Mode of action of the crustacean hyperglycaemic hormone. Amer. Zool. 
25:223-232. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
259 
Sedlmeier, D. (1988) The crustacean hyperglycemic hormone (CHH) releases amaylase 
from the crayfish midgut gland. Regul Peptides 20:91-98. 
Sefiani, M.,.Le Caer, J-P. and Soyez, D. (1996) Characterization of hyperglycemic and 
molt-inhibiting activity from sinus glands of the penaeid shrimp Pennaeus vannamei. Gen. 
Compo Endocrinol. 103:41-53. 
Shafir, S., Tom, M~, Ovadia, M. and Lubzens, R (1992) Protein, vitellogenin and vitellin 
levels during ovarian development in Penaeus semisulcatus (de Haan). Bio!. Bull. 
183:394-400. 
Shih, T-W., Suzuki, Y, Nagasawa, H. and Aida, K. (1998) Immunohistochemical 
identification of hyperglycemic hormone- and molt-inhibiting hormone-producing cells in 
the eyestalk of the Kuruma prawn, Penaeus japon/cus. "Zool. Sci. 15:389-397. 
Shlagman, A., Lewinsohn, C. and Tom, M. (1986) Aspec:ts of the reproductive activity of 
Penaeus semisulcatus (de Haan) along the southeastern coast of the Mediterranean. Mar. 
Ecol. 7:15-22. 
Sithigorngul, W., Jaideechoey, S., Saraithongkum, W., Longyant, S. and Sithigorngul, P. 
(1999a) Purification and characterization of an isoform of crustacean hyperglycemic 
hormone from the eyestalk of Machrobrachium rosenbergii. J. Exp. Zool. 284:217-224. 
SithigornguI, P., Panchan, N., Vilvaivan, T., Sithigorngul, W. and Petsom, A. {l999b) 
Immunocytochemical analysis and immunocytochemical localization of crustacean 
hyperglycemic hormone from the eyestalk of Machrobrachium rosenbergii. Compo 
Biochem. Physiol. B. 124:73-80. 
Smith, W.A. and Sedlmeier, D. (1990) Neurohormonal control of ecdysone production: 
comparison of insects and crustaceans. Invert. Reprod. Dev. 18:77-89. 
Sonobe, H. Kamba, M., Ohta, K., Ikeda, M. and Naya, Y. (1991) In vitro secretion of 
ecdysteroids by Y-organs of the crayfish, Procambarus clarkii. Experientia 47:948-952. 
Un
ive
rsi
ty 
of 
C
p
 To
wn
260 
Soumoff, C and O'Connor, ID. (1982) Repression ofY-organ activity by molt-inhibiting 
hormone in the crab Pachygrapsus crassipes. Gen. Compo Endocrinol. 48:432-439. 
Soyez, D., Van Deijnen, IE. and Martin, M. (1987). Isolation and characterization ofa 
vitellogenesis-inhibiting factor from sinus glands of the lobster Homarus americanus. J 
Exp. Zool. 224:479-484. 
Soyez, D., Noel, P.Y., Van Deijnen, IE., Martin, M., Morel, A. and Payen, G.G. (1990) 
Neuropeptides from the sinus gland of the lobster Hoamrus americanus: characterization 
of hyperglycemic peptides. Gen. Compo Endocrinol. 76:261-274. 
Soyez, D., Le Caer, IP., Noel, P.Y. and Rossier, I (1991) Primary structure oft\vo 
isoforms of the vitellogenesis-inhibiting hormone from the lobster Homarus americanus. 
Neuropeptides 20:25-32. 
Soyez, D., Van Herp, F., Rossier, I, Le Caer, J-P., Tensen, CP. and Lafont, R. (1994) 
Evidence for a conformational polymorphism of invertebrate neurohormones. J Bio!. 
Chem. 269: 18295-18298. 
Spaziani, E. (1990) Morphology, histology, and ultrastructure of the ecdysial gland (Y-
organ) in Crustacea. Vol. I, Part 2, Embryonic and post-embryonic sources. In: Gupta, 
A.P. (Ed.) Morphogenetic hormones of arthropods. Rutgers U. Press, New Brunswick. 
pp. 233-267. 
Spaziani, E., Rees, H.H., Wang, W.L. and Watson, R.D. (1989) Evidence that Y-organs 
of the crab Cancer antennarius secrete 3-dehydroecdysone. Mol. Cell. Endocrinol. 
66:17-25. 
Sun, P .S. (1994) Molecular cloning and sequence analysis of a cDNA encoding a molt-
inhibiting hormone-like neuropeptide from the white shrimp Penaeus vannamei. Mol. 
Mar. Bioi. Biotechnol. 3: 1-6. 
Tang, C, Lu, W. Wainwright, G., Webster, S.G., Rees, H.H. and Turner, P. Molecular 
characterization and expression of mandibular organ-inhibiting hormone, a recently 
Un
ive
r i
t  
of 
Ca
pe
 To
wn
261 
discovered neuropeptide involved in the regulation of growth and reproduction in the crab 
Cancer pagurus. Biochem. J 343:355-360. 
Tensen, C.P., Janssen, KP.C. and Van Herp, F. (1989) Isolation, characterization and 
physiological specificity of the crustacean hyperglycemic factors from the sinus gland of 
the lobster Homarus americanus (Milne-Edwards). Invert. Reprod. Dev. 16: 155-164. 
Tensen, c.P., De Kleijn, D.P.V., and Van Herp, F. (l991a) Cloning and sequence 
analysis of cDNA encoding two crustacean hyperglycemic hormones from the lobster 
Homarus americanus. Eur. J Biochem. 200:103-106. 
Tensen, c.P., Verhoeven, A.RM., Gaus, G., Janssen, KP.C., Keller, R and Van Herp 
(1991 b) Isolation and amino acid sequence of crustacean hyperglycemic hormone 
precursor-related peptides. Peptides 12:673-681. 
Terauchi, A. Tsutsumi, R, Yang, W-J., Aida, K, Nagasawa, R and Sonobe, H. (1996) 
A novel neuropeptide with molt-inhibiting activity from the sinus gland of the crayfish, 
Procambarus clarkii. Zool. Sci. 13:295-298. 
Thurn,. M.l and Hall, M.R (1999) Ovarian function in the giant tiger prawn (Penaeus 
monodon) as determined by in vitro bioassay. Physiol. Biochem. Zool. 72:588-596. 
Udomkit, A., Choduck, S., Sonthayanon, B. and Panyim, S. (2000) Molecular cloning of 
. a cDNA encoding a member of ClllIIMlli/GIH family from Penaeus monodon and 
analysis of its gene structure. J Exp. Mar. Biol. Ecol. 244:145-156. 
Umphrey, H.R, Lee, KJ., Watson, RD. and Spaziani, E. (1998) Molecular cloning of a 
eDNA encoding molt-inhibiting hormone of the crab, Cancer magister. Mol. Cell. 
Endocrinol. 136:145-149. 
Van Deijnen, J.E., Vek, F and Van Herp, (1985) An immunocytochemical study of the 
optic ganglia of the crayfish Astacus leptodactylus (Nordmann 1842) with antisera 
against biologically active peptides of vertebrates and invertebrates. Cell Tiss. Res. 
240:175-183. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
262 
Van Herp, F. (1998) Molecular, cytological and physiological aspects of the crustacean 
hyperglycaernic hormone family. In: Coast, G.M., Webster, S.G. (Eds.) Recent advances 
in arthropod endocrinology. Cambridge Univ. Press; Cambridge. Society/or 
Experimental Biology Seminar Series 65:53-70. 
Van Herp, F. and Soyez, D. (1997) 8. Arthropoda - Crustacea. In: Adiyodi, K.G. and 
Adiyodi, R.G. (Eds.) Progress in reproductive Endocrinology. Series: Reproductive 
Biology o/Invertebrates. VoL VIII (Series Ed.: T.S. Adams). Oxford and IBH Publishing 
Co., New Delhi. pp.247-275. 
Von Gliscynslci, U., Delbecque, J-P., Bocking, D., Sedhneier, D., Dircksen, H. and 
Lafont, R. (1995) Three new antisera with high sensitivity to ecdysone, 3-
dehydroecdysone and other A-ring derivatives: production and characterization. Eur. J 
Eniomol.92:75-79. 
Wainwright, G., Webster, S.G., Wilkinson, M.C., Chung, J.S. and Rees, H.H. (1996) 
Structure and significance of mandibular organ-inhibiting hormone in the crab, Cancer 
pagurus. J BioI. Chem. 271: 12749-12754. 
Webster, S.G. (1986). Neurohormonal control ofecdysteroid biosynthesis by Carcinus 
maenas Y-organs in vitro, and preliminary characterization of the putative molt-inhibiting 
hormone (MIH). Gen. Compo Endocrinol. 61 :237-247. 
Webster, S.G. (1991) Amino acid sequence of a putative moult-inhibiting hormone from 
the crab Carcinus maenas. Proc. R Soc. Lond. [B} 244:247-252. 
Webster, S.G. (1993) High-affinity binding of a putative moult-inhibiting hormone (MIH) 
and crustacean hyperglycaemic hormone (CHH) to membrane-bound receptors on the y-
organ of the shore crab Carcinus maenas. Proc. R. Soc. Land. B. 251:53-59. 
Webster, S.G. (1998) Neuropeptides inhibiting growth and reproduction in crustaceans. 
In: Coast, G.M. and Webster, S.G. (Eds.) Recent Advances in Arthropod Endocrinology. 
Cambridge, MA: Cambridge University Press; Society for Experimental Biology Seminar 
Series 65. pp. 33-52. 
Un
ive
rsi
ty 
f C
ap
e T
ow
n
263 
Webster, S.G. and Chung, J.S. (1999) Roles ofmoult-inbibiting hormone and crustacean 
hyperglycemic hormone in controlling moulting in decapod crustaceans. In: Roubos, E.W., 
Wendelaar Bonga, S.B., Vaudry, H., De Loof, A. (Eds.). Recent Developments in 
Comparative EndOCrinology and Neurobiology. Shaker; Maastricht, pp. 213-216. 
Webster, S.G. and Keller, R. (1986) Purification, characterization and amino acid 
composition of the putative moult-iribibiting hormone (MIH) of Carcinus maenas (Crustacea, 
Decapoda). J. Compo Phys/ol. 156:617-624. 
Webster, S.G., Dircksen, H. and Chung, J.S. (2000) Endocrine cells in the gut of the shore 
crab Care/nus maenas immunoreactive to crustacean hyperglycaemic hormone and its 
precursor-related peptide. Cell Tiss. Res. 300:193-205. 
Weidemann, W., Gromoll, J. and Keller R. (1989) Cloning and sequence analysis of eDNA 
for precursor of a crustacean hyperglycemic hormone. FEBS Lett 257:31-34. 
Wilcockson, D.C., Chung, J.S. and Webster, S.G. (1998) The crustacean hyperglycemic 
hormone precursor-related peptide (CPRP) of the edible crab, Cancer pagurus - structure, 
localisation and progress towards identifYing its functions. Conf. Proceedings of 1 flh 
Conforence oJEuropean Comparative Endocrinologists p.78. 
Willig, A. and Keller, R. (1973) Molting hormone content, cuticle growth and gastrolith 
growth in the molt cycle of the crayfish Orconectes limosus. J. Camp. Physiol. 86:377-388. 
Yang, W.J., Aida, K and Nagasawa, H. (1995) Amino acid sequences ofa hyperglycaemic 
hormone and its related peptides from the Kuruma prawn, Penaeus japonicus. Aquaculture 
135:205-212. 
Yang, W-J., Aida, K., Terauchi, A., Sonobe, H. and Nagasawa, H. (1996) Amino acid 
sequence of a peptide with molt iribibiting activity from Kuruma prawn Penaeus japonicus. 
Peptides 17:197-202. 
Yang, WJ., Aida, K. and Nagasawa, H. (1997) Amino acid sequences and activities of 
multiple hyperglycemic hormones from the Kuruma prawn, Penaeus japonicus. Peptides 
18:479-485. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
264 
Yang, W -J., Aida, K. and Nagasawa, H. (1999) Characterization of chromatophorotropic 
neuropeptides from the Kuruma pravvn Penaeus japonicus. Gen. Compo Endocrinol. 
114:415-424. 
Yasuda, A. (1997) Structural variants of CHH family: occurrence of genetic variants and 
posttranslationally modified variants. Conference Proceedings of XlII International 
Congress of Comparative Endocrinology, Yokohama, Japan, pp. 57-62. 
Yasuda, A., Yasuda, W., Fujita, T. and Naya, Y. (1994) Characterization of crustacean 
hyperglycemic hormone from the crayfish (Procambarus clarkii): Multiplicity of 
molecular forms by stereoinversion and diverse function. Gen. Compo Endocrinol. 
95:387-398. 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
